BackgroundUsing O +
antibodies O +
to O +
specific O +
protein O +
antigens O +
is O +
the O +
method O +
of O +
choice O +
to O +
assign O +
and O +
identify O +
cell O +
lineage O +
through O +
simultaneous O +
analysis O +
of O +
surface O +
molecules O +
and O +
intracellular O +
markers O -
. O +

Embryonic O +
stem O +
cell O +
research O +
can O +
be O +
benefited O +
from O +
using O +
antibodies O +
specific O +
to O +
transcriptional O +
factors O -
/ O -
markers O +
that O +
contribute O +
to O +
the O +
" O -
stemness O -
" O +
phenotype O +
or O +
critical O +
for O +
cell O +
lineage O -
. O +

ResultsIn O +
this O +
report O -
, O +
we O +
have O +
developed O +
and O +
validated O +
antibodies O +
( O -
either O +
monoclonal O +
or O +
polyclonal O -
) O +
specific O +
to O +
human O +
embryonic O +
stem O +
cell O +
antigens O +
and O +
early O +
differentiation O +
transcriptional O +
factors O -
/ O -
markers O +
that O +
are O +
critical O +
for O +
cell O +
differentiation O +
into O +
definite O +
lineage O -
. O +

ConclusionThese O +
antibodies O +
enable O +
stem O +
cell O +
biologists O +
to O +
conveniently O +
identify O +
stem O +
cell O +
characteristics O +
and O +
to O +
quantitatively O +
assess O +
differentiation O -
. O +

Although O +
the O +
stem O +
cell O +
concept O +
was O +
introduced O +
decades O +
ago O -
, O +
to O +
date O -
, O +
stem O +
cells O +
can O +
only O +
be O +
defined O +
functionally O -
, O +
not O +
morphologically O +
or O +
phenotypically O -
. O +

Two O +
functions O +
define O +
stem O +
cells O -
. O +

Firstly O -
, O +
they O +
are O +
self O -
- O -
renewing O -
, O +
thus O +
able O +
to O +
propagate O +
to O +
generate O +
additional O +
stem O +
cells O -
. O +

Secondly O +
they O +
can O +
differentiate O +
into O +
various O +
progenitor O +
cells O -
, O +
which O +
commit O +
to O +
further O +
maturation O +
along O +
a O +
specific O +
lineage O -
. O +

While O +
stem O +
cells O +
can O +
be O +
best O +
defined O +
functionally O -
, O +
a O +
good O +
number O +
of O +
molecular O +
markers O +
have O +
been O +
used O +
to O +
prospectively O +
identify O +
various O +
stem O +
cell O +
populations O -
. O +

Although O +
the O +
functional O +
importance O +
of O +
many O +
of O +
these O +
antigens O +
remains O +
unknown O -
, O +
their O +
unique O +
expression O +
pattern O +
and O +
timing O +
of O +
expression O +
provide O +
a O +
useful O +
tool O +
for O +
scientists O +
to O +
identify O +
as O +
well O +
as O +
isolate O +
stem O +
cells O -
. O +

Embryonic O +
stem O +
cells O +
( O -
ESC O -
) O -
, O +
derived O +
from O +
the O +
inner O +
cell O +
mass O +
of O +
pre O -
- O -
implantation O +
embryos O -
, O +
have O +
been O +
recognized O +
as O +
the O +
earliest O +
stem O +
cell O +
population O +
[ O -
1,2 O -
] O -
. O +

This O +
pluripotent O +
population O +
can O +
differentiate O +
into O +
all O +
somatic O +
tissue O +
including O +
germ O +
cells O -
. O +

In O +
the O +
case O +
of O +
human O +
ESC O -
, O +
they O +
can O +
differentiate O +
into O +
some O +
extra O -
- O -
embryonic O +
derivatives O +
as O +
well O -
. O +

Like O +
mouse O +
ESC O -
, O +
human O +
ES O +
cells O +
can O +
be O +
maintained O +
and O +
propagated O +
on O +
mouse O +
fibroblast O +
feeders O +
for O +
extended O +
periods O +
in O +
media O +
containing O +
basic O +
fibroblast O +
growth O +
factor O +
( O -
bFGF O -
) O +
[ O -
3 O -
] O -
. O +

Gene O +
expression O +
of O +
undifferentiated O +
human O +
ES O +
cells O +
has O +
been O +
investigated O +
among O +
several O +
ES O +
cell O +
lines O +
by O +
a O +
variety O +
of O +
techniques O -
. O +

They O +
include O +
comparison O +
with O +
databases O -
, O +
reverse O +
transcriptase O -
- O -
polymerase O +
chain O +
reaction O -
, O +
focused O +
cDNA O +
microarrays O -
, O +
and O +
immunocytochemistry O -
. O +

A O +
list O +
of O +
molecules O +
comprised O +
of O +
known O +
ES O -
- O -
specific O +
or O +
-highly O +
expressed O +
genes O +
and O +
candidates O +
that O +
can O +
serve O +
as O +
markers O +
for O +
human O +
ESCs O +
and O +
may O +
also O +
contribute O +
to O +
the O +
" O -
stemness O -
" O +
phenotype O +
has O +
been O +
established O +
[ O -
3 O -
- O -
11 O -
] O -
. O +

For O +
example O -
, O +
pluripotent O +
ESC O +
can O +
be O +
characterized O +
by O +
high O +
level O +
expression O +
of O +
Oct3 O -
/ O -
4 O +
( O -
POU O +
domain O -
, O +
class O +
5 O -
, O +
transcription O +
factor O +
1 O -
, O +
Pou5f1 O -
) O +
and O +
Nanog O -
, O +
which O +
are O +
a O +
member O +
of O +
POU O +
domain O +
and O +
homeobox O +
transcription O +
factors O +
respectively O -
. O +

A O +
critical O +
amount O +
of O +
Oct3 O -
/ O -
4 O +
and O +
Nanog O +
expression O +
is O +
required O +
to O +
sustain O +
stem O -
- O -
cell O +
pluripotency O +
and O +
both O +
of O +
these O +
markers O +
are O +
downregulated O +
as O +
cells O +
differentiate O +
in O +
vitro O +
and O +
in O +
vivo O +
[ O -
4 O -
- O -
9 O -
] O -
. O +

Antibodies O +
to O +
Oct3 O -
/ O -
4 O +
which O +
cross O +
react O +
with O +
human O +
Oct O +
3 O -
/ O -
4 O +
have O +
been O +
widely O +
used O +
to O +
monitor O +
the O +
presence O +
of O +
undifferentiated O +
ESC O -
. O +

No O +
single O +
marker O +
however O +
is O +
sufficient O +
or O +
unique O +
for O +
identifying O +
ESCs O -
. O +

Oct3 O -
/ O -
4 O +
for O +
example O +
is O +
expressed O +
by O +
germ O +
cells O +
and O +
may O +
be O +
expressed O +
by O +
specific O +
populations O +
later O +
in O +
development O -
. O +

Likewise O -
, O +
Nanog O +
has O +
been O +
shown O +
to O +
express O +
in O +
other O +
tissues O -
. O +

We O +
and O +
other O +
have O +
noted O +
however O -
, O +
that O +
while O +
no O +
single O +
marker O +
is O +
sufficient O +
a O +
constellation O +
of O +
positive O +
and O +
negative O +
markers O +
can O +
in O +
concert O +
unambiguously O +
allow O +
one O +
to O +
define O +
the O +
state O +
of O +
ESC O +
cultures O +
and O +
that O +
surface O +
markers O +
in O +
combination O +
can O +
be O +
used O +
to O +
prospectively O +
sort O +
for O +
ESC O -
. O +

Based O +
on O +
published O +
data O +
at O +
the O +
level O +
of O +
gene O +
expression O -
, O +
we O +
have O +
cloned O +
a O +
number O +
of O +
candidate O +
marker O +
genes O -
. O +

We O +
have O +
also O +
expressed O +
the O +
recombinant O +
protein O +
and O +
generated O +
a O +
panel O +
of O +
monoclonal O +
or O +
polyclonal O +
antibodies O +
to O +
these O +
proteins O -
. O +

Using O +
these O +
antibodies O +
we O +
have O +
confirmed O +
the O +
specificity O +
and O +
selectivity O +
of O +
these O +
antibodies O +
on O +
several O +
ESC O +
lines O +
and O +
established O +
their O +
utility O +
as O +
stem O +
cells O +
markers O -
. O +

Our O +
results O +
confirm O +
the O +
expression O +
pattern O +
and O +
timing O +
of O +
these O +
cell O +
markers O +
at O +
the O +
protein O +
level O -
, O +
whereas O +
previous O +
data O +
reported O +
at O +
the O +
level O +
of O +
gene O +
expression O -
. O +

Characterization O +
of O +
undifferentiated O +
human O +
ES O +
cells O +
and O +
differentiated O +
EBs O +
by O +
antibodiesAll O +
monoclonal O +
antibodies O +
were O +
initially O +
selected O +
for O +
their O +
abilities O +
to O +
recognize O +
recombinant O +
proteins O +
in O +
direct O +
ELISAs O -
. O +

A O +
subset O +
were O +
also O +
tested O +
by O +
Western O +
Blot O +
analysis O +
using O +
recombinant O +
proteins O +
and O +
cell O +
lysate O +
to O +
confirm O +
binding O +
to O +
a O +
single O +
epitope O -
. O +

The O +
best O +
clone O +
was O +
later O +
screened O +
for O +
its O +
applications O +
for O +
immunocytochemistry O +
and O +
flow O +
cytometry O +
using O +
various O +
cell O +
lines O -
. O +

Human O +
peripheral O +
blood O +
platelets O +
were O +
used O +
for O +
screening O +
mouse O +
anti O -
- O -
human O +
CD9 O +
antibody O -
. O +

MCF-7 B-CellLine +
cells O +
were O +
used O +
for O +
screening O +
mouse O +
anti O -
- O -
human O +
E O -
- O -
Cadherin O +
and O +
PODXL O +
( O -
podocalyxin O -
- O -
like O -
) O +
antibodies O -
. O +

MG-63 B-CellLine +
cells O +
were O +
used O +
for O +
screening O +
mouse O +
anti O -
- O -
human O +
GATA1 O +
( O -
GATA O +
binding O +
protein O +
1 O -
) O +
antibody O -
. O +

Beta B-CellLine -
- I-CellLine -
TC6 I-CellLine +
cells O +
were O +
used O +
for O +
screening O +
for O +
mouse O +
anti O -
- O -
human O -
/ O -
mouse O +
PDX-1 O +
( O -
pancreatic O +
duodenal O +
homeobox-1 O -
) O +
antibody O -
. O +

NTERA-2 B-CellLine +
cells O +
were O +
used O +
for O +
screening O +
mouse O +
anti O -
- O -
human O +
Oct3 O -
/ O -
4 O +
and O +
SOX2 O +
( O -
sex O -
- O -
determining O +
region O +
Y O -
- O -
box O +
2 O -
) O +
antibodies O -
. O +

All O +
polyclonal O +
antibodies O +
were O +
affinity O -
- O -
purified O +
using O +
recombinant O +
proteins O +
and O +
validated O +
by O +
direct O +
ELISAs O +
and O +
Western O -
. O +

Caco-2 B-CellLine +
cells O +
were O +
used O +
for O +
validation O +
of O +
goat O +
anti O -
- O -
human O +
GATA6 O +
antibody O +
and O +
NTERA-2 B-CellLine +
cells O +
were O +
used O +
for O +
validation O +
of O +
goat O +
anti O -
- O -
human O +
Nanog O +
and O +
anti O -
- O -
human O +
Oct3 O -
/ O -
4 O +
antibodies O +
( O -
Summarized O +
in O +
Table O +
1 O -
) O -
.Table O +
1Summary O +
list O +
of O +
antibody O +
verification O +
by O +
western O +
blot O -
. O +

AntibodySample O +
used O +
for O +
analysisMol O -
. O +

Wt O -
. O +

( O -
KD O -
) O -
Gt O +
× O +
hBrachyurymouse O +
ES O -
- O -
derived O +
EB O +
lysate48Ms O +
× O +
hDPPA5N O -
/ O -
AN O -
/ O -
AGt O +
× O +
hGATA6Caco2 O +
cell B-CellLine +
lysate65Gt O +
× O +
hNanogNTERA-2 O +
cell O +
lysate33Gt O +
× O +
hOct O +
3 O -
/ O -
4NTERA-2 O +
cell O +
lysate39Gt O +
× O +
hPDX1beta O -
- B-CellLine -
TC I-CellLine +
6 I-CellLine +
cell O +
lysate32Gt O +
× O +
hSOX17mouse O +
ES O -
- O -
derived O +
EB O +
lysate45Ms O +
× O +
hCD9PBMC25Rt O +
× O +
hGATA-1N O -
/ O -
AN O -
/ O -
AMs O +
× O +
hE O -
- O -
CadherinMCF-7 O +
cell B-CellLine +
lysate97Ms O +
× O +
hPODXLMCF-7 O +
cell B-CellLine +
lysate57Ms O +
× O +
hSOX2NTERA-2 O +
cell O +
lysate36N O -
/ O -
A O -
: O +
1 O -
. O +

DPPA5 O +
is O +
still O +
being O +
subcloned O -
. O +

Only O +
Elisa O +
verification O +
is O +
available.2 O -
. O +

The O +
clone O +
for O +
GATA-1 O +
( O -
MAB1779 O -
) O +
does O +
not O +
work O +
for O +
Western O +
blot O +
application O +
but O +
is O +
useful O +
for O +
IHC O -
, O +
The O +
clone O +
picked O +
for O +
Western O +
blot O +
analysis O +
does O +
not O +
work O +
for O +
IHC O +
( O -
MAB17791 O -
, O +
see O +
data O +
in O +
) O -
.After O +

antibodies O +
were O +
validated O +
in O +
direct O +
ELISAs O -
, O +
Western O +
blot O +
or O +
cell O +
lines O +
( O -
Fig. O +
1 O +
and O +
data O +
not O +
shown O -
) O -
, O +
they O +
were O +
used O +
to O +
examine O +
the O +
expression O +
of O +
individual O +
molecules O +
in O +
undifferentiated O +
human O +
ES O +
cells O +
and O +
differentiated O +
EBs O -
. O +

When O +
examined O +
by O +
immunohistochemistry O -
, O +
high O +
level O +
of O +
expressions O +
of O +
Oct3 O -
/ O -
4 O -
, O +
SOX2 O -
, O +
E O -
- O -
Cadherin O -
, O +
PODXL O +
and O +
Nanog O +
were O +
observed O +
in O +
undifferentiated O +
human O +
ES O +
cells O +
( O -
Fig. O +
2A O -
, O +
2B O +
and O +
2C O -
) O -
. O +

DPPA5 O +
( O -
developmental O +
pluripotency O +
associated O +
5 O -
) O +
expression O +
was O +
also O +
observed O +
in O +
undifferentiated O +
human O +
ES O +
cells O +
( O -
data O +
not O +
shown O -
) O -
. O +

We O +
noted O +
that O +
a O +
subset O +
of O +
the O +
proteins O +
used O +
were O +
membrane O +
bound O +
proteins O -
. O +

To O +
test O +
if O +
any O +
of O +
the O +
antibodies O +
generated O +
could O +
recognize O +
an O +
extracellular O +
epitope O +
and O +
thus O +
be O +
used O +
for O +
live O +
cell O +
sorting O -
, O +
we O +
repeated O +
staining O +
of O +
live O +
cells O +
as O +
previously O +
described O -
. O +

The O +
CD9 O -
, O +
E O -
- O -
Cadherin O +
and O +
PODXL O +
antibodies O +
recognized O +
an O +
extracellular O +
epitope O +
and O +
their O +
ability O +
to O +
select O +
cells O +
by O +
FACS O +
was O +
confirmed O +
( O -
Fig. O +
3 O -
) O -
. O +

Minimal O +
or O +
no O +
expressions O +
of O +
Oct3 O -
/ O -
4 O -
, O +
E O -
- O -
Cadherin O -
, O +
PODXL O +
and O +
Nanog O +
were O +
detected O +
in O +
the O +
differentiated O +
EBs O +
( O -
Fig. O +
2D O -
, O +
2E O +
and O +
2F O -
) O -
. O +

However O -
, O +
SOX2 O +
expression O -
, O +
which O +
is O +
observed O +
in O +
neural O +
progenitor O +
cells O -
, O +
is O +
persistent O +
in O +
subsets O +
of O +
EBs O -
. O +

Figure O +
1Western O +
blot O +
analysis O +
for O +
Gt O +
× O +
hOct3 O -
/ O -
4 O +
( O -
A O -
) O -
, O +
Gt O +
× O +
hNanog O +
( O -
B O -
) O +
and O +
Ms O +
× O +
hSOX2 O +
( O -
C O -
) O +
in O +
NTERA-2 B-CellLine +
cell O +
lysate O -
, O +
Ms O +
× O +
hE O -
- O -
Cadherin O +
( O -
D O -
) O +
in O +
MCF-7 B-CellLine +
cell O +
lysate O -
, O +
Ms O +
× O +
hCD9 O +
( O -
E O -
) O +
in O +
PBMC O +
lysate O +
and O +
Ms O +
× O +
hPDX-1 O -
( O -
F O -
) O +
in O +
β B-CellLine -
- I-CellLine -
TC-6 I-CellLine +
cell B-CellLine +
lysate O -
. O +

Numbers O +
indicate O +
the O +
positions O +
of O +
molecular O +
weight O +
markers O -
. O +

Figure O +
2Undifferentiated O +
human O +
ES O +
cells O +
( O -
A O -
, O +
B O -
, O +
and O +
C O -
) O +
and O +
differentiated O +
EBs O +
( O -
D O -
, O +
E O +
and O +
F O -
) O +
were O +
analyzed O +
using O +
antibodies O +
to O +
indicated O +
molecular O +
markers O -
. O +

Immunostaining O +
with O +
goat O +
anti O -
- O -
human O +
Oct3 O -
/ O -
4 O +
( O -
Red O +
in O +
A O +
and O +
D O -
) O -
, O +
mouse O +
anti O -
- O -
human O +
SOX2 O +
( O -
Green O +
in O +
A O +
and O +
D O -
) O -
, O +
goat O +
anti O -
- O -
human O +
E O -
- O -
Cadherin O +
( O -
Red O +
in O +
B O +
and O +
E O -
) O -
, O +
mouse O +
anti O -
- O -
human O +
PODXL O +
( O -
Green O +
in O +
B O +
and O +
E O -
) O -
, O +
and O +
goat O +
anti O -
- O -
human O +
Nanog O +
( O -
Red O +
in O +
C O +
and O +
F O -
) O -
, O +
are O +
contrasted O +
with O +
DAPI O +
nuclear O +
staining O +
( O -
Blue O +
in O +
C O -
- O -
F O -
) O -
. O +

Note O +
the O +
dramatic O +
downregulation O +
of O +
ESC O +
specific O +
markers O +
( O -
Oct3 O -
/ O -
4 O -
, O +
E O -
- O -
Cadherin O -
, O +
PODXL O -
, O +
and O +
Nanog O -
) O +
in O +
EBs O -
. O +

However O -
, O +
SOX2 O +
expression O +
is O +
persistent O +
in O +
subsets O +
of O +
EB O +
cells O -
. O +

Scale O +
bars O +
= O +
100 O +
μm O -
. O +

Figure O +
3Human O +
embryonic O +
stem O +
cells O +
stained O +
with O +
anti O -
- O -
CD9 O +
( O -
A O -
) O -
, O +
anti O -
- O -
E O -
- O -
Cadherin O +
( O -
B O -
) O -
, O +
and O +
anti O -
- O -
PODXL O +
( O -
C O -
) O +
and O +
antigen O +
expression O +
detected O +
by O +
a O +
flow O +
cytometer O -
. O +

The O +
specific O +
staining O +
is O +
indicated O +
by O +
green O +
histogram O +
and O +
corresponding O +
isotype O +
control O +
is O +
indicated O +
by O +
black O +
histogram O -
. O +

Suspension O +
culture O +
with O +
FGF O +
withdrawal O +
is O +
known O +
to O +
induce O +
differentiation O +
of O +
ES O +
cells O +
to O +
all O +
three O +
germ O +
layer O +
precursors O +
[ O -
12 O -
] O -
. O +

The O +
differentiation O +
status O +
of O +
the O +
EB O +
used O +
here O +
was O +
detected O +
to O +
contain O +
all O +
germ O +
cell O +
markers O +
by O +
RT O -
- O -
PCR O +
( O -
Fig. O +
4 O -
) O -
. O +

In O +
order O +
to O +
examine O +
how O +
more O +
antibodies O +
can O +
be O +
used O +
for O +
characterization O +
of O +
early O +
differentiation O +
events O +
from O +
human O +
ES O +
cells O -
, O +
we O +
examined O +
the O +
expressions O +
of O +
endodermal O +
markers O -
, O +
SOX17 O -
, O +
GATA6 O +
and O +
PDX-1 O -
, O +
and O +
mesodermal O +
markers O -
, O +
Brachyury O +
and O +
GATA1 O -
, O +
in O +
the O +
undifferentiated O +
human O +
ES O +
cells O +
and O +
differentiated O +
EBs O -
. O +

Expressions O +
of O +
SOX17 O -
, O +
GATA6 O -
, O +
PDX-1 O -
, O +
Brachyury O +
and O +
GATA1 O +
were O +
not O +
detected O +
in O +
undifferentiated O +
human O +
ES O +
cells O +
( O -
data O +
not O +
shown O -
) O -
. O +

In O +
contrast O +
to O +
the O +
undifferentiated O +
ES O +
cells O -
, O +
subpopulations O +
of O +
SOX17- O -
, O +
GATA6- O -
, O +
Brachyury- O +
and O +
GATA1-positive O +
cells O +
were O +
observed O +
( O -
Fig O +
4 O -
) O -
. O +

These O +
results O +
suggest O +
that O +
both O +
endodermal O +
and O +
mesodermal O +
precursors O +
exist O +
in O +
EBs O +
with O +
FGF O +
withdrawal O +
for O +
8 O +
days O -
. O +

However O -
, O +
no O +
PDX-1-positive O +
cells O +
were O +
seen O +
in O +
EBs O +
differentiated O +
with O +
the O +
same O +
treatment O +
( O -
data O +
not O +
shown O -
) O -
.Figure O +
4Differentiated O +
EBs O +
were O +
analyzed O +
by O +
either O +
immunocytochemistry O +
or O +
RT O -
- O -
PCR O +
to O +
the O +
indicated O +
molecular O +
markers O -
. O +

( O -
A O -
) O +
Immunostaining O +
with O +
goat O +
anti O -
- O -
human O +
SOX17 O +
( O -
Red O -
) O -
, O +
is O +
contrasted O +
with O +
Fluoro O +
Nissl O +
nuclear O +
staining O +
( O -
Green O -
) O -
. O +

( O -
B O -
) O +
Immunostaining O +
with O +
goat O +
anti O -
- O -
human O +
GATA6 O +
( O -
Red O -
) O -
, O +
is O +
contrasted O +
with O +
DAPI O +
nuclear O +
staining O +
( O -
Blue O -
) O -
. O +

( O -
C O -
) O +
Immunostaining O +
with O +
goat O +
anti O -
- O -
human O +
brachyury O +
( O -
Red O -
) O -
, O +
is O +
contrasted O +
with O +
DAPI O +
nuclear O +
staining O +
( O -
Blue O -
) O -
. O +

( O -
D O -
) O +
Immunostaining O +
with O +
mouse O +
anti O -
- O -
human O +
GATA1 O +
( O -
Red O -
) O -
. O +

Note O +
that O +
each O +
antibody O +
recognizes O +
subsets O +
of O +
EB O +
cells O -
. O +

Scale O +
bars O +
= O +
100 O +
μm O -
. O +

( O -
E O -
) O +
The O +
differentiation O +
status O +
of O +
EB O +
is O +
detected O +
by O +
RT O -
- O -
PCR O +
using O +
different O +
germ O +
layer O +
cell O +
markers O -
. O +

Selected O +
endoderm O +
markers O +
AFP O -
, O +
FoxA2 O -
; O +
mesoderm O +
markers O +
Hand1 O -
, O +
MSX1 O +
and O +
ectoderm O +
marker O +
Msl1 O +
were O +
all O +
highly O +
expressed O +
in O +
the O +
EB O +
samples O +
while O +
their O +
expression O +
was O +
either O +
undetectable O +
or O +
at O +
low O +
level O +
in O +
the O +
ES O +
samples O -
. O +

G3PDH O +
was O +
a O +
positive O +
control O +
showing O +
similar O +
amount O +
of O +
RNA O +
samples O +
were O +
used O +
for O +
analysis O -
. O +

Examination O +
of O +
cross O -
- O -
reactivity O +
of O +
antibodies O +
on O +
mouse O +
ES O +
and O +
differentiated O +
cellsWe O +
have O +
also O +
examined O +
the O +
cross O -
- O -
reactivities O +
of O +
these O +
antibodies O +
to O +
mouse O +
ES O +
cells O +
using O +
mouse O +
D3 B-CellLine +
ES O +
cell O +
line O +
and O +
mouse O +
fetal O +
endodermal O +
tissue O -
. O +

Cross O -
- O -
reactivity O +
to O +
mouse O +
of O +
goat O +
anti O -
- O -
Oct3 O -
/ O -
4 O -
, O +
goat O +
anti O -
- O -
PDX-1 O -
, O +
goat O +
anti O -
- O -
SOX17 O +
and O +
mouse O +
anti O -
- O -
SOX2 O +
was O +
detected O -
. O +

Minimal O +
cross O -
- O -
reactivity O +
to O +
mouse O -
, O +
measured O +
by O +
10 O -
% O +
intensity O +
to O +
human O +
by O +
higher O +
than O +
control O +
cells O -
, O +
was O +
observed O +
in O +
mouse O +
anti O -
- O -
CD9 O +
and O +
mouse O +
anti O -
- O -
E O -
- O -
cadherin O +
antibodies O -
. O +

Goat O +
anti O -
- O -
Nanog O +
and O +
mouse O +
anti O -
- O -
PODXL O +
antibodies O +
appear O +
to O +
be O +
human O -
- O -
specific O +
as O +
well O +
( O -
data O +
not O +
shown O -
) O -
. O +

The O +
subtypes O +
of O +
monoclonal O +
antibodies O +
were O +
also O +
identified O +
in O +
the O +
best O +
clones O -
. O +

These O +
results O +
are O +
summarized O +
in O +
Table O +
2.Table O +
2Summary O +
of O +
antibodies O +
detection O +
in O +
ES O +
and O +
EB O +
samples O -
. O +

AntibodyESEBReactivity O +
to O +
mouseIsotype O +
of O +
monoclonal O +
antibody O +
( O -
Clone O +
No. O -
) O -
Gt O +
× O +
hBrachyuryNoYesNT*Ms O +
× O +
hDPPA5YesNT*NT*ND*Gt O +
× O +
hGATA6NoYesNT*Gt O +
× O +
hNanogYesDownNoGt O +
× O +
hOct O +
3 O -
/ O -
4YesDownYesGt O +
× O +
hPDX-1NoNoYesGt O +
× O +
hSOX17NoYesYesMs O +
× O +
hCD9YesNoMinimalMouse O +
IgG2B O +
( O -
clone O +
209306 O -
) O -
Ms O +
× O +
hE O -
- O -
cadherinYesNoMinimalMouse O +
IgG2B O +
( O -
clone O +
180224 O -
) O -
Ms O +
× O +
hGATA1NoYesNT*Rat O +
IgG2B O +
( O -
clone O +
234732 O -
) O -
Ms O +
× O +
hPODXLYesNoNoMouse O +
IgG2A O +
( O -
clone O +
222328 O -
) O -
Ms O +
× O +
hSOX2YesYesYesMouse O +
IgG2A O +
( O -
clone O +
245610 O -
) O -
*NT O -
, O +
Not O +
tested O -
; O +
ND O -
, O +
Not O +
determined O -
. O +

The O +
expression O +
patterns O +
detected O +
using O +
antibodies O +
developed O +
in O +
our O +
facility O +
are O +
consistent O +
with O +
data O +
reported O +
using O +
reverse O +
transcriptase O -
- O -
polymerase O +
chain O +
reaction O +
or O +
cDNA O +
microarrays O -
. O +

Moreover O +
several O +
of O +
the O +
monoclonal O +
antibodies O +
have O +
differing O +
heavy O +
chain O +
subunits O +
allowing O +
double O +
labeling O +
using O +
subtype O +
specific O +
markers O +
to O +
be O +
performed O -
. O +

In O +
summary O -
, O +
we O +
have O +
developed O +
a O +
useful O +
collection O +
of O +
antibodies O +
that O +
would O +
be O +
useful O +
for O +
identification O +
of O +
stem O +
cell O +
characteristics O +
and O +
assessment O +
of O +
differentiation O -
. O +

Several O +
additional O +
antibodies O +
to O +
the O +
molecules O +
that O +
have O +
been O +
identified O +
as O +
potential O +
cell O +
lineage O +
markers O +
[ O -
13 O -
] O +
are O +
currently O +
under O +
development O +
using O +
the O +
same O +
approach O -
. O +

Cloning O +
and O +
expression O +
of O +
Brachyury O -
, O +
DPPA5 O -
, O +
CD9 O -
, O +
E O -
- O -
Cadherin O -
, O +
GATA1 O -
, O +
GATA6 O -
, O +
Nanog O -
, O +
Oct3 O -
/ O -
4 O -
, O +
PDX-1 O -
, O +
PODXL O -
, O +
SOX2 O +
and O +
SOX17Brachyury O +
( O -
aa O -
. O +

1–202 O -
) O -
, O +
DPPA5 O +
( O -
a.a O -
. O +

1–116 O -
) O -
, O +
GATA1 O +
( O -
a.a O -
. O +
1–413 O -
) O -
, O +
GATA6 O +
( O -
aa O -
. O +

1–449 O -
) O -
, O +
Nanog O +
( O -
aa O -
. O +

153–305 O -
) O -
, O +
Oct3 O -
/ O -
4 O +
( O -
aa O -
. O +
1–265 O -
) O -
, O +
PDX-1 O +
( O -
aa O -
. O +

1–283 O -
) O -
, O +
SOX2 O +
( O -
aa O -
. O +
135–317 O -
) O +
and O +
SOX17 O +
( O -
aa O -
. O +
177–414 O -
) O +
were O +
expressed O +
in O +
E. O +
Coli O +
and O +
extracellular O +
domains O +
of O +
CD9 O -
, O +
E O -
- O -
Cadherin O -
, O +
PODXL O +
were O +
expressed O +
in O +
mouse O +
NSO O +
cells O -
. O +

All O +
proteins O +
were O +
purified O +
and O +
sequenced O +
before O +
they O +
were O +
used O +
as O +
antigens O +
for O +
immunizations O +
and O +
as O +
substrate O +
for O +
antibody O +
screening O +
and O +
subcloning O -
. O +

Production O +
and O +
purification O +
of O +
antibodiesAll O +
monoclonal O +
antibodies O +
were O +
derived O +
from O +
fusions O +
of O +
mouse O +
myeloma O +
with O +
B O +
cells O +
obtained O +
from O +
BALB O -
/ O -
c O +
mice O +
which O +
had O +
been O +
immunized O +
with O +
purified O +
antigen O -
. O +

The O +
IgG O +
fraction O +
of O +
the O +
culture O +
supernatant O +
was O +
purified O +
by O +
Protein O +
G O +
affinity O +
chromatography O +
( O -
Sigma O -
) O -
. O +

Each O +
panel O +
of O +
antibodies O +
was O +
screened O +
and O +
selected O +
for O +
their O +
abilities O +
to O +
detect O +
purified O +
recombinant O +
antigen O +
in O +
direct O +
ELISA O +
and O +
Western O +
blot O -
. O +

All O +
polyclonal O +
antibodies O +
were O +
derived O +
from O +
sera O +
of O +
goats O +
which O +
had O +
been O +
immunized O +
and O +
boost O +
it O +
with O +
purified O +
antigen O -
. O +

Antibody O +
was O +
purified O +
from O +
the O +
sera O +
by O +
an O +
antigen O -
- O -
affinity O +
chromatography O -
. O +

Cells O +
and O +
cell O +
cultureHuman O +
Caco-2 B-CellLine -
, O +
MG-63 B-CellLine -
, O +
MCF-7 B-CellLine -
, O +
NTERA-2 B-CellLine +
and O +
mouse O +
D3 B-CellLine +
cells O +
were O +
purchased O +
from O +
American O +
Type O +
Culture O +
Collection O +
( O -
ATCC O -
) O -
. O +

Cells O +
were O +
cultured O +
according O +
to O +
the O +
ATCC O +
instructions O -
. O +

Information O +
regarding O +
human O +
ES O +
cell O +
line O +
HSF-6 B-CellLine +
( O -
NIH O +
code O +
UC06 B-CellLine -
) O +
can O +
be O +
obtained O +
at O +
the O +
website O +
[ O -
14 O -
] O -
. O +

Undifferentiated O +
human O +
ES O +
cells O +
were O +
cultured O +
according O +
to O +
the O +
protocol O +
provided O +
by O +
the O +
University O +
of O +
California O -
, O +
San O +
Francisco O +
in O +
human O +
ES O +
culture O +
medium O +
[ O -
DMEM O +
supplemented O +
with O +
20 O -
% O +
KnockOut O +
Serum O +
Replacement O +
( O -
Invitrogen O -
) O +
and O +
5 O +
ng O -
/ O -
mL O +
of O +
bFGF O +
( O -
R&D O +
Systems O -
) O -
] O -
. O +

To O +
induce O +
formation O +
of O +
embryoid O +
bodies O +
( O -
EBs O -
) O -
, O +
ES O +
colonies O +
were O +
harvested O -
, O +
separated O +
from O +
the O +
MEF O +
feeder O +
cells O +
by O +
gravity O -
, O +
gently O +
resuspended O +
in O +
ES O +
culture O +
medium O +
and O +
transferred O +
to O +
non O -
- O -
adherent O +
suspension O +
culture O +
dishes O +
( O -
Corning O -
) O -
. O +

Unless O +
otherwise O +
noted O -
, O +
EBs O +
derived O +
from O +
human O +
ES O +
cell O +
aggregates O +
were O +
cultured O +
for O +
8 O +
days O +
in O +
ES O +
culture O +
medium O +
deprived O +
of O +
bFGF O +
and O +
used O +
for O +
analysis O +
by O +
immunohistochemistry O +
as O +
described O -
. O +

Western O +
blotCells O +
are O +
solubilized O +
in O +
hot O +
2 O -
× O +
SDS O +
gel O +
sample O +
buffer O +
( O -
20 O +
mM O +
dithiothreitol O -
, O +
6 O -
% O +
SDS O -
, O +
0.25 O +
M O +
Tris O -
, O +
pH O +
6.8 O -
, O +
10 O -
% O +
glycerol O -
, O +
10 O +
mM O +
NaF O +
and O +
bromophenyl O +
blue O -
) O +
at O +
2 O +
× O +
106 O +
per O +
mL. O +
The O +
extracts O +
are O +
heated O +
in O +
a O +
boiling O +
water O +
bath O +
for O +
5 O +
minutes O +
and O +
sonicated O +
with O +
a O +
probe O +
sonicator O +
with O +
3–4 O +
bursts O +
of O +
5–10 O +
seconds O +
each O -
. O +

Samples O +
are O +
diluted O +
with O +
1 O -
× O +
SDS O +
sample O +
buffer O +
to O +
the O +
desired O +
loading O +
of O +
1–5 O +
× O +
103 O +
per O +
lane O -
. O +

Lysates O +
were O +
resolved O +
by O +
SDS O -
- O -
PAGE O -
, O +
transferred O +
to O +
Immobilon O -
- O -
P O +
membrane O -
, O +
and O +
immunoblotted O +
with O +
0.5 O +
μg O -
/ O -
mL O +
primary O +
Abs O +
as O +
described O +
in O +
R&D O +
Systems O +
Website O +
[ O -
15 O -
] O -
. O +

ImmunohistochemistryAntibodies O +
were O +
used O +
with O +
the O +
appropriate O +
secondary O +
reagents O +
at O +
a O +
concentration O +
of O +
5 O +
to O +
10 O +
μg O -
/ O -
ml O -
. O +

Cells O +
or O +
sections O +
of O +
EBs O +
were O +
fixed O +
with O +
4 O -
% O +
paraformaldehyde O +
in O +
PBS O +
at O +
room O +
temperature O +
for O +
20 O +
min O -
, O +
then O +
blocked O +
and O +
permeabilized O +
with O +
0.1 O -
% O +
Triton O +
X-100 O -
, O +
1 O -
% O +
BSA O -
, O +
10 O -
% O +
normal O +
donkey O +
serum O +
in O +
PBS O +
at O +
room O +
temperature O +
for O +
45 O +
min O -
. O +

After O +
blocking O -
, O +
cells O +
were O +
incubated O +
with O +
diluted O +
primary O +
antibody O +
overnight O +
at O +
4 O -
° O -
C O +
followed O +
by O +
coupled O +
anti O -
- O -
mouse O +
or O +
anti O -
- O -
goat O +
IgG O +
( O -
Molecular O +
Probes O -
) O +
at O +
room O +
temperature O +
in O +
the O +
dark O +
for O +
an O +
hour O -
. O +

Between O +
each O +
step O +
cells O +
were O +
washed O +
with O +
PBS O +
with O +
0.1 O -
% O +
BSA O -
. O +

RT O -
- O -
PCRTotal O +
RNA O +
was O +
extracted O +
from O +
EBs O +
using O +
Trizol O +
LS O +
( O -
Invitrogen O -
) O -
. O +

cDNA O +
was O +
synthesized O +
by O +
using O +
Superscript O +
II O +
reverse O +
transcriptase O +
( O -
Invitrogen O -
) O +
according O +
to O +
the O +
manufacturer O -
's O +
recommendations O -
. O +

The O +
PCR O +
primers O +
are O +
available O +
upon O +
request O -
. O +

Flow O +
cytometryAntibodies O +
were O +
prepared O +
at O +
the O +
concentration O +
of O +
0.1 O +
mg O -
/ O -
mL. O +
10 O +
μL O +
of O +
the O +
stock O +
solution O +
was O +
added O +
to O +
1 O +
– O +
2.5 O +
× O +
105 O +
cells O +
in O +
a O +
total O +
reaction O +
volume O +
not O +
exceeding O +
200 O +
μL. O +
The O +
sample O +
was O +
then O +
incubated O +
for O +
20 O +
min O +
at O +
2–8 O +
° O -
C O -
. O +

Following O +
incubation O -
, O +
excess O +
antibody O +
was O +
removed O +
by O +
washing O +
cells O +
twice O +
with O +
FACS O +
buffer O +
( O -
2 O -
% O +
FCS O +
and O +
0.1 O -
% O +
sodium O +
azide O +
in O +
Hank O -
's O +
buffer O -
) O -
. O +

After O +
wash O -
, O +
cells O +
were O +
resuspend O +
in O +
200 O +
μL O +
of O +
FACS O +
buffer O +
and O +
the O +
binding O +
of O +
unlabeled O +
monoclonal O +
antibodies O +
was O +
visualized O +
by O +
adding O +
10 O +
μL O +
of O +
a O +
25 O +
μg O -
/ O -
mL O +
stock O +
solution O +
of O +
a O +
secondary O +
developing O +
reagent O +
such O +
as O +
goat O +
anti O -
- O -
mouse O +
IgG O +
conjugated O +
to O +
a O +
fluorochrome O +
for O +
20 O +
min O +
at O +
2–8 O -
° O -
C O -
. O +

Following O +
incubation O -
, O +
cells O +
were O +
washed O +
once O +
with O +
FACS O +
buffer O -
, O +
once O +
with O +
PBS O -
. O +

After O +
wash O -
, O +
cells O +
were O +
resuspend O +
in O +
400 O +
μL O +
of O +
PBS O +
and O +
analyzed O +
on O +
a O +
FACScant O +
flow O +
cytometer O +
( O -
Becton O -
- O -
Dickinson O -
, O +
Mountain O +
View O -
, O +
CA O -
) O -
. O +

Five O +
thousand O +
events O +
were O +
collected O +
and O +
analyzed O +
using O +
CELL O +
Quest O +
software O -
. O +

BackgroundIn O +
order O +
to O +
compare O +
the O +
gene O +
expression O +
profiles O +
of O +
human O +
embryonic O +
stem O +
cell O +
( O -
hESC O -
) O +
lines O +
and O +
their O +
differentiated O +
progeny O +
and O +
to O +
monitor O +
feeder O +
contaminations O -
, O +
we O +
have O +
examined O +
gene O +
expression O +
in O +
seven O +
hESC O +
lines O +
and O +
human O +
fibroblast O +
feeder O +
cells O +
using O +
Illumina O -
® O +
bead O +
arrays O +
that O +
contain O +
probes O +
for O +
24,131 O +
transcript O +
probes O -
. O +

ResultsA O +
total O +
of O +
48 O +
different O +
samples O +
( O -
including O +
duplicates O -
) O +
grown O +
in O +
multiple O +
laboratories O +
under O +
different O +
conditions O +
were O +
analyzed O +
and O +
pairwise O +
comparisons O +
were O +
performed O +
in O +
all O +
groups O -
. O +

Hierarchical O +
clustering O +
showed O +
that O +
blinded O +
duplicates O +
were O +
correctly O +
identified O +
as O +
the O +
closest O +
related O +
samples O -
. O +

hESC O +
lines O +
clustered O +
together O +
irrespective O +
of O +
the O +
laboratory O +
in O +
which O +
they O +
were O +
maintained O -
. O +

hESCs O +
could O +
be O +
readily O +
distinguished O +
from O +
embryoid O +
bodies O +
( O -
EB O -
) O +
differentiated O +
from O +
them O +
and O +
the O +
karyotypically O +
abnormal O +
hESC O +
line O +
BG01V B-CellLine -
. O +

The O +
embryonal O +
carcinoma O +
( O -
EC O -
) O +
line O +
NTera2 B-CellLine +
is O +
a O +
useful O +
model O +
for O +
evaluating O +
characteristics O +
of O +
hESCs O -
. O +

Expression O +
of O +
subsets O +
of O +
individual O +
genes O +
was O +
validated O +
by O +
comparing O +
with O +
published O +
databases O -
, O +
MPSS O +
( O -
Massively O +
Parallel O +
Signature O +
Sequencing O -
) O +
libraries O -
, O +
and O +
parallel O +
analysis O +
by O +
microarray O +
and O +
RT O -
- O -
PCR.Conclusionwe O +
show O +
that O +
Illumina O -
's O +
bead O +
array O +
platform O +
is O +
a O +
reliable O -
, O +
reproducible O +
and O +
robust O +
method O +
for O +
developing O +
base O +
global O +
profiles O +
of O +
cells O +
and O +
identifying O +
similarities O +
and O +
differences O +
in O +
large O +
number O +
of O +
samples O -
. O +

Embryonic O +
stem O +
cells O +
( O -
ESCs O -
) O -
, O +
derived O +
from O +
the O +
inner O +
cell O +
mass O +
of O +
pre O -
- O -
implantation O +
embryos O -
, O +
have O +
been O +
recognized O +
as O +
the O +
most O +
pluripotent O +
stem O +
cell O +
population O -
. O +

Human O +
ES O +
cells O +
( O -
hESCs O -
) O +
can O +
be O +
maintained O +
and O +
propagated O +
on O +
mouse O +
or O +
human O +
fibroblast O +
feeders O +
for O +
extended O +
periods O +
in O +
media O +
containing O +
basic O +
fibroblast O +
growth O +
factor O +
( O -
bFGF O -
) O +
[ O -
1 O -
- O -
4 O -
] O +
while O +
retaining O +
the O +
ability O +
to O +
differentiate O +
into O +
ectoderm O -
, O +
endoderm O +
and O +
mesoderm O +
as O +
well O +
as O +
trophoectoderm O +
and O +
germ O +
cells O -
. O +

Gene O +
expression O +
in O +
hESC O +
has O +
been O +
investigated O +
by O +
a O +
variety O +
of O +
techniques O +
including O +
massively O +
parallel O +
signature O +
sequencing O +
( O -
MPSS O -
) O -
, O +
serial O +
analysis O +
of O +
gene O +
expression O +
( O -
SAGE O -
) O -
, O +
expressed O +
sequence O +
tag O +
( O -
EST O -
) O +
scan O -
, O +
large O +
scale O +
microarrays O -
, O +
focused O +
cDNA O +
microarrays O -
, O +
and O +
immunocytochemistry O +
[ O -
5 O -
- O -
7 O -
] O -
. O +

Markers O +
for O +
hESCs O +
that O +
may O +
also O +
contribute O +
to O +
the O +
" O -
stemness O -
" O +
phenotype O +
have O +
been O +
established O +
and O +
markers O +
that O +
distinguish O +
ESCs O +
from O +
embryoid O +
bodies O +
( O -
EB O -
) O +
have O +
been O +
developed O -
. O +

Novel O +
stage O -
- O -
specific O +
genes O +
that O +
distinguish O +
between O +
hESCs O +
and O +
EBs O +
have O +
been O +
identified O +
and O +
allelic O +
differences O +
between O +
ESC O +
have O +
begun O +
to O +
be O +
recognized O +
[ O -
8 O -
- O -
10 O -
] O -
. O +

As O +
the O +
potential O +
of O +
hESCs O +
and O +
their O +
derivatives O +
for O +
regenerative O +
medicine O +
is O +
being O +
evaluated O -
, O +
it O +
has O +
become O +
clear O +
that O +
the O +
overall O +
state O +
of O +
the O +
cells O -
, O +
degree O +
of O +
contamination O +
and O +
comparisons O +
of O +
the O +
more O +
than O +
a O +
hundred O +
different O +
newly O +
derived O +
lines O +
will O +
need O +
to O +
be O +
performed O -
. O +

It O +
will O +
be O +
necessary O +
to O +
develop O +
methods O +
to O +
monitor O +
and O +
assess O +
hESC O +
and O +
their O +
derivatives O +
on O +
a O +
routine O +
basis O -
. O +

Since O +
differentiated O +
cells O +
are O +
often O +
scattered O +
within O +
or O +
at O +
the O +
edge O +
of O +
colonies O +
[ O -
11 O -
] O +
and O +
the O +
differentiation O +
is O +
so O +
subtle O +
that O +
morphological O +
characteristics O +
and O +
even O +
immunohistochemistry O +
are O +
insufficient O +
to O +
detect O +
it O -
, O +
larger O +
scale O +
methods O +
of O +
analysis O +
need O +
to O +
be O +
developed O -
. O +

Our O +
strategy O +
was O +
to O +
compare O +
a O +
variety O +
of O +
different O +
hESC O +
lines O +
that O +
were O +
derived O +
and O +
expanded O +
by O +
three O +
different O +
institutions O +
( O -
WiCell O +
Research O +
Institute O -
, O +
BresaGen O -
, O +
Inc. O -
, O +
and O +
Technion O -
- O -
Israel O +
Institute O +
of O +
Technology O -
) O -
, O +
and O +
cultured O +
in O +
two O +
separate O +
laboratories O +
( O -
Burnham O +
Institute O +
and O +
NIA O -
) O +
to O +
a O +
baseline O +
set O +
of O +
data O +
against O +
which O +
cell O +
samples O +
can O +
be O +
compared O -
. O +

By O +
using O +
cells O +
grown O +
in O +
different O +
conditions O +
we O +
expected O +
to O +
be O +
able O +
to O +
identify O +
core O +
commonalities O +
and O +
by O +
comparing O +
feeders O +
and O +
embryoid O +
bodies O +
( O -
EB O -
) O +
with O +
hESC O +
identify O +
measures O +
of O +
contamination O +
and O +
early O +
markers O +
of O +
differentiation O -
. O +

Further O -
, O +
by O +
comparing O +
embryonal O +
carcinoma O +
cell O +
( O -
EC O -
) O +
and O +
karyotypically O +
variant O +
lines O +
with O +
hESC O -
, O +
we O +
would O +
be O +
able O +
to O +
directly O +
assess O +
their O +
utility O +
as O +
surrogates O +
( O -
for O +
quality O +
control O +
purposes O -
) O +
for O +
hESC O -
. O +

We O +
employed O +
a O +
pre O -
- O -
commercial O +
prototype O +
of O +
the O +
Illumina O +
HumanRef-8 O +
BeadChip O +
[ O -
12 O -
] O -
, O +
a O +
genome O -
- O -
scale O +
bead O +
based O +
array O +
technology O +
that O +
combines O +
the O +
sensitivity O +
and O +
low O +
cost O +
of O +
a O +
focused O +
array O +
with O +
the O +
coverage O +
of O +
a O +
large O +
scale O +
array O -
, O +
while O +
requiring O +
much O +
smaller O +
sample O +
sizes O +
than O +
MPSS O -
, O +
EST O +
scan O +
or O +
SAGE O -
. O +

We O +
show O +
that O +
the O +
Illumina O +
bead O +
based O +
array O +
correctly O +
identified O +
blinded O +
duplicates O +
as O +
the O +
closest O +
related O +
samples O +
and O +
readily O +
distinguished O +
between O +
hESC O +
lines O -
, O +
as O +
well O +
as O +
between O +
ESCs O +
and O +
EBs O +
derived O +
from O +
them O -
. O +

This O +
array O +
allowed O +
us O +
to O +
estimate O +
the O +
degree O +
of O +
feeder O +
contamination O +
present O +
in O +
the O +
cultures O -
. O +

Similarities O +
and O +
differences O +
between O +
EC O +
line O +
NTera2 B-CellLine +
and O +
hESC O +
lines O +
could O +
be O +
determined O +
and O +
verified O -
, O +
and O +
the O +
database O +
comparisons O +
allowed O +
us O +
to O +
identify O +
core O +
self O -
- O -
renewal O +
pathways O +
that O +
regulate O +
hESC O +
propagation O -
. O +

Multiple O +
hESC O +
lines O +
can O +
be O +
assessed O +
by O +
Illumina O +
bead O +
arrayForty O -
- O -
eight O +
samples O +
were O +
selected O +
from O +
multiple O +
laboratories O +
and O +
gene O +
expression O +
profiles O +
were O +
examined O +
using O +
a O +
bead O +
array O +
containing O +
24,131 O +
transcripts O +
derived O +
from O +
the O +
Human O +
RefSeq O +
database O +
that O +
included O +
full O +
length O +
and O +
splice O +
variants O -
. O +

Each O +
gene O +
was O +
represented O +
by O +
sequences O +
containing O +
an O +
average O +
of O +
thirty O +
beads O +
to O +
provide O +
an O +
internal O +
measure O +
of O +
reliability O -
. O +

Samples O +
included O +
7 O +
hESC O +
lines O +
BG01 B-CellLine -
, O +
BG02 B-CellLine -
, O +
BG03 B-CellLine -
, O +
I6 B-CellLine -
, O +
H1 B-CellLine -
, O +
H7 B-CellLine +
and O +
H9 B-CellLine -
, O +
EBs O +
that O +
were O +
differentiated O +
from O +
hESCs O +
of O +
the O +
three O +
BG O +
lines O -
, O +
human O +
fibroblast O +
feeder O +
HS27 B-CellLine +
( O -
ATCC O -
) O -
, O +
hESC O -
- O -
derived O +
fibroblasts O -
, O +
karyotypically O +
abnormal O +
hESC O +
line O +
BG01 B-CellLine +
Variant I-CellLine +
( O -
BG01V B-CellLine -
) O +
[ O -
13 O -
] O +
and O +
EC O +
line O +
NTera2 B-CellLine +
[ O -
14 O -
] O -
. O +

Samples O +
were O +
blinded O +
and O +
biological O +
and O +
technical O +
repeats O +
were O +
examined O +
at O +
the O +
same O +
time O -
. O +

A O +
single O +
slide O +
contained O +
eight O +
replicates O +
and O +
six O +
such O +
slides O +
were O +
used O +
for O +
the O +
present O +
set O +
of O +
samples O -
. O +

Results O +
were O +
normalized O +
to O +
average O +
following O +
Illumina O +
Beadstudio O +
manual O +
and O +
the O +
quality O +
of O +
each O +
sample O +
was O +
assessed O +
by O +
immunocytochemitsry O +
and O +
RT O -
- O -
PCR O +
prior O +
to O +
subjecting O +
them O +
for O +
analysis O +
( O -
data O +
not O +
shown O -
) O -
. O +

Results O +
from O +
the O +
entire O +
sample O +
set O +
are O +
available O +
for O +
download O +
as O +
an O +
excel O +
spreadsheet O +
( O -
Additional O +
file O +
1 O -
) O +
and O +
a O +
CD O +
of O +
the O +
results O +
is O +
available O +
upon O +
request O -
. O +

The O +
total O +
number O +
of O +
genes O +
identified O +
as O +
expressed O +
at O +
> O -
0.99 O +
confidence O +
is O +
summarized O +
in O +
Table O +
1 O -
. O +

Intensity O +
results O +
are O +
reported O +
in O +
arbitrary O +
units O +
and O +
ranged O +
from O +
10 O +
to O +
20,000 O +
( O -
a O +
two O +
thousand O +
fold O +
range O -
) O -
. O +

Although O +
the O +
sensitivity O +
of O +
the O +
array O +
has O +
been O +
reported O +
to O +
be O +
high O -
, O +
in O +
the O +
present O +
report O +
we O +
have O +
restricted O +
our O +
analysis O +
to O +
expression O +
of O +
at O +
least O +
100 O +
units O +
in O +
any O +
one O +
sample O -
. O +

Using O +
this O +
cutoff O -
, O +
on O +
average O +
cells O +
expressed O +
approximately O +
8,000 O +
transcripts O +
( O -
Table O +
1 O -
, O +
2 O -
) O -
, O +
a O +
number O +
similar O +
to O +
the O +
number O +
detected O +
by O +
SAGE O -
, O +
MPSS O +
and O +
EST O +
analysis O +
[ O -
5 O -
- O -
7,10,15,16 O -
] O -
. O +

As O +
with O +
other O +
analysis O -
, O +
genes O +
with O +
the O +
highest O +
abundance O +
were O +
housekeeping O +
genes O -
, O +
ribosomal O +
genes O +
and O +
structural O +
genes O +
( O -
Table O +
2 O +
and O +
Additional O +
file O +
1 O -
) O -
. O +

These O +
genes O +
were O +
similar O +
in O +
most O +
samples O +
though O +
relative O +
levels O +
varied O -
. O +

Table O +
1Correlation O +
coefficients O +
of O +
paired O +
samples O +
in O +
this O +
bead O +
array O +
In O +
order O +
to O +
test O +
the O +
reproducibility O +
and O +
reliability O +
of O +
the O +
bead O +
array O -
, O +
duplicate O +
samples O +
of O +
hESC O +
lines O +
H9 B-CellLine -
, O +
I6 B-CellLine -
, O +
and O +
EC O +
line O +
NTera2 B-CellLine +
and O +
human O +
fibroblast O +
feeders O +
( O -
HS27 B-CellLine -
) O +
were O +
run O +
at O +
the O +
same O +
time O +
and O +
correlation O +
coefficients O +
( O -
R2 O -
) O +
of O +
duplicates O +
were O +
generated O +
using O +
the O +
entire O +
data O +
of O +
all O +
genes O +
with O +
expression O +
level O +
> O -
0 O +
( O -
§ O -
) O -
, O +
or O +
genes O +
with O +
detection O +
confidence O +
> O -
0.99 O +
( O -
* O -
) O -
, O +
or O +
genes O +
with O +
detection O +
confidence O +
> O -
0.99 O +
and O +
expression O +
level O +
> O +
100 O +
arbitrary O +
units O +
( O -
# O -
) O -
. O +

Note O +
that O +
the O +
correlation O +
coefficients O +
are O +
in O +
the O +
range O +
of O +
0.9382–0.9761 O +
and O +
the O +
number O +
of O +
genes O +
was O +
in O +
the O +
range O +
of O +
10,000–14,000.Duplicate O +
SamplesNo O -
. O +
of O +
all O +
genes O +
( O -
expr.>0 O -
) O -
§R2of O +
all O +
genes O +
( O -
expr O -
. O +

> O -
0 O -
) O -
No O -
. O +
of O +
genes O +
( O -
> O -
0.99 O -
) O -
*R2 O +
of O +
genes O +
( O -
> O -
0.99 O -
) O -
*No O -
. O +
( O -
> O -
0.99 O -
, O +
level>100 O -
) O -
#H918,8990.868113,6720.97087,408I619,1390.866312,5700.97616,826NTera219,1620.874114,0360.93827,147Feeder18,1570.872410,6060.97517,021Table O +
2Distribution O +
of O +
genes O +
with O +
expression O +
levels O +
< O -
50 O +
and O +
> O -
50–10,000 O +
as O +
detected O +
by O +
Illumina O +
bead O +
array O +
in O +
8 O +
hESC O +
populations O +
All O +
human O +
ESC O +
samples O +
were O +
hybridized O +
in O +
one O +
experiment O +
and O +
the O +
relative O +
detection O +
levels O +
of O +
genes O +
were O +
binned O +
to O +
obtain O +
a O +
global O +
overview O +
of O +
transcription O -
, O +
approximately O +
8 O -
, O +
000 O +
genes O +
( O -
~50 O -
% O -
) O +
were O +
greater O +
than O +
100 O +
arbitrary O +
units O -
. O +

The O +
numbers O +
are O +
similar O +
to O +
results O +
obtained O +
by O +
other O +
large O +
scale O +
analysis O +
such O +
as O +
MPSS.Abundance O +
( O -
relative O +
detection O +
levels O -
) O -
H9H9 B-CellLine +
on O +
human O +
feedersI6BG01BG02BG03BG01VPooled O +
( O -
H1 B-CellLine -
, O +
H7 B-CellLine -
, O +
H9 B-CellLine -
) O -
No.%No.%No.%No.%No.%No.%No.%No.%<502,90921.26,06738.43,55925.34,52830.74,25630.54,70632.24194.35,80334.4>5010,81778.89,74761.610,48474.710,23269.39,69469.59,91567.89,43895.711,08565.6>1008,12659.27,53947.77,40952.87,70352.27,49653.77,43050.87,23073.38,21748.7>5003,07722.42,94718.62,62618.73,06520.82,95021.12,85219.52,85128.92,94117.4>10001,62911.91,62510.31,49010.61,63811.11,58911.41,51710.41,56615.91,5549.2>50002481.82571.62561.82561.72631.92621.82752.82511.5>10000900.7940.61120.8920.61000.71070.71011.0940.6Total O +
No. O +
of O +
genes O +
detected O +
at O +
> O -
0.99 O +
confidence13,72615,81414,04314,76013,95014,6219,85716,888One O +
of O +
the O +
advantages O +
of O +
the O +
Illumina O +
arrays O +
is O +
the O +
ability O +
of O +
running O +
multiple O +
samples O +
simultaneously O +
thus O +
allowing O +
multiple O +
pairwise O +
comparisons O +
to O +
be O +
performed O +
readily O -
. O +

To O +
show O +
the O +
similarity O +
of O +
relative O +
gene O +
expression O +
between O +
samples O -
, O +
we O +
have O +
used O +
Illumina O +
Beadstudio O +
and O +
clustering O +
software O +
packages O +
Pcluster O +
[ O -
17 O -
] O +
and O +
TreeView O +
[ O -
18 O -
] O +
to O +
generate O +
a O +
heat O -
- O -
map O +
( O -
Figure O +
1 O -
) O +
and O +
a O +
dendrogram O +
( O -
Figure O +
2 O -
) O -
. O +

Based O +
on O +
their O +
properties O -
, O +
we O +
classified O +
some O +
of O +
our O +
samples O +
into O +
four O +
groups O -
, O +
( O -
A O -
) O +
undifferentiated O +
hESCs O +
( O -
including O +
a O +
sample O +
from O +
karyotypically O +
abnormal O +
variant O -
, O +
designated O +
as O +
" O -
ES O -
" O -
, O +
n O +
= O +
11 O -
) O -
; O +
( O -
B O -
) O +
differentiated O +
ES O +
cells O +
and O +
EBs O +
( O -
designated O +
as O +
" O -
EB O -
" O -
, O +
n O +
= O +
6 O -
) O -
; O +
( O -
C O -
) O +
hESC O +
derived O +
neural O +
cells O +
( O -
designated O +
as O +
" O -
NS O -
" O -
, O +
n O +
= O +
3 O -
) O -
; O +
and O +
( O -
D O -
) O +
hESC O +
derived O +
mesenchyme O +
and O +
human O +
fibroblast O +
feeder O +
cells O +
( O -
designated O +
as O +
" O -
FB O -
" O -
, O +
n O +
= O +
5 O -
) O +
and O +
these O +
groups O +
were O +
shown O +
in O +
the O +
heat O -
- O -
map O -
. O +

Comparing O +
the O +
overall O +
pattern O +
of O +
expression O -
, O +
we O +
made O +
several O +
important O +
observations O -
: O +
1 O -
) O +
Duplicates O +
clustered O +
close O +
to O +
each O +
other O +
and O +
were O +
more O +
related O +
to O +
each O +
other O +
than O +
to O +
any O +
other O +
sample O -
; O +
2 O -
) O +
ESCs O +
appeared O +
more O +
similar O +
to O +
each O +
other O +
than O +
to O +
EBs O -
; O +
3 O -
) O +
NTera2 B-CellLine +
cells O +
appeared O +
more O +
similar O +
to O +
ESCs O +
while O +
differentiated O +
NTera2 B-CellLine +
and O +
EBs O +
can O +
be O +
readily O +
distinguished O +
from O +
their O +
parent O +
populations O +
( O -
Figure O +
2 O -
) O -
; O +
4 O -
) O +
BG01V B-CellLine +
appeared O +
similar O +
to O +
undifferentiated O +
BG01 B-CellLine +
cells O -
; O +
5 O -
) O +
In O +
general O +
ESC O +
lines O +
grown O +
in O +
one O +
laboratory O +
appeared O +
more O +
similar O +
than O +
samples O +
grown O +
in O +
other O +
laboratories O -
, O +
suggesting O +
that O +
culture O +
conditions O +
affected O +
gene O +
expression O +
but O +
that O +
this O +
effect O +
was O +
much O +
smaller O +
than O +
the O +
effect O +
of O +
differentiation O -
. O +

Figure O +
1Unsupervised O +
two O -
- O -
way O +
hierarchical O +
cluster O +
analysis O +
of O +
differentially O +
expressed O +
genes O +
illustrated O +
in O +
a O +
heat O -
- O -
map O -
. O +

Each O +
row O +
represents O +
the O +
relative O +
levels O +
of O +
expression O +
of O +
a O +
single O +
gene O -
. O +

Each O +
column O +
represents O +
a O +
sample O -
. O +

The O +
samples O +
include O +
four O +
groups O +
of O +
cells O -
, O +
ES O +
designates O +
11 O +
samples O +
of O +
hESCs O -
, O +
EB O +
contains O +
6 O +
samples O +
of O +
differentiated O +
ESCs O +
and O +
EBs O -
, O +
NS O +
consists O +
of O +
3 O +
hESC O +
derived O +
neural O +
cells O +
and O +
FB O +
is O +
a O +
collection O +
of O +
hESC O +
derived O +
mesenchyme O +
and O +
fibroblasts O -
. O +

High O +
expressions O +
relative O +
to O +
mean O +
are O +
colored O +
red O -
. O +

Low O +
expressions O +
are O +
colored O +
green O -
. O +

Black O +
represents O +
no O +
significant O +
change O +
in O +
expression O +
level O +
between O +
mean O +
and O +
sample O -
. O +

Samples O +
cluster O +
closer O +
within O +
their O +
own O +
group O +
than O +
samples O +
from O +
other O +
groups O -
. O +

Figure O +
2Dendrogram O +
of O +
unsupervised O +
one O -
- O -
way O +
hierarchical O +
clustering O +
analysis O +
of O +
relative O +
expression O +
of O +
genes O +
in O +
selected O +
samples O -
. O +

The O +
clustering O +
analysis O +
was O +
based O +
on O +
the O +
average O +
linkage O +
and O +
Euclidean O +
distances O +
as O +
the O +
similarity O +
metric O +
using O +
differentially O +
expressed O +
genes O +
identified O +
by O +
ANOVA O +
( O -
p O +
< O +
0.05 O -
) O -
. O +

hESCs O +
clustered O +
together O +
and O +
BG O +
lines O +
cultured O +
in O +
the O +
same O +
laboratory O +
shared O +
the O +
largest O +
similarities O -
. O +

EBs O +
were O +
separated O +
from O +
hESCs O +
from O +
which O +
they O +
were O +
derived O -
. O +

EC O +
line O +
NTera2 B-CellLine +
and O +
feeder O +
cells O +
can O +
be O +
distinguished O +
from O +
hESCs O +
respectively O -
. O +

The O +
global O +
analysis O +
suggested O +
that O +
the O +
bead O +
arrays O +
used O +
were O +
sufficiently O +
sensitive O +
such O +
that O +
individual O +
subsets O +
of O +
genes O +
could O +
be O +
analyzed O -
, O +
different O +
populations O +
of O +
cells O +
could O +
be O +
readily O +
distinguished O +
and O +
that O +
a O +
subset O +
of O +
candidate O +
genes O +
could O +
be O +
sufficient O +
to O +
distinguish O +
between O +
groups O +
of O +
cells O -
. O +

The O +
comparison O +
across O +
multiple O +
samples O +
will O +
allow O +
a O +
set O +
of O +
core O +
stem O +
cell O +
markers O +
to O +
be O +
identified O -
. O +

In O +
subsequent O +
sections O +
we O +
have O +
performed O +
such O +
analysis O -
. O +

Readers O +
are O +
urged O +
to O +
analyze O +
the O +
expression O +
of O +
desired O +
genes O +
directly O +
as O +
it O +
is O +
impossible O +
to O +
test O +
every O +
gene O +
given O +
the O +
large O +
body O +
of O +
data O +
generated O -
. O +

Comparison O +
between O +
MPSS O +
and O +
Illumina O +
bead O +
array O +
resultsWe O +
have O +
previously O +
used O +
EST O +
scan O +
and O +
MPSS O +
to O +
analyze O +
pooled O +
samples O +
of O +
ESCs O +
and O +
EBs O +
from O +
three O +
different O +
WiCell O +
lines O +
( O -
H1 B-CellLine -
, O +
H7 B-CellLine +
and O +
H9 B-CellLine -
) O +
[ O -
5 O -
] O -
. O +

Comparison O +
between O +
the O +
two O +
methodologies O +
indicated O +
that O +
while O +
there O +
is O +
good O +
concordance O +
for O +
genes O +
expressed O +
at O +
high O +
levels O -
, O +
this O +
does O +
not O +
hold O +
for O +
genes O +
expressed O +
at O +
lower O +
levels O -
. O +

As O +
a O +
test O +
of O +
the O +
quality O +
of O +
the O +
data O +
generated O +
in O +
these O +
experiments O +
and O +
to O +
evaluate O +
whether O +
comparisons O +
can O +
be O +
made O +
across O +
different O +
methodologies O -
, O +
we O +
re O -
- O -
ran O +
the O +
identical O +
samples O +
on O +
the O +
bead O +
array O +
platform O -
. O +

The O +
complete O +
comparison O +
of O +
gene O +
expression O +
is O +
shown O +
in O +
Additional O +
file O +
2 O +
and O +
is O +
summarized O +
in O +
Tables O +
3 O +
and O +
Table O +
4 O -
. O +

Overall O -
, O +
concordance O +
in O +
Illumina O +
array O +
was O +
better O +
than O +
that O +
evident O +
between O +
EST O +
scan O +
and O +
MPSS O +
datasets O +
[ O -
9 O -
] O -
, O +
but O +
clearly O +
showed O +
much O +
wider O +
differences O +
than O +
that O +
seen O +
with O +
running O +
duplicates O +
in O +
the O +
same O +
assay O +
format O -
. O +

Nevertheless O -
, O +
this O +
comparison O +
provides O +
an O +
independent O +
verification O +
of O +
the O +
data O +
and O +
suggests O +
that O +
if O +
a O +
sample O +
is O +
detected O +
in O +
more O +
than O +
one O +
large O -
- O -
scale O +
analysis O -
, O +
the O +
reliability O +
of O +
the O +
gene O +
expression O +
detection O +
is O +
high O -
, O +
which O +
also O +
reduces O +
the O +
number O +
of O +
individual O +
genes O +
needed O +
to O +
be O +
verified O -
. O +

Caution O +
should O +
be O +
observed O +
in O +
comparing O +
different O +
samples O +
run O +
on O +
different O +
platforms O -
, O +
especially O +
when O +
there O +
has O +
not O +
been O +
rigorous O +
bioinformatic O +
matching O +
of O +
the O +
source O +
sequences O +
used O +
to O +
identify O +
genes O +
in O +
the O +
platforms O -
. O +

Often O +
genes O +
called O +
by O +
the O +
same O +
symbol O +
originate O +
from O +
different O +
database O +
records O -
, O +
which O +
may O +
originate O +
from O +
different O +
splice O +
variants O +
or O +
contain O +
sequence O +
differences O +
due O +
to O +
polymorphisms O +
or O +
outright O +
error O +
[ O -
19 O -
] O -
.Table O +
3Expression O +
of O +
hESC O +
specific O +
markers O +
in O +
pooled O +
hESC O +
sample O +
as O +
detected O +
by O +
Illumina O +
bead O +
array O +
The O +
expression O +
of O +
previously O +
identified O +
hESC O +
markers O +
was O +
examined O +
in O +
all O +
hESC O +
samples O +
( O -
the O +
values O +
displayed O +
represent O +
the O +
expression O +
level O +
of O +
pooled O +
H1 B-CellLine -
, O +
H7 B-CellLine +
and O +
H9 B-CellLine -
) O -
. O +

Most O +
of O +
the O +
genes O +
were O +
also O +
identified O +
using O +
Illumina O +
bead O +
array O +
in O +
all O +
8 O +
hESC O +
populations O +
in O +
this O +
study O +
( O -
1 O -
* O -
) O -
, O +
the O +
gene O +
CER1 O +
was O +
detected O +
in O +
all O +
except O +
one O +
duplicate O +
of O +
H9 B-CellLine +
( O -
2 O -
* O -
) O -
, O +
Nanog O +
was O +
not O +
detected O +
in O +
all O +
populations O +
( O -
3 O -
* O -
) O +
and O +
Sox2 O -
, O +
Lin41 O -
, O +
NR6A1 O +
and O +
FoxD3 O +
were O +
not O +
detected O +
in O +
the O +
array O +
although O +
they O +
were O +
present O +
in O +
the O +
chips O +
for O +
hybridization O +
( O -
4* O -
) O -
.AccessionSymbolPooled O +
ES O +
( O -
H1 B-CellLine -
, O +
7 B-CellLine -
, O +
9 B-CellLine -
) O -
CommentsNM_003641.1IFITM188441*NM_020997.2LEFTB6579.61*NM_024674.3LIN283944.11*NM_175849.1DNMT3B33911*NM_003212.1TDGF131691*NM_001769.2CD92930.81*NM_000165.2GJA12404.41*NM_021195.2CLDN62247.21*NM_004360.2CDH11972.91*NM_021127.1PMAIP11601.51*NM_032805.1ZNF2061504.51*NM_003577.1UTF11444.11*XM_050625.2SFRP21353.91*NM_006548.3IMP-212061*NM_152312.2GYLTL1B1066.61*NM_015973.2GAL1043.31*NM_003240.2EBAF944.11*NM_054023.2SCGB3A2890.51*NM_020990.2CKMT1742.41*NM_033668.1ITGB1694.71*NM_003744.3NUMB618.31*NM_007015.1LECT1597.41*NM_021912.2GABRB3482.71*NM_006729.2DIAPH2467.11*NM_000222.1KIT188.91*NM_005454.1CER1151.52*NM_024865.1NANOG56.93*NM_002701.1POU5F1694.41*NM_003106SOX2ND4*NM_006458.2LIN41ND4*NM_001489.3NR6A1ND4*NM_012183FOXD3ND4*Table O +
4Comparison O +
of O +
MPSS O +
and O +
Illumina O +
bead O +
array O +
results O +
The O +
samples O +
were O +
analyzed O +
by O +
MPSS O +
and O +
bead O +
array O -
. O +

The O +
number O +
of O +
genes O +
detected O +
by O +
each O +
method O +
and O +
the O +
degree O +
of O +
overlap O +
is O +
summarized O -
. O +

Note O +
much O +
higher O +
degree O +
of O +
overlap O +
when O +
the O +
top O +
2000 O +
hits O +
were O +
compared O -
. O +

* O -
: O +
Most O +
of O +
the O +
genes O +
detected O +
by O +
MPSS O +
were O +
novel O +
genes O +
not O +
included O +
in O +
the O +
bead O +
array O -
. O +

ESNo.%Common O +
in O +
both O +
( O -
Top O +
2000 O +
hits O -
) O -
1,62281.1Common O +
in O +
both O +
( O -
All O +
hits O -
) O -
5,07146.0By O +
bead O +
array O +
only3,46231.4By O +
MPSS O +
only O +
* O -
2,50422.7Total11,037100EBNo.%Common O +
in O +
both O +
( O -
All O +
hits O -
) O -
5,16843.1By O +
bead O +
array O +
only4,13134.4By O +
MPSS O +
only O +
* O -
2,69422.5Total11,993100 O +
Human O +
feeders O +
and O +
hESCs O +
can O +
be O +
readily O +
distinguished O +
and O +
contamination O +
can O +
be O +
readily O +
assessedFor O +
all O +
samples O -
, O +
we O +
conducted O +
an O +
unsupervised O +
one O -
- O -
way O +
hierarchical O +
clustering O +
analysis O -
. O +

The O +
clustering O +
analysis O +
was O +
based O +
on O +
the O +
average O +
linkage O +
and O +
Euclidean O +
distances O +
as O +
the O +
similarity O +
metric O +
using O +
differentially O +
expressed O +
genes O +
identified O +
by O +
ANOVA O +
( O -
P O +
< O +
0.05 O -
) O -
. O +

The O +
analysis O +
revealed O +
the O +
underlying O +
features O +
and O +
variation O +
patterns O +
of O +
gene O +
expression O +
in O +
each O +
cell O +
types O -
. O +

Figure O +
2 O +
shows O +
results O +
of O +
the O +
cluster O +
analysis O +
of O +
relative O +
gene O +
expression O +
in O +
selected O +
samples O -
. O +

As O +
one O +
of O +
our O +
purposes O +
of O +
this O +
study O +
was O +
to O +
distinguish O +
between O +
human O +
fibroblast O +
feeders O +
cells O +
and O +
hESCs O +
and O +
hEBs O -
, O +
wishing O +
to O +
readily O +
detect O +
feeder O +
contamination O +
in O +
hESCs O -
, O +
we O +
included O +
one O +
of O +
the O +
human O +
feeder O +
cells O +
HS27 B-CellLine +
( O -
ATCC O -
) O +
in O +
this O +
study O -
. O +

We O +
have O +
been O +
using O +
HS27 B-CellLine +
as O +
feeder O +
cells O +
for O +
H9 B-CellLine +
hESCs O +
for O +
more O +
than O +
two O +
years O +
and O +
all O +
hESCs O +
grown O +
on O +
HS27 B-CellLine +
had O +
normal O +
karyotype O -
, O +
expressed O +
all O +
undifferentiated O +
markers O -
, O +
and O +
made O +
teratomas O +
with O +
all O +
germ O +
layers O +
( O -
data O +
not O +
show O -
) O -
. O +

The O +
global O +
pairwise O +
comparison O +
clearly O +
showed O +
that O +
human O +
feeders O +
were O +
far O +
more O +
dissimilar O +
to O +
hESCs O +
than O +
hESCs O +
grown O +
in O +
different O +
laboratories O -
, O +
hESCs O +
compared O +
to O +
their O +
differentiated O +
EBs O +
that O +
contained O +
mesodermal O +
tissue O -
, O +
and O +
hESCs O +
compared O +
to O +
the O +
karyotypically O +
variant O +
hESC O +
line O +
BG01V B-CellLine -
. O +

Pairwise O +
comparisons O +
of O +
human O +
feeders O +
with O +
hESCs O +
resulted O +
in O +
a O +
correlation O +
coefficient O +
of O +
0.66 O -
, O +
which O +
was O +
less O +
than O +
the O +
correlation O +
coefficient O +
of O +
0.71–0.74 O +
observed O +
between O +
hESCs O +
and O +
their O +
corresponding O +
EBs O -
. O +

The O +
large O +
difference O +
between O +
human O +
feeders O +
and O +
hESCs O +
suggested O +
that O +
it O +
would O +
be O +
possible O +
to O +
identify O +
markers O +
that O +
were O +
robust O +
and O +
reliable O +
in O +
distinguishing O +
the O +
two O +
populations O -
, O +
and O +
these O +
markers O +
would O +
be O +
sufficiently O +
sensitive O +
in O +
detecting O +
contamination O +
of O +
feeders O -
. O +

We O +
examined O +
the O +
data O +
to O +
develop O +
a O +
list O +
of O +
genes O +
that O +
had O +
high O +
levels O +
of O +
expression O +
in O +
human O +
feeder O +
cells O +
maintained O +
in O +
hESC O +
medium O +
but O +
whose O +
expression O +
was O +
low O +
or O +
absent O +
in O +
either O +
ESCs O +
or O +
EBs O -
. O +

The O +
absence O +
of O +
expression O +
in O +
EBs O +
was O +
used O +
as O +
a O +
control O +
for O +
spontaneous O +
differentiation O +
of O +
ESC O +
colonies O +
( O -
including O +
mesodermal O +
differentiation O -
) O +
which O +
may O +
occur O +
and O +
the O +
markers O +
selected O +
should O +
be O +
able O +
to O +
distinguish O +
between O +
these O +
two O +
events O -
. O +

A O +
complete O +
list O +
of O +
genes O +
expressed O +
at O +
least O +
ten O -
- O -
fold O +
higher O +
in O +
human O +
feeders O +
is O +
provided O +
in O +
Figure O +
3 O -
. O +

Quantitative O +
RT O -
- O -
PCR O +
( O -
qPCR O -
) O +
was O +
used O +
to O +
verify O +
the O +
fold O +
change O +
of O +
the O +
expression O +
of O +
4 O +
genes O -
, O +
including O +
THBS1 O -
, O +
MMP3 O -
, O +
TNFRSF11B O +
and O +
KRTHA4 O +
( O -
Figure O +
3C O -
) O -
. O +

Further O +
confirmation O +
can O +
also O +
be O +
done O +
using O +
immunocytochemistry O -
, O +
as O +
antibodies O +
against O +
these O +
genes O +
are O +
commercially O +
available O -
. O +

Figure O +
3Human O +
fibroblast O +
feeder O +
cells O +
can O +
be O +
distinguished O +
from O +
hESCs O +
and O +
EBs O -
. O +

Bead O +
array O +
identified O +
lists O +
of O +
genes O +
that O +
were O +
uniquely O +
expressed O +
in O +
human O +
fibroblast O +
feeders O +
as O +
compared O +
to O +
hESCs O +
( O -
A O -
) O +
and O +
hEBs O +
( O -
B O -
) O -
. O +

The O +
four O +
genes O +
whose O +
expression O +
was O +
confirmed O +
by O +
qPCR O +
( O -
C O -
) O +
were O +
in O +
bold O -
. O +

In O +
the O +
graph O +
( O -
C O -
) O -
, O +
gene O +
expression O +
of O +
each O +
gene O +
in O +
feeder O +
cells O +
was O +
designated O +
as O +
1 O +
fold O +
and O +
the O +
bars O +
represented O +
fold O +
decrease O +
for O +
each O +
gene O -
. O +

Thus O +
this O +
comparison O +
allowed O +
us O +
to O +
distinguish O +
between O +
hESCs O +
and O +
human O +
feeders O +
and O +
identify O +
candidate O +
markers O +
that O +
could O +
detect O +
feeder O +
cell O +
contamination O +
should O +
human O +
feeders O +
be O +
used O +
in O +
the O +
propagation O +
of O +
hESCs O -
. O +

hESCs O +
and O +
EBs O +
can O +
be O +
distinguished O +
from O +
each O +
otherIllumina O +
bead O +
array O +
analysis O +
confirmed O +
that O +
hESCs O +
could O +
be O +
readily O +
distinguished O +
from O +
EBs O +
by O +
global O +
analysis O -
. O +

This O +
raised O +
the O +
possibility O +
that O +
specific O +
subsets O +
of O +
markers O +
could O +
be O +
identified O -
. O +

We O +
and O +
others O +
have O +
used O +
MPSS O +
and O +
EST O +
scan O +
and O +
generated O +
array O +
data O +
to O +
make O +
lists O +
of O +
hESC O -
- O -
specific O +
genes O +
[ O -
5,9,10,20 O -
] O -
. O +

As O +
discussed O +
above O -
, O +
most O +
hESC O +
markers O +
identified O +
by O +
MPSS O +
have O +
been O +
detected O +
in O +
the O +
present O +
bead O +
array O +
analysis O +
( O -
Table O +
3 O -
) O -
, O +
confirming O +
the O +
utility O +
of O +
these O +
previously O +
identified O +
markers O +
for O +
use O +
in O +
assessing O +
undifferentiated O +
status O +
of O +
hESCs O -
. O +

In O +
addition O -
, O +
we O +
have O +
generated O +
a O +
list O +
of O +
genes O +
differentially O +
expressed O +
at O +
higher O +
level O +
in O +
EBs O +
than O +
in O +
hESCs O -
, O +
a O +
subset O +
of O +
which O +
is O +
shown O +
in O +
Table O +
5 O -
. O +

These O +
markers O +
were O +
common O +
to O +
all O +
EB O +
samples O +
tested O +
and O +
included O +
genes O +
known O +
to O +
be O +
expressed O +
in O +
ectoderm O -
, O +
endoderm O +
and O +
mesoderm O -
. O +

The O +
entire O +
set O +
of O +
differentially O +
expressed O +
genes O +
is O +
provided O +
in O +
Additional O +
file O +
3 O -
. O +

Thus O -
, O +
the O +
bead O +
array O +
format O -
, O +
which O +
allows O +
multiple O +
pairwise O +
comparisons O -
, O +
can O +
be O +
used O +
to O +
identify O +
genes O +
that O +
are O +
expressed O +
by O +
all O +
differentiating O +
EB O +
samples O +
in O +
the O +
present O +
study O -
. O +

Our O +
data O +
suggested O +
that O +
a O +
core O +
set O +
of O +
limited O +
markers O +
might O +
be O +
sufficient O +
to O +
monitor O +
the O +
process O +
of O +
differentiation O -
. O +

By O +
suitable O +
selection O +
of O +
different O +
germ O +
cell O +
layer O +
specific O +
markers O +
one O +
may O +
also O +
assess O +
the O +
overall O +
quality O +
of O +
differentiation O +
toward O +
germ O +
cells O -
. O +

Table O +
5Genes O +
which O +
are O +
differentially O +
expressed O +
at O +
higher O +
levels O +
in O +
EBs O +
than O +
in O +
hESCsSymbolAll O +
EBAll O +
ESEB O -
/ O -
ESRELN11120.52224.0SST1394.25.5253.5SLC40A11210.19.1133.0IGF24896.938.4127.5SLN2017.817118.7DCN7588.176.299.6ANXA84048.941.996.6AQP11665.420.581.2APOB1256.415.879.5AHSG1414.320.868.0NID21476.731.447.0FGB221052.442.2LUM8439.4205.441.1MGP2772.469.839.7THBD1206.434.435.1SERPINA11255.643.728.7HAND112294437.428.1HBE11106.542.626.0TTR7661.2347.122.1HBG21601.185.618.7COL2A11636.291.817.8KIAA09771370.87817.6AFP8941552.316.2COL3A11355796714.0IGFBP38446.3603.414.0PAX61577.8118.213.3APOA19398.1709.813.2FRZB3523.7315.711.2SPON21548.7159.49.7CEBPD1100.2122.79.0DLK13355.8374.89.0RDC11589.7192.18.3BMP41851.5227.38.1PITX21057.9131.28.1ACTA25045629.88.0GAS11215.61547.9AGTRL11053.8135.17.8COL5A15876.4765.47.7CDKN1C3134.1412.97.6CXCL142220.5312.67.1DOK41011.1145.27.0ARHGDIB1635.3246.56.6FLRT21879.5314.36.0MSX12771.8499.75.5 O +
Smaller O +
but O +
distinct O +
differences O +
among O +
undifferentiated O +
hESC O +
linesOur O +
cluster O +
analysis O +
indicated O +
that O +
BG01 B-CellLine -
, O +
BG02 B-CellLine +
and O +
BG03 B-CellLine +
cell O +
lines O +
were O +
overall O +
more O +
similar O +
to O +
each O +
other O +
than O +
to O +
other O +
lines O +
( O -
Figure O +
1 O +
and O +
2 O -
) O -
, O +
but O +
nevertheless O +
showed O +
additional O +
differences O +
than O +
technical O +
or O +
biological O +
repeats O +
of O +
the O +
same O +
sample O -
. O +

This O +
raised O +
the O +
possibility O +
that O +
this O +
microarray O +
strategy O +
may O +
be O +
sufficiently O +
sensitive O +
to O +
identify O +
relatively O +
cell O +
type O +
specific O +
candidate O +
genes O +
that O +
could O +
be O +
used O +
to O +
distinguish O +
one O +
hESC O +
population O +
from O +
another O +
or O +
to O +
identify O +
differences O +
that O +
were O +
due O +
to O +
varied O +
isolation O +
and O +
growth O +
conditions O -
. O +

As O +
a O +
test O +
we O +
looked O +
for O +
differences O +
between O +
BG01 B-CellLine -
, O +
BG02 B-CellLine +
and O +
BG03 B-CellLine -
, O +
which O +
were O +
grown O +
in O +
the O +
same O +
laboratory O +
under O +
the O +
same O +
conditions O -
. O +

Lists O +
of O +
candidate O +
genes O +
are O +
shown O +
in O +
Figure O +
4A O -
, O +
C O +
and O +
4E O +
and O +
the O +
comparison O +
of O +
these O +
three O +
lines O +
are O +
shown O +
in O +
scatter O +
plots O +
in O +
Figure O +
4B O -
, O +
D O +
and O +
4F.Figure O +
4BG O +
lines O +
show O +
small O +
but O +
distinct O +
differences O +
as O +
assessed O +
by O +
bead O +
array O -
. O +

These O +
three O +
hESC O +
lines O +
share O +
high O +
similarities O +
as O +
shown O +
by O +
the O +
scatterplots O +
of O +
BG01 B-CellLine +
vs O +
BG02 B-CellLine +
( O -
B O -
) O -
, O +
BG01 B-CellLine +
vs O +
BG03 B-CellLine +
( O -
D O -
) O +
and O +
BG02 B-CellLine +
vs O +
BG03 B-CellLine +
( O -
F O -
) O -
. O +

Comparisons O +
of O +
all O +
three O +
lines O +
were O +
made O +
and O +
lists O +
of O +
selected O +
genes O +
that O +
were O +
specifically O +
expressed O +
in O +
BG01 B-CellLine +
( O -
A O -
) O -
, O +
BG02 B-CellLine +
( O -
C O -
) O +
and O +
BG03 B-CellLine +
( O -
F O -
) O +
are O +
shown O -
. O +

Correlation O +
coefficients O +
( O -
R2 O -
) O +
were O +
generated O +
using O +
all O +
genes O +
with O +
expression O +
level O +
> O -
0 O +
( O -
black O +
and O +
blue O +
dots O -
) O -
, O +
or O +
all O +
genes O +
with O +
detection O +
confidence O +
> O -
0.99 O +
( O -
blue O +
dots O -
) O -
. O +

Genes O +
outside O +
the O +
two O +
thin O +
red O +
lines O +
were O +
detected O +
at O +
> O -
2.5- O +
fold O +
difference O -
. O +

We O +
reasoned O +
as O +
well O +
that O +
such O +
a O +
global O +
comparison O +
should O +
allow O +
us O +
to O +
distinguish O +
between O +
male O +
and O +
female O +
lines O +
if O +
genes O +
present O +
on O +
the O +
Y O +
chromosome O +
were O +
expressed O +
at O +
high O +
levels O +
in O +
the O +
undifferentiated O +
state O +
and O +
were O +
detected O +
by O +
the O +
bead O +
array O -
. O +

Several O +
such O +
candidate O +
genes O +
were O +
identified O -
. O +

The O +
most O +
robust O +
were O +
RPS4Y O -
, O +
RPS4Y2 O -
, O +
and O +
EIF1AY O +
( O -
Figure O +
5 O -
) O -
. O +

To O +
confirm O +
that O +
these O +
were O +
useful O +
markers O -
, O +
we O +
designed O +
RT O -
- O -
PCR O +
primers O +
and O +
tested O +
their O +
expression O +
in O +
a O +
male O +
( O -
BG01 B-CellLine -
) O +
and O +
a O +
female O +
( O -
BG03 B-CellLine -
) O +
line O +
( O -
Figure O +
5B O -
) O -
. O +

We O +
noted O +
that O +
several O +
of O +
these O +
continued O +
to O +
be O +
expressed O +
at O +
high O +
levels O +
as O +
ESCs O +
differentiated O +
to O +
form O +
EBs O +
and O +
upon O +
further O +
differentiation O +
( O -
data O +
not O +
shown O -
) O -
, O +
suggesting O +
that O +
these O +
markers O +
might O +
be O +
used O +
in O +
adult O +
stem O +
cell O +
and O +
germ O +
cell O +
populations O +
as O +
well O -
. O +

Figure O +
5Male O +
and O +
female O +
hESC O +
lines O +
can O +
be O +
distinguished O +
by O +
genes O +
identified O +
by O +
bead O +
array O -
. O +

Five O +
potential O +
genes O +
RPS4Y O -
, O +
RPS4Y2 O -
, O +
EIF1AY O -
, O +
VCY O -
, O +
and O +
AMELY O +
are O +
located O +
in O +
the O +
Y O +
chromosome O -
. O +

By O +
comparing O +
the O +
expression O +
level O +
of O +
these O +
genes O +
in O +
all O +
hESC O +
lines O -
, O +
we O +
have O +
found O +
that O +
3 O +
out O +
of O +
5 O +
were O +
specifically O +
expressed O +
in O +
male O +
hESC O +
lines O +
I6 B-CellLine -
, O +
BG01 B-CellLine +
and O +
BG02 B-CellLine +
( O -
A O -
) O +
and O +
this O +
was O +
verified O +
by O +
RT O -
- O -
PCR O +
in O +
male O +
line O +
BG01 B-CellLine +
and O +
female O +
line O +
BG03 B-CellLine +
( O -
B O -
) O -
. O +

G3PDH O +
was O +
used O +
as O +
an O +
internal O +
control O -
. O +

* O -
: O +
represents O +
the O +
gene O +
expression O +
level O +
is O +
detected O +
at O +
< O -
0.99 O +
confidence O -
. O +

In O +
summary O -
, O +
our O +
data O +
suggest O +
that O +
the O +
bead O +
array O +
format O +
is O +
sufficiently O +
sensitive O +
and O +
global O +
that O +
it O +
can O +
distinguish O +
one O +
cell O +
line O +
from O +
another O +
even O +
if O +
those O +
two O +
cell O +
lines O +
are O +
grown O +
in O +
the O +
same O +
laboratory O +
under O +
virtually O +
identical O +
conditions O -
. O +

Bead O +
array O +
can O +
also O +
be O +
used O +
to O +
distinguish O +
between O +
male O +
and O +
female O +
lines O -
. O +

Comparison O +
of O +
diploid O +
pluripotent O +
cells O +
with O +
NTera2 B-CellLine +
and O +
BG01 B-CellLine +
variantOur B-CellLine +
previous O +
results O +
have O +
suggested O +
that O +
EC O +
lines O +
share O +
many O +
of O +
the O +
properties O +
of O +
hESCs O +
and O +
can O +
be O +
used O +
as O +
a O +
useful O +
model O +
for O +
initial O +
testing O +
of O +
biological O +
questions O +
[ O -
21 O -
] O -
. O +

More O +
recently O +
we O +
have O +
identified O +
BG01V B-CellLine +
as O +
a O +
karyotypically O +
abnormal O +
variant O +
that O +
behaves O +
much O +
like O +
its O +
normal O +
counterpart O +
BG01 B-CellLine -
, O +
but O +
is O +
not O +
subject O +
to O +
the O +
same O +
constraints O +
of O +
use O +
as O +
karyotypically O +
normal O +
hESCs O +
[ O -
13 O -
] O -
. O +

Given O +
the O +
sensitivity O +
of O +
the O +
bead O +
array O +
analysis O -
, O +
we O +
tested O +
its O +
ability O +
to O +
detect O +
the O +
overall O +
similarities O +
and O +
differences O +
between O +
NTera2 B-CellLine +
and O +
a O +
pooled O +
ESC O +
sample O +
or O +
between O +
the O +
karyotypically O +
abnormal O +
BG01V B-CellLine +
and O +
its O +
normal O +
parent O +
line O +
( O -
Figure O +
6 O -
) O -
.Figure O +
6Diploid O +
pluripotent O +
EC O +
cell O +
line O +
NTera2 B-CellLine +
and O +
karyotypically O +
abnormal O +
hESC O +
line O +
BG01V B-CellLine +
can O +
be O +
distinguished O +
from O +
normal O +
hESCs O +
using O +
Illumina O +
array O -
. O +

Comparison O +
of O +
NTera2 B-CellLine +
and O +
pooled O +
hESC O +
sample O +
resulted O +
a O +
correlation O +
coefficient O +
of O +
0.8997 O -
. O +

Two O +
lists O +
of O +
genes O -
, O +
which O +
were O +
specifically O +
expressed O +
in O +
NTera2 B-CellLine +
( O -
C O -
) O +
or O +
in O +
hESCs O +
( O -
E O -
) O +
were O +
identified O -
. O +

Likewise O -
, O +
while O +
sharing O +
similarities O +
with O +
BG01 B-CellLine +
( O -
B O -
, O +
correlation O +
coefficient= O +
0.9043 O -
) O -
, O +
BG01V B-CellLine +
was O +
different O +
from O +
BG01 B-CellLine +
in O +
expression O +
for O +
many O +
genes O -
, O +
particularly O +
genes O +
from O +
the O +
TGFβ O +
pathway O +
( O -
D O -
, O +
F O -
) O -
. O +

Black O +
dots O +
represent O +
genes O +
that O +
were O +
detected O +
at O +
> O -
0 O +
expression O +
level O -
, O +
blue O +
dots O +
represent O +
genes O +
that O +
were O +
detected O +
both O +
at O +
> O +
0 O +
expression O +
level O +
and O +
at O +
> O -
0.99 O +
confidence O -
. O +

Genes O +
plotted O +
outside O +
the O +
two O +
thin O +
red O +
lines O +
were O +
detected O +
at O +
> O -
2.5- O +
fold O +
difference O -
. O +

Our O +
results O +
showed O +
that O -
, O +
while O +
NTera2 B-CellLine +
shared O +
a O +
high O +
similarity O +
with O +
hESCs O +
[ O -
21 O -
] O -
, O +
it O +
did O +
have O +
important O +
differences O +
with O +
hESC O +
lines O -
. O +

Examining O +
these O +
differences O +
( O -
summarized O +
in O +
Figure O +
6C O +
and O +
6E O -
) O -
, O +
we O +
noted O +
that O +
some O +
reflected O +
the O +
origin O +
of O +
the O +
tumor O +
cells O +
from O +
which O +
this O +
line O +
was O +
derived O +
[ O -
14 O -
] O -
. O +

Several O +
germ O +
cell O +
markers O +
such O +
as O +
GAGE2 O -
, O +
GAGE7 O +
and O +
GAGE8 O +
were O +
highly O +
expressed O +
in O +
NTera2 B-CellLine +
but O +
were O +
absent O +
( O -
or O +
present O +
at O +
low O +
levels O -
) O +
in O +
any O +
of O +
the O +
hESC O +
lines O +
examined O +
( O -
See O +
Figure O +
6C O +
and O +
Additional O +
file O +
1 O -
. O +

Note O +
that O +
the O +
GAGE O +
genes O +
are O +
highly O +
similar O +
in O +
sequence O -
, O +
making O +
it O +
difficult O +
to O +
distinguish O +
one O +
family O +
member O +
from O +
another O +
through O +
hybridization O -
; O +
thus O -
, O +
while O +
all O +
of O +
these O +
GAGE O +
gene O +
probes O +
gave O +
positive O +
signal O -
, O +
it O +
is O +
difficult O +
to O +
say O +
if O +
the O +
signal O +
came O +
from O +
the O +
specific O +
gene O +
itself O +
or O +
from O +
cross O -
- O -
hybridization O +
from O +
one O +
of O +
the O +
other O +
family O +
members O -
) O -
. O +

None O +
of O +
these O +
were O +
present O +
in O +
BG01V B-CellLine -
, O +
indicating O +
that O +
the O +
karyotypically O +
abnormal O +
variant O +
is O +
not O +
the O +
equivalent O +
of O +
a O +
teratocarcinoma O +
line O +
such O +
as O +
NTera2 B-CellLine -
. O +

In O +
addition O +
to O +
the O +
expression O +
of O +
germ O +
cell O +
markers O -
, O +
we O +
noticed O +
a O +
significant O +
difference O +
in O +
the O +
expression O +
of O +
genes O +
in O +
the O +
TGFβ O +
pathway O -
, O +
such O +
as O +
GDF3 O +
( O -
Figure O +
6C O -
) O -
, O +
TGFBI O -
, O +
CDKN1A O -
, O +
IGFBP7 O -
, O +
IGFBP3 O -
, O +
NODAL O -
, O +
CER1 O +
and O +
BMP2 O +
( O -
Figure O +
6E O -
) O -
. O +

This O +
is O +
consistent O +
with O +
the O +
postulated O +
role O +
of O +
this O +
pathway O +
in O +
germ O +
cell O +
differentiation O +
[ O -
22,23 O -
] O +
and O +
suggests O +
that O +
TGFβ O +
pathway O +
can O -
not O +
be O +
reliably O +
tested O +
using O +
NTera2 B-CellLine +
as O +
a O +
model O +
for O +
hESC.The O +
BG01V B-CellLine +
showed O +
clear O +
differences O +
from O +
its O +
normal O +
counterpart O +
and O +
some O +
major O +
changes O +
are O +
summarized O +
in O +
Figure O +
6D O +
and O +
6F O -
. O +

Early O +
markers O +
of O +
differentiation O +
appeared O +
to O +
be O +
present O +
at O +
higher O +
levels O +
in O +
BG01V B-CellLine +
as O +
compared O +
to O +
any O +
of O +
the O +
hESC O +
lines O +
examined O -
, O +
although O +
hESC O +
specific O +
genes O +
continued O +
to O +
be O +
expressed O +
at O +
high O +
levels O +
( O -
see O +
Additional O +
file O +
4 O -
) O -
. O +

In O +
particular O -
, O +
the O +
Wnt O +
pathway O +
and O +
the O +
TGFβ O +
signaling O +
pathway O +
( O -
Figure O +
6D O -
) O -
, O +
both O +
of O +
which O +
involved O +
in O +
the O +
early O +
process O +
of O +
differentiation O +
[ O -
24,25 O -
] O -
, O +
appeared O +
to O +
be O +
activated O +
( O -
Additional O +
file O +
4 O -
) O -
, O +
suggesting O +
that O +
the O +
role O +
of O +
growth O +
factors O +
and O +
signaling O +
in O +
these O +
early O +
events O +
can O -
not O +
be O +
readily O +
studied O +
in O +
this O +
cell O +
line O -
. O +

In O +
summary O -
, O +
the O +
analysis O +
highlighted O +
the O +
utility O +
of O +
the O +
potential O +
reference O +
standards O +
NTera2 B-CellLine +
and O +
BG01V B-CellLine -
, O +
demonstrated O +
their O +
general O +
similarity O +
and O +
provided O +
detail O +
on O +
potential O +
caveats O +
to O +
their O +
application O -
. O +

Global O +
arrays O +
provide O +
a O +
snapshot O +
of O +
the O +
state O +
of O +
the O +
cells O +
and O +
identify O +
core O +
self O -
- O -
renewal O +
pathwaysWe O +
have O +
utilized O +
a O +
small O +
fraction O +
of O +
the O +
data O +
to O +
demonstrate O +
the O +
overall O +
utility O +
of O +
this O +
approach O +
and O +
its O +
sensitivity O +
in O +
identifying O +
small O +
differences O +
in O +
cell O +
populations O -
. O +

An O +
additional O +
potential O +
application O +
of O +
such O +
an O +
analysis O +
is O +
the O +
ability O +
to O +
examine O +
the O +
general O +
state O +
of O +
a O +
particular O +
signaling O +
pathway O +
and O +
determine O +
whether O +
it O +
is O +
active O -
. O +

By O +
comparing O +
across O +
many O +
samples O -
, O +
a O +
procedure O +
previously O +
expensive O +
and O +
difficult O +
in O +
terms O +
of O +
the O +
RNA O +
and O +
replicate O +
requirement O -
, O +
one O +
can O +
rapidly O +
identify O +
key O +
regulatory O +
pathways O -
. O +

To O +
test O +
whether O +
we O +
could O +
use O +
such O +
multiple O +
pairwise O +
comparisons O +
to O +
elucidate O +
the O +
major O +
regulatory O +
pathways O +
that O +
may O +
be O +
required O +
for O +
hESC O +
self O -
- O -
renewal O -
, O +
we O +
examined O +
several O +
metabolic O +
pathways O -
. O +

The O +
results O +
of O +
the O +
analysis O +
of O +
the O +
insulin O -
/ O -
insulin O -
- O -
like O +
growth O +
factor O +
( O -
IGF O -
) O +
signaling O +
pathway O +
are O +
shown O +
in O +
Figure O +
7 O -
. O +

Using O +
the O +
same O +
4 O +
groups O +
of O +
samples O +
as O +
in O +
Figure O +
1 O -
, O +
we O +
conducted O +
PAM O +
( O -
Prediction O +
Analysis O +
of O +
Microarray O -
) O +
[ O -
26 O -
] O -
, O +
in O +
search O +
for O +
biomarkers O +
used O +
in O +
diagnostic O +
identification O +
of O +
these O +
four O +
groups O -
, O +
ES O -
, O +
EB O -
, O +
NS O -
, O +
and O +
FB O -
. O +

In O +
PAM O -
, O +
a O +
list O +
of O +
significant O +
IGF O +
pathway O +
genes O +
whose O +
expression O +
characterizes O +
each O +
diagnostic O +
class O +
was O +
obtained O -
. O +

The O +
average O +
gene O +
expression O +
level O +
in O +
each O +
class O +
was O +
divided O +
by O +
the O +
within O -
- O -
class O +
standard O +
deviation O -
. O +

The O +
nearest O +
centroid O +
classification O +
computed O +
took O +
the O +
gene O +
expression O +
profile O +
from O +
a O +
new O +
sample O +
and O +
compared O +
it O +
to O +
each O +
of O +
these O +
class O +
centroids O -
. O +

For O +
cross O -
- O -
validation O +
of O +
prediction O +
results O -
, O +
multiple O +
classification O +
processes O +
were O +
performed O +
on O +
two O +
data O +
sets O +
randomly O +
constructed O +
each O +
time O +
from O +
the O +
entire O +
gene O +
expression O +
dataset O -
. O +

The O +
first O +
dataset O -
, O +
consisting O +
of O +
70 O -
% O +
of O +
the O +
total O +
data O -
, O +
was O +
used O +
as O +
the O +
training O +
dataset O -
, O +
and O +
the O +
other O +
dataset O -
, O +
containing O +
the O +
remaining O +
30 O -
% O +
of O +
data O -
, O +
was O +
used O +
for O +
the O +
data O +
prediction O +
and O +
verification O +
process O -
. O +

The O +
final O +
biomarkers O +
were O +
determined O +
in O +
such O +
a O +
way O +
that O +
the O +
misclassification O +
error O +
rate O +
was O +
minimal O -
. O +

The O +
resulting O +
graph O +
( O -
Figure O +
7 O -
) O +
showed O +
the O +
shrunken O +
class O +
centroids O +
for O +
genes O +
that O +
had O +
at O +
least O +
one O +
nonzero O +
difference O +
in O +
each O +
diagnostic O +
class O -
. O +

The O +
genes O +
with O +
nonzero O +
components O +
in O +
each O +
class O +
were O +
almost O +
mutually O +
exclusive O +
and O +
represented O +
candidate O +
biomarkers O +
for O +
the O +
diagnosis O +
of O +
each O +
class O -
. O +

All O +
data O +
analyses O +
were O +
performed O +
using O +
the O +
bioconductor O +
package O +
[ O -
17 O -
] O -
.Figure O +
7Identification O +
of O +
diagnostic O +
markers O +
by O +
PAM O -
. O +

The O +
shrunken O +
class O +
centroids O +
for O +
genes O +
which O +
have O +
at O +
least O +
one O +
nonzero O +
difference O +
are O +
shown O -
. O +

The O +
genes O +
with O +
nonzero O +
components O +
in O +
each O +
class O +
were O +
almost O +
mutually O +
exclusive O +
and O +
were O +
the O +
candidate O +
molecular O +
markers O +
for O +
the O +
diagnosis O +
of O +
the O +
four O +
groups O +
of O +
cell O +
populations O -
, O +
including O -
, O +
( O -
from O +
left O +
to O +
right O -
) O +
hESC O +
derived O +
mesenchyme O +
and O +
human O +
fibroblast O +
feeder O +
cells O +
( O -
" O -
FB O -
" O -
, O +
n O +
= O +
5 O -
) O -
, O +
undifferentiated O +
hESCs O +
( O -
" O -
ES O -
" O -
, O +
n O +
= O +
11 O -
) O -
, O +
hESC O +
derived O +
neural O +
cells O +
( O -
" O -
NS O -
" O -
, O +
n O +
= O +
3 O -
) O -
, O +
and O +
differentiated O +
ES O +
cells O +
and O +
EB O -
, O +
( O -
" O -
EB O -
" O -
, O +
n O +
= O +
6 O -
) O -
. O +

The O +
identified O +
biomarkers O +
can O +
be O +
used O +
to O +
distinguish O +
the O +
four O +
groups O +
of O +
cell O +
populations O -
. O +

Undifferentiated O +
hESCs O +
have O +
been O +
analyzed O +
by O +
EST O +
scan O -
, O +
MPSS O -
, O +
SAGE O +
and O +
microarray O +
[ O -
5,10,16 O -
] O -
. O +

The O +
goal O +
of O +
these O +
experiments O +
including O +
our O +
own O +
is O +
to O +
develop O +
a O +
low O +
cost O +
reliable O +
method O +
to O +
assess O +
multiple O +
samples O +
to O +
generate O +
a O +
global O +
database O +
of O +
markers O +
and O +
to O +
provide O +
a O +
method O +
of O +
identifying O +
core O +
measures O +
of O +
similarities O +
and O +
differences O +
across O +
multiple O +
laboratories O -
. O +

We O +
and O +
others O +
have O +
proposed O +
three O +
alternative O +
methods O +
of O +
assessment O -
: O +
Quantitative O +
RT O -
- O -
PCR O +
[ O -
9,20 O -
] O -
, O +
focused O +
arrays O +
[ O -
27 O -
] O +
or O +
a O +
large O +
scale O +
array O +
with O +
bioinformatics O +
tools O +
being O +
utilized O +
to O +
focus O +
on O +
appropriate O +
subsets O +
of O +
genes O +
[ O -
5,7,15,16,28 O -
] O -
. O +

Each O +
of O +
these O +
methods O +
has O +
its O +
advantages O +
and O +
disadvantages O -
. O +

The O +
present O +
results O +
suggest O +
that O +
the O +
global O +
Illumina O +
bead O +
array O +
retains O +
the O +
advantages O +
of O +
low O +
cost O +
per O +
sample O +
associated O +
with O +
focused O +
arrays O +
yet O +
still O +
has O +
the O +
strength O +
of O +
the O +
global O +
attributes O +
of O +
MPSS O +
or O +
EST O +
scan O +
while O +
requiring O +
much O +
less O +
RNA O +
and O +
turnaround O +
time O -
. O +

To O +
test O +
this O +
array O +
format O +
we O +
examined O +
samples O +
from O +
a O +
variety O +
of O +
laboratories O +
in O +
a O +
blinded O +
fashion O +
to O +
determine O +
whether O +
the O +
array O +
was O +
sufficiently O +
sensitive O +
and O +
rapid O +
for O +
routine O +
assessment O -
. O +

Duplicates O +
using O +
100 O +
ng O +
of O +
RNA O +
were O +
run O +
and O +
results O +
obtained O +
forty O -
- O -
eight O +
hours O +
later O -
. O +

The O +
resolution O +
was O +
sufficient O +
that O +
ESC O +
samples O +
could O +
be O +
distinguished O +
from O +
one O +
another O +
and O +
a O +
variant O +
karyotypically O +
abnormal O +
subclone O +
could O +
be O +
distinguished O +
from O +
the O +
parent O +
population O +
( O -
correlation O +
coefficient O +
= O +
0.9043 O -
) O -
. O +

Aliquots O +
of O +
the O +
pooled O +
ES O +
and O +
pooled O +
EB O +
samples O -
, O +
which O +
we O +
had O +
prepared O +
for O +
MPSS O -
, O +
were O +
included O +
in O +
this O +
run O +
to O +
compare O +
these O +
two O +
methods O +
directly O -
. O +

The O +
current O +
analysis O +
confirms O +
that O +
comparison O +
across O +
platforms O +
is O +
difficult O +
and O +
that O +
only O +
positive O +
results O +
can O +
be O +
treated O +
with O +
any O +
reliability O -
. O +

The O +
absence O +
of O +
expression O +
can O -
not O +
be O +
readily O +
interpreted O -
. O +

In O +
particular O -
, O +
genes O +
expressed O +
at O +
low O +
levels O +
( O -
greater O +
than O +
70 O -
% O +
of O +
all O +
genes O +
detected O -
) O +
should O +
not O +
be O +
assessed O +
in O +
cross O +
platform O +
comparisons O -
. O +

The O +
limited O +
concordance O +
at O +
low O +
levels O +
raises O +
a O +
question O +
as O +
to O +
how O +
many O +
genes O +
are O +
actually O +
expressed O +
by O +
any O +
one O +
cell O +
line O +
and O +
whether O +
the O +
cutoff O +
of O +
3 O +
tpm O +
used O +
for O +
MPSS O +
or O +
100 O +
intensity O +
units O +
for O +
bead O +
arrays O +
is O +
a O +
reasonable O +
cutoff O -
. O +

We O +
used O +
100 O +
units O +
for O +
our O +
analysis O +
and O +
we O +
would O +
suggest O +
that O +
readers O +
exercise O +
similar O +
caution O -
. O +

Nevertheless O +
even O +
at O +
this O +
higher O +
cutoff O +
the O +
arrays O +
were O +
remarkably O +
sensitive O +
and O +
allowed O +
us O +
to O +
readily O +
distinguish O +
between O +
samples O +
including O +
cells O +
grown O +
in O +
the O +
same O +
laboratory O -
. O +

The O +
basis O +
of O +
the O +
sensitivity O +
could O +
be O +
attributed O +
to O +
a O +
limited O +
set O +
of O +
genes O +
and O +
those O +
genes O +
could O +
be O +
identified O +
for O +
future O +
use O -
. O +

For O +
example O +
BG01V B-CellLine -
, O +
while O +
much O +
more O +
similar O +
to O +
BG01 B-CellLine +
than O +
to O +
any O +
other O +
cell O +
type O -
, O +
could O +
still O +
be O +
distinguished O +
from O +
a O +
biological O +
replicate O +
of O +
BG01 B-CellLine +
by O +
the O +
expression O +
of O +
a O +
particular O +
subset O +
of O +
differentiation O +
markers O +
( O -
Figure O +
6 O -
) O -
. O +

EC O +
cells O +
such O +
as O +
NTera2 B-CellLine +
could O +
be O +
distinguished O +
from O +
hESCs O +
by O +
the O +
expression O +
of O +
germ O +
cell O +
markers O +
and O +
the O +
presence O +
of O +
a O +
partially O +
inactivated O +
TGFβ O +
( O -
BMP O -
) O +
signaling O +
pathway O +
( O -
Figure O +
6 O -
) O -
. O +

Distinguishing O +
ESCs O +
from O +
EBs O +
was O +
relatively O +
straightforward O -
. O +

We O +
have O +
confirmed O +
the O +
utility O +
of O +
previously O +
identified O +
markers O +
for O +
use O +
in O +
this O +
platform O +
as O +
well O +
as O +
identified O +
an O +
additional O +
set O +
of O +
markers O +
that O +
can O +
serve O +
as O +
biomarkers O +
to O +
distinguish O +
between O +
the O +
hESC O +
and O +
EB O +
states O -
. O +

A O +
subset O +
of O +
these O +
markers O +
have O +
been O +
used O +
to O +
develop O +
a O +
qPCR O +
assay O +
that O +
shows O +
such O +
a O +
high O +
sensitivity O +
that O +
changes O +
in O +
cell O +
behavior O +
can O +
be O +
detected O +
after O +
as O +
little O +
as O +
twenty O -
- O -
four O +
hours O +
and O +
the O +
development O +
of O +
EBs O +
can O +
be O +
reliably O +
staged O +
[ O -
10,20 O -
] O -
. O +

During O +
the O +
identification O +
of O +
ES O +
and O +
EB O +
specific O +
markers O -
, O +
we O +
have O +
noticed O +
that O +
some O +
known O +
hESC O +
markers O -
, O +
such O +
as O +
Nanog O -
, O +
was O +
not O +
detected O +
in O +
all O +
populations O +
of O +
hESCs O +
that O +
were O +
included O +
in O +
this O +
analysis O -
. O +

Several O +
ESC O -
- O -
specific O +
gene O -
, O +
including O +
Lin41 O -
, O +
Sox2 O +
and O +
FoxD3 O -
, O +
were O +
not O +
detected O +
in O +
the O +
array O +
either O +
( O -
Table O +
3 O -
) O -
. O +

We O +
believe O +
that O +
the O +
problem O +
with O +
Lin O +
41 O -
, O +
Sox2 O +
and O +
FoxD3 O +
is O +
a O +
technical O +
one O +
as O +
we O +
were O +
able O +
to O +
confirm O +
expression O +
using O +
alternate O +
methods O -
. O +

We O +
are O +
in O +
progress O +
of O +
redesigning O +
appropriate O +
probes O +
for O +
these O +
genes O -
. O +

In O +
the O +
case O +
of O +
the O +
gene O +
Nanog O -
, O +
there O +
are O +
several O +
pseudo O +
genes O +
in O +
the O +
genome O +
for O +
Nanog O +
and O +
it O +
has O +
been O +
a O +
major O +
technical O +
challenge O +
designing O +
primers O +
or O +
probes O +
that O +
are O +
specific O +
and O +
sensitive O -
. O +

We O +
believe O +
that O +
a O +
partial O +
explanation O +
for O +
the O +
variability O +
in O +
Nanog O +
expression O +
is O +
due O +
to O +
the O +
lack O +
of O +
sensitivity O +
to O +
this O +
gene O -
. O +

However O -
, O +
immunocytochemistry O +
while O +
not O +
strictly O +
quantitative O +
shows O +
similar O +
variability O +
when O +
used O +
to O +
assess O +
Nanog O +
expression O +
in O +
different O +
cell O +
lines O +
[ O -
9,27,28 O -
] O -
. O +

This O +
large O +
comparison O +
between O +
samples O +
allowed O +
us O +
to O +
identify O +
markers O +
that O +
distinguish O +
human O +
feeder O +
cells O +
from O +
hESC O -
. O +

While O +
we O +
have O +
listed O +
19 O +
potential O +
markers O +
( O -
Figure O +
3 O -
) O +
and O +
identified O +
several O +
hundred O +
potential O +
markers O +
as O +
shown O +
in O +
Additional O +
file O +
5 O -
, O +
we O +
suggest O +
that O +
as O +
few O +
as O +
3–4 O +
genes O +
may O +
be O +
sufficient O -
. O +

Previously O +
we O +
found O +
that O +
as O +
few O +
as O +
four O +
were O +
satisfactory O +
to O +
distinguish O +
between O +
hESCs O +
and O +
hEBs O -
, O +
which O +
are O +
two O +
much O +
more O +
closely O +
related O +
samples O +
[ O -
9 O -
] O -
. O +

In O +
this O +
study O +
we O +
have O +
confirmed O +
by O +
qPCR O +
the O +
differential O +
expression O +
of O +
four O +
genes O -
, O +
THBS1 O -
, O +
MMP3 O -
, O +
TNFRSF11B O +
and O +
KRTH4 O -
, O +
to O +
separate O +
human O +
fibroblast O +
feeders O +
and O +
hESCs O +
( O -
Figure O +
3 O -
) O -
. O +

Several O +
markers O +
such O +
as O +
MMP3 O +
and O +
TNFRSF11B O +
have O +
commercially O +
available O +
antibodies O +
( O -
R&D O +
systems O -
) O +
that O +
may O +
be O +
used O +
to O +
further O +
confirm O +
contamination O +
of O +
feeder O +
cells O +
by O +
immunocytochemistry O -
. O +

Efforts O +
to O +
identify O +
other O +
useful O +
antibodies O +
based O +
on O +
these O +
results O +
continue O +
[ O -
29 O -
] O -
. O +

While O +
we O +
have O +
focused O +
on O +
the O +
immediate O +
utility O +
of O +
the O +
Illumina O +
array O +
platform O -
, O +
it O +
is O +
important O +
to O +
remember O +
that O +
this O +
array O +
provides O +
a O +
global O +
snapshot O +
of O +
cell O +
state O +
and O +
the O +
data O +
obtained O +
can O +
be O +
readily O +
compared O +
in O +
order O +
to O +
determine O +
key O +
signaling O +
pathways O -
. O +

The O +
ability O +
to O +
compare O +
multiple O +
samples O +
in O +
one O +
run O +
enhances O +
data O +
selectivity O +
and O +
reliability O -
. O +

To O +
make O +
such O +
analysis O +
more O +
readily O +
available O -
, O +
we O +
utilized O +
several O +
software O +
tools O +
including O +
the O +
software O +
package O +
available O +
through O +
Illumina O -
. O +

The O +
BeadStudio O +
software O +
provided O +
with O +
the O +
BeadLab O +
and O +
BeadStudio O +
genetic O +
analysis O +
systems O +
for O +
use O +
with O +
the O +
bead O +
array O +
datasets O +
provides O +
a O +
useful O +
set O +
of O +
analytical O +
and O +
presentation O +
tools O +
that O +
allow O +
straightforward O +
comparisons O -
, O +
which O +
are O +
sufficient O +
for O +
average O +
users O -
. O +

For O +
detailed O +
analysis O +
we O +
recommend O +
using O +
more O +
specific O +
commercial O +
tools O +
or O +
software O +
packages O +
developed O +
by O +
NCBI O -
. O +

In O +
summary O -
, O +
the O +
Illumina O +
bead O +
array O +
has O +
several O +
key O +
strengths O +
including O +
high O +
throughput O -
, O +
low O +
cost O +
and O +
high O +
sensitivity O -
. O +

By O +
using O +
this O +
array O -
, O +
we O +
can O +
readily O +
detect O +
contaminating O +
feeders O +
and O +
spontaneous O +
differentiation O -
, O +
differentiate O +
male O +
and O +
female O +
lines O +
and O +
distinguish O +
between O +
one O +
undifferentiated O +
population O +
and O +
another O -
. O +

Such O +
a O +
global O +
analysis O +
allows O +
us O +
to O +
assess O +
context O +
dependent O +
signaling O +
and O +
identify O +
biomarkers O +
of O +
particular O +
states O +
of O +
cells O -
. O +

Our O +
future O +
efforts O +
will O +
focus O +
on O +
data O +
mining O +
and O +
developing O +
better O +
cross O +
platform O +
comparison O +
tools O +
and O +
generating O +
focused O +
high O +
throughput O +
arrays O +
for O +
quality O +
control O +
in O +
clinical O +
and O +
research O +
settings O -
. O +

hESC O +
cultureThe O +
hESC O +
lines O +
H1 B-CellLine -
, O +
H7 B-CellLine +
and O +
H9 B-CellLine +
( O -
WiCell O -
, O +
Madison O -
, O +
WI O -
) O +
were O +
cultured O +
on O +
feeder O +
layers O +
derived O +
from O +
mitotically O +
inactivated O +
HS27 B-CellLine +
human O +
fibroblast O +
cells O +
( O -
HS27 B-CellLine -
, O +
ATCC O -
) O -
, O +
or O +
mouse O +
embryonic O +
fibroblsts O +
or O +
under O +
feeder O -
- O -
free O +
conditions O +
on O +
Matrigel O +
( O -
BD O -
, O +
Franklin O +
Lakes O -
, O +
NJ O -
) O +
coated O +
plates O +
for O +
at O +
least O +
10 O +
passages O -
. O +

Culture O +
medium O +
for O +
all O +
cultures O +
was O +
composed O +
of O +
DMEM O -
/ O -
F12-Glutamax O +
1:1 O -
, O +
20 O -
% O +
Knockout O +
Serum O +
Replacement O -
, O +
2 O +
mM O +
nonessential O +
amino O +
acids O -
, O +
100 O +
μM O +
beta O -
- O -
mercaptoethanol O -
, O +
50 O +
μg O -
/ O -
ml O +
Pen O -
- O -
Strep O +
( O -
all O +
from O +
Invitrogen O -
, O +
Carlsbad O -
, O +
CA O -
) O -
, O +
and O +
4 O +
ng O -
/ O -
ml O +
human O +
recombinant O +
basic O +
fibroblast O +
growth O +
factor O +
( O -
bFGF O -
/ O -
FGF2 O -
; O +
PeproTech O +
Inc. O -
, O +
Rocky O +
Hill O -
, O +
NJ O -
. O -
) O +

Feeder O -
- O -
free O +
cultures O +
were O +
prepared O +
for O +
gene O +
expression O +
analysis O +
by O +
manually O +
harvesting O +
individual O +
colonies O +
with O +
uniform O +
typical O +
undifferentiated O +
ESC O +
morphology O -
. O +

BG01 B-CellLine +
( O -
46 O -
, O +
XY O -
) O -
, O +
BG02 B-CellLine +
( O -
46 O -
, O +
XY O -
) O -
, O +
BG03 B-CellLine +
( O -
46 O -
, O +
XX O -
) O -
, O +
I6 B-CellLine +
( O -
46 O -
, O +
XY O -
) O +
and O +
BG01V B-CellLine +
( O -
BG01 B-CellLine +
karyotypic O +
variant O -
: O +
49 O -
, O +
XXY O -
, O +
+ O -
12 O -
, O +
+ O -
17 O -
) O -
: O +
Cells O +
were O +
maintained O +
for O +
3 O +
( O -
BG01V B-CellLine -
) O -
, O +
7 O +
( O -
BG02 B-CellLine -
) O -
, O +
8 O +
( O -
BG01 B-CellLine -
) O -
, O +
or O +
21 O +
( O -
BG03 B-CellLine -
) O +
passages O +
under O +
feeder O -
- O -
free O +
condition O +
on O +
fibronectin O -
- O -
coated O +
plates O +
in O +
medium O +
that O +
had O +
been O +
conditioned O +
by O +
mouse O +
embryonic O +
fibroblasts O +
for O +
24 O +
hours O -
. O +

Culture O +
medium O +
was O +
DMEM O -
/ O -
F12 O -
, O +
1:1 O +
supplemented O +
with O +
20 O -
% O +
Knockout O +
Serum O +
Replacement O -
, O +
2 O +
mM O +
non O -
- O -
essential O +
amino O +
acids O -
, O +
2 O +
mM O +
L O -
- O -
glutamine O -
, O +
50 O +
μg O -
/ O -
ml O +
Pen O -
- O -
Strep O -
, O +
100 O +
μM O +
beta O -
- O -
mercaptoethanol O -
, O +
and O +
4 O +
ng O -
/ O -
ml O +
of O +
bFGF.Different O +
hESC O +
lines O +
were O +
grown O +
in O +
slightly O +
different O +
culture O +
conditions O +
as O +
described O +
above O -
. O +

H O +
lines O +
were O +
grown O +
on O +
Matrigel O +
coated O +
dishes O -
, O +
while O +
BG O +
lines O +
on O +
fibronectin O +
treated O +
dishes O -
. O +

These O +
coating O +
substrata O +
supported O +
the O +
growth O +
of O +
hESCs O +
similarly O -
, O +
as O +
evaluated O +
by O +
colony O +
morphology O -
, O +
immunocytochemistry O +
and O +
proliferation O +
rate O +
( O -
data O +
not O +
shown O -
) O -
.Embryoid O +
bodies O +
( O -
EBs O -
) O +
were O +
prepared O +
from O +
BG O +
lines O +
as O +
described O +
in O +
[ O -
5 O -
] O -
. O +

Cells O +
were O +
aggregated O +
and O +
cultured O +
on O +
non O -
- O -
adherent O +
substrata O +
for O +
fourteen O +
days O -
. O +

Other O +
cellsNTera2 O +
cells O +
were O +
purchased O +
from O +
ATCC O +
and O +
cultured O +
in O +
parallel O +
with O +
hESCssamples O +
using O +
protocols O +
described O +
previously O +
[ O -
21 O -
] O -
. O +

HS27 B-CellLine +
embryonic O +
human O +
newborn O +
foreskin O +
cells O +
( O -
ATCC O +
CRL-1634 O -
) O +
were O +
grown O +
in O +
DMEM O +
with O +
10%FBS.All O +
samples O +
included O +
in O +
this O +
study O +
can O +
be O +
found O +
in O +
Additional O +
file O +
6.Bead O +
array O +
gene O +
expression O +
analysisRNA O +
was O +
isolated O +
from O +
cultured O +
cells O +
using O +
the O +
Qiagen O +
RNEasy O +
kit O +
( O -
Qiagen O -
, O +
Inc O -
, O +
Valencia O -
, O +
CA O -
) O -
. O +

Sample O +
amplification O +
was O +
performed O +
using O +
100 O +
ng O +
of O +
total O +
RNA O +
as O +
input O +
material O +
by O +
the O +
method O +
of O +
Van O +
Gelder O +
et O +
al O +
[ O -
30 O -
] O -
. O +

Amplified O +
RNA O +
synthesized O +
from O +
limited O +
quantities O +
of O +
heterogenous O +
cDNA O +
[ O -
30 O -
] O +
was O +
performed O +
using O +
the O +
Illumina O +
RNA O +
Amplification O +
kit O +
( O -
Ambion O -
, O +
Inc. O -
, O +
Austin O -
, O +
TX O -
) O +
following O +
the O +
Manufacturer O +
instructions O -
. O +

Labeling O +
was O +
achieved O +
by O +
use O +
of O +
the O +
incorporation O +
of O +
biotin-16-UTP O +
( O -
Perkin O +
Elmer O +
Life O +
and O +
Analytical O +
Sciences O -
, O +
Boston O -
, O +
MA O -
) O +
present O +
at O +
a O +
ratio O +
of O +
1:1 O +
with O +
unlabeled O +
UTP O -
. O +

Labeled O -
, O +
amplified O +
material O +
( O -
700 O +
ng O +
per O +
array O -
) O +
was O +
hybridized O +
to O +
a O +
pilot O +
version O +
of O +
the O +
Illumina O +
HumanRef-8 O +
BeadChip O +
according O +
to O +
the O +
Manufacturer O -
's O +
instructions O +
( O -
Illumina O -
, O +
Inc. O -
, O +
San O +
Diego O -
, O +
CA O -
) O -
. O +

Amersham O +
fluorolink O +
streptavidin O -
- O -
Cy3 O +
( O -
GE O +
Healthcare O +
Bio O -
- O -
Sciences O -
, O +
Little O +
Chalfont O -
, O +
UK O -
) O +
following O +
the O +
BeadChip O +
manual O -
. O +

Arrays O +
were O +
scanned O +
with O +
an O +
Illumina O +
Bead O +
array O +
Reader O +
confocal O +
scanner O +
according O +
to O +
the O +
Manufacturer O -
's O +
instructions O -
. O +

Array O +
data O +
processing O +
and O +
analysis O +
was O +
performed O +
using O +
Illumina O +
BeadStudio O +
software O -
. O +

Identification O +
of O +
differentially O +
expressed O +
genes O +
and O +
clustering O +
analysisDifferentially O +
expressed O +
genes O +
between O +
ES O +
and O +
EB O +
were O +
identified O +
by O +
ANOVA O +
at O +
p O +
value O +
0.05 O +
using O +
bioconductor O +
[ O -
17 O -
] O -
. O +

Unsupervised O +
hierarchical O +
clustering O +
analysis O +
and O +
principal O +
component O +
analysis O +
( O -
PCA O -
) O +
were O +
conducted O +
using O +
software O +
Pcluster O +
[ O -
31 O -
] O +
and O +
TreeView O +
[ O -
18 O -
] O -
.Identification O +
of O +
diagnostic O +
markersPAM O +
( O -
prediction O +
analysis O +
of O +
microarray O -
) O +
was O +
employed O +
for O +
the O +
identification O +
of O +
diagnostic O +
markers O +
from O +
insulin O +
pathway O +
genes O +
by O +
using O +
the O +
software O +
package O +
bioconductor O +
[ O -
17 O -
] O -
. O +

PAM O +
is O +
a O +
class O +
prediction O +
method O +
for O +
expression O +
data O +
mining O -
. O +

It O +
can O +
provide O +
a O +
list O +
of O +
significant O +
genes O +
whose O +
expression O +
characterizes O +
each O +
diagnostic O +
class O -
. O +

The O +
average O +
gene O +
expression O +
level O +
in O +
multiple O +
classes O -
, O +
such O +
as O +
ES O -
, O +
EB O -
, O +
NS O -
, O +
and O +
FB O -
, O +
was O +
divided O +
by O +
the O +
within O -
- O -
class O +
standard O +
deviation O +
for O +
that O +
gene O -
. O +

The O +
nearest O +
centroid O +
classification O +
computed O +
by O +
PAM O +
takes O +
the O +
protein O +
expression O +
profile O +
from O +
a O +
new O +
sample O -
, O +
and O +
compares O +
it O +
to O +
each O +
of O +
these O +
class O +
centroids O +
[ O -
26 O -
] O -
.RT O -
- O -
PCR O +
and O +
quantitative O +
real O -
- O -
time O +
PCR O +
analysisTotal O +
RNA O +
was O +
isolated O +
with O +
TRIzol O +
( O -
Invitrogen O -
. O +

cDNA O +
was O +
synthesized O +
using O +
2.5 O +
μg O +
total O +
RNA O +
in O +
a O +
20-μl O +
reaction O +
with O +
Superscript O +
II O +
( O -
Invitrogen O -
) O +
and O +
oligo O +
( O -
dT O -
) O -
12–18 O +
( O -
Promega O -
; O +
Madison O -
, O +
WI O -
) O -
. O +

One O +
microliter O +
RNase O +
H O +
( O -
Invitrogen O -
) O +
was O +
added O +
to O +
each O +
tube O +
and O +
incubated O +
for O +
20 O +
minutes O +
at O +
37 O -
° O -
C O +
before O +
proceeding O +
to O +
the O +
RT O -
- O -
PCR O +
analysis O -
. O +

The O +
PCR O +
primers O +
are O -
: O +
RPS4Y O -
- O -
forward O -
: O +
5 O -
' O +
AGATTCTCTTCCGTCGCAG O +
3 O -
' O -
, O +
RPS4Y O -
- O -
reverse O -
, O +
5 O -
' O +
CTCCACCAATCACCATACAC O +
3 O -
' O -
; O +
EIFAY O -
- O -
forward O -
, O +
5 O -
' O +
CTGCTGCATCTTAGTTCAGTC O +
3 O -
' O -
; O +
EIFAY O -
- O -
reverse O +
5 O -
' O +
CTTCCAATCGTCCATTTCCC O +
3 O -
' O -
. O +

Quantitative O +
real O +
time O +
PCR O +
gene O +
specific O +
primer O +
pairs O +
and O +
probes O +
were O +
purchased O +
from O +
Applied O +
Biosystems O +
( O -
Foster O +
City O -
, O +
CA O -
) O +
for O +
the O +
following O +
genes O -
: O +
MMP3 O +
( O -
Hs00233962_m1 O -
) O -
, O +
TFRSF11B O +
( O -
Hs00171068_m1 O -
) O -
, O +
THBS1 O +
( O -
Hs00170236_m1 O -
) O -
, O +
KRTHA4 O +
( O -
Hs00606019_gH O -
) O -
, O +
and O +
for O +
internal O +
control O +
β O -
- O -
actin O +
( O -
ACTB O -
, O +
Hs99999903_m1 O -
) O -
. O +

This O +
work O +
uncovers O +
novel O +
mechanisms O +
of O +
aging O +
within O +
stem O +
cell O +
niches O +
that O +
are O +
evolutionarily O +
conserved O +
between O +
mice O +
and O +
humans O +
and O +
affect O +
both O +
embryonic O +
and O +
adult O +
stem O +
cells O -
. O +

Specifically O -
, O +
we O +
have O +
examined O +
the O +
effects O +
of O +
aged O +
muscle O +
and O +
systemic O +
niches O +
on O +
key O +
molecular O +
identifiers O +
of O +
regenerative O +
potential O +
of O +
human O +
embryonic O +
stem O +
cells O +
( O -
hESCs O -
) O +
and O +
post O -
- O -
natal O +
muscle O +
stem O +
cells O +
( O -
satellite O +
cells O -
) O -
. O +

Our O +
results O +
reveal O +
that O +
aged O +
differentiated O +
niches O +
dominantly O +
inhibit O +
the O +
expression O +
of O +
Oct4 O +
in O +
hESCs O +
and O +
Myf-5 O +
in O +
activated O +
satellite O +
cells O -
, O +
and O +
reduce O +
proliferation O +
and O +
myogenic O +
differentiation O +
of O +
both O +
embryonic O +
and O +
tissue O -
- O -
specific O +
adult O +
stem O +
cells O +
( O -
ASCs O -
) O -
. O +

Therefore O -
, O +
despite O +
their O +
general O +
neoorganogenesis O +
potential O -
, O +
the O +
ability O +
of O +
hESCs O -
, O +
and O +
the O +
more O +
differentiated O +
myogenic O +
ASCs O +
to O +
contribute O +
to O +
tissue O +
repair O +
in O +
the O +
old O +
will O +
be O +
greatly O +
restricted O +
due O +
to O +
the O +
conserved O +
inhibitory O +
influence O +
of O +
aged O +
differentiated O +
niches O -
. O +

Significantly O -
, O +
this O +
work O +
establishes O +
that O +
hESC O -
- O -
derived O +
factors O +
enhance O +
the O +
regenerative O +
potential O +
of O +
both O +
young O +
and O -
, O +
importantly O -
, O +
aged O +
muscle O +
stem O +
cells O +
in O +
vitro O +
and O +
in O +
vivo O -
; O +
thus O -
, O +
suggesting O +
that O +
the O +
regenerative O +
outcome O +
of O +
stem O +
cell O -
- O -
based O +
replacement O +
therapies O +
will O +
be O +
determined O +
by O +
a O +
balance O +
between O +
negative O +
influences O +
of O +
aged O +
tissues O +
on O +
transplanted O +
cells O +
and O +
positive O +
effects O +
of O +
embryonic O +
cells O +
on O +
the O +
endogenous O +
regenerative O +
capacity O -
. O +

Comprehensively O -
, O +
this O +
work O +
points O +
toward O +
novel O +
venues O +
for O +
in O +
situ O +
restoration O +
of O +
tissue O +
repair O +
in O +
the O +
old O +
and O +
identifies O +
critical O +
determinants O +
of O +
successful O +
cell O -
- O -
replacement O +
therapies O +
for O +
aged O +
degenerating O +
organs O -
. O +

Embryonic O +
stem O +
cells O +
( O -
ESCs O -
) O +
are O +
distinguished O +
by O +
their O +
ability O +
to O +
self O -
- O -
renew O +
and O +
to O +
differentiate O +
into O +
any O +
other O +
cell O +
type O +
via O +
asymmetric O +
cell O +
divisions O -
, O +
in O +
which O +
one O +
daughter O +
cell O +
maintains O +
' O -
stemness O -
' O +
while O +
the O +
other O +
daughter O +
cell O +
differentiates O +
into O +
a O +
particular O +
tissue O +
type O -
. O +

ESCs O -
, O +
including O +
those O +
of O +
human O +
origin O +
( O -
hESCs O -
) O -
, O +
are O +
derived O +
from O +
the O +
blastocyst O +
and O +
can O +
be O +
propagated O +
in O +
vitro O +
( O -
Evans O +
& O +
Kaufman O -
, O +
1981 O -
; O +
Thomson O +
et O +
al. O -
, O +
1998 O -
; O +
Wobus O +
& O +
Boheler O -
, O +
2005 O -
) O -
. O +

Their O +
tremendous O +
potential O +
for O +
organogenesis O +
has O +
created O +
a O +
great O +
interest O +
in O +
using O +
hESCs O +
for O +
replacing O +
tissues O +
and O +
organs O +
lost O +
to O +
disease O -
, O +
or O +
old O +
age O +
( O -
reviewed O +
in O +
Wobus O +
& O +
Boheler O -
, O +
2005 O -
) O -
. O +

As O +
such O -
, O +
the O +
use O +
of O +
hESCs O +
is O +
particularly O +
important O -
, O +
due O +
to O +
the O +
fact O +
that O +
adult O +
organ O +
stem O +
cells O +
are O +
often O +
limited O +
in O +
number O -
, O +
cell O -
- O -
fate O +
plasticity O -
, O +
expansion O +
capacity O -
, O +
telomere O +
length O -
, O +
and O +
lifespan O +
( O -
Mayhall O +
et O +
al. O -
, O +
2004 O -
) O -
. O +

The O +
general O +
goal O +
behind O +
most O +
cell O -
- O -
replacement O +
approaches O +
is O +
to O +
expand O +
and O +
then O +
differentiate O +
hESCs O +
in O +
vitro O -
, O +
thus O +
producing O +
a O +
cell O +
type O +
of O +
interest O -
, O +
such O +
as O +
neuronal O -
, O +
blood O -
, O +
endothelial O -
, O +
pancreatic O -
, O +
bone O -
, O +
and O +
others O -
. O +

These O +
differentiated O +
cells O +
are O +
expected O +
to O +
replace O +
their O +
dysfunctional O +
counterparts O +
in O +
vivo O -
. O +

The O +
scope O +
of O +
disorders O +
that O +
can O +
be O +
potentially O +
treated O +
with O +
a O +
neoorganogenesis O +
approach O +
is O +
large O +
and O +
includes O +
many O +
that O +
are O +
currently O +
incurable O -
, O +
such O +
as O +
muscle O +
atrophy O -
, O +
diabetes O -
, O +
Alzheimer O -
's O +
disease O -
, O +
Parkinson O -
's O +
disease O -
, O +
and O +
other O +
degenerative O +
diseases O +
that O +
often O +
accompany O +
human O +
aging O +
( O -
McDonald O +
et O +
al. O -
, O +
1999 O -
; O +
Liu O +
et O +
al. O -
, O +
2000 O -
; O +
Hori O +
et O +
al. O -
, O +
2002 O -
; O +
Kim O +
et O +
al. O -
, O +
2002 O -
; O +
Blyszczuk O +
et O +
al. O -
, O +
2003 O -
) O -
. O +

While O +
many O +
studies O +
have O +
focused O +
on O +
the O +
derivation O -
, O +
propagation O -
, O +
and O +
in O +
vitro O +
differentiation O +
of O +
hESCs O +
( O -
reviewed O +
in O +
Hoffman O +
& O +
Carpenter O -
, O +
2005 O -
; O +
Wobus O +
& O +
Boheler O -
, O +
2005 O -
) O -
, O +
relatively O +
few O +
have O +
examined O +
the O +
properties O +
of O +
these O +
cells O +
and O +
their O +
more O +
differentiated O +
progeny O +
in O +
the O +
aged O -
, O +
as O +
opposed O +
to O +
the O +
young O -
, O +
systemic O +
and O +
local O +
organ O +
environments O -
. O +

Recently O +
published O +
data O +
suggest O +
that O +
these O +
extrinsic O +
cues O +
become O +
altered O +
with O +
age O +
in O +
ways O +
that O +
preclude O +
activation O +
of O +
organ O +
stem O +
cells O +
( O -
such O +
as O +
satellite O +
cells O -
) O -
, O +
inhibit O +
repair O -
- O -
specific O +
molecular O +
signaling O +
( O -
such O +
as O +
delta O -
- O -
Notch O -
) O -
, O +
and O +
interfere O +
with O +
productive O +
tissue O +
repair O +
( O -
Conboy O +
et O +
al. O -
, O +
2003 O -
, O +
2005 O -
; O +
Janzen O +
et O +
al. O -
, O +
2006 O -
; O +
Krishnamurthy O +
et O +
al. O -
, O +
2006 O -
; O +
Molofsky O +
et O +
al. O -
, O +
2006 O -
) O -
. O +

Furthermore O -
, O +
at O +
least O +
two O +
lines O +
of O +
evidence O +
suggest O +
that O +
stem O +
cell O -
- O -
based O +
tissue O -
- O -
replacement O +
therapies O +
might O +
be O +
hindered O +
in O +
the O +
elderly O -
, O +
because O +
all O +
cells O +
along O +
the O +
developmental O +
lineage O +
( O -
e.g. O -
, O +
stem O +
cells O -
, O +
more O +
differentiated O +
progenitor O +
cells O +
or O +
even O +
tissues O +
containing O +
a O +
pool O +
of O +
precursors O -
) O +
might O +
rapidly O +
' O -
age O -
' O +
and O +
fail O +
to O +
contribute O +
to O +
organ O +
repair O +
when O +
introduced O +
into O +
the O +
old O +
organism O +
in O +
vivo O -
. O +

First O -
, O +
in O +
heterochronic O +
tissue O -
- O -
transplantation O +
studies O -
, O +
the O +
age O +
of O +
the O +
host O +
environment O +
determined O +
the O +
regenerative O +
outcome O -
, O +
as O +
both O +
young O +
and O +
old O +
skeletal O +
muscle O +
explants O +
containing O +
differentiated O +
and O +
precursor O +
cells O +
effectively O +
regenerated O +
in O +
young O -
, O +
but O +
not O +
in O +
old O +
animals O +
( O -
Zacks O +
& O +
Sheff O -
, O +
1982 O -
; O +
Carlson O +
& O +
Faulkner O -
, O +
1989 O -
) O -
. O +

Second O -
, O +
using O +
parabiotically O +
paired O +
young O +
and O +
old O +
mice O -
, O +
the O +
regenerative O +
potential O +
of O +
muscle O +
and O +
liver O +
was O +
shown O +
to O +
be O +
influenced O +
by O +
the O +
age O +
of O +
the O +
systemic O +
environment O +
( O -
Conboy O +
et O +
al. O -
, O +
2005 O -
) O -
. O +

Thus O -
, O +
we O +
sought O +
to O +
determine O +
whether O +
key O +
molecular O +
identifiers O +
of O +
stem O +
cell O +
properties O -
, O +
the O +
rate O +
of O +
cell O +
proliferation O -
, O +
and O +
the O +
myogenic O +
capacity O +
would O +
be O +
influenced O +
by O +
the O +
age O +
of O +
extrinsic O +
milieu O -
, O +
regardless O +
of O +
whether O +
stem O +
cells O +
are O +
embryonic O +
or O +
the O +
more O +
differentiated O -
, O +
muscle O -
- O -
specific O +
satellite O +
cells O -
. O +

Satellite O +
cells O +
are O +
muscle O +
stem O +
cells O +
situated O +
in O +
direct O +
contact O +
with O +
myofibers O -
, O +
the O +
differentiated O +
muscle O +
cells O -
. O +

When O +
myofibers O +
are O +
damaged O -
, O +
quiescent O +
satellite O +
cells O +
are O +
activated O +
to O +
proliferate O +
and O +
then O +
differentiate O +
into O +
fusion O -
- O -
competent O +
myoblasts O +
that O +
continue O +
to O +
proliferate O +
and O +
can O +
form O +
primary O +
cultures O -
, O +
but O +
are O +
also O +
capable O +
of O +
producing O +
new O -
, O +
multinucleated O +
myofibers O +
or O +
myotubes O +
in O +
vitro O +
and O +
in O +
vivo O +
( O -
Morgan O +
et O +
al. O -
, O +
2002 O -
; O +
Collins O +
et O +
al. O -
, O +
2005 O -
; O +
Wagers O +
& O +
Conboy O -
, O +
2005 O -
) O -
. O +

Activated O +
satellite O +
cells O +
express O +
myogenic O +
markers O -
, O +
such O +
as O +
Myf5 O -
, O +
M O -
- O -
cadherin O -
, O +
and O +
Paired O +
box O +
gene O +
7 O +
( O -
Pax7 O -
) O -
; O +
fusion O -
- O -
competent O +
myoblasts O +
express O +
high O +
levels O +
of O +
desmin O -
, O +
and O +
de O +
novo O +
generated O +
myofibers O +
or O +
myotubes O +
express O +
embryonic O +
myosin O +
heavy O +
chain O +
( O -
eMyHC O -
) O +
and O +
continue O +
to O +
express O +
desmin O +
( O -
Schultz O +
& O +
McCormick O -
, O +
1994 O -
; O +
Wagers O +
& O +
Conboy O -
, O +
2005 O -
) O -
. O +

While O +
desmin O +
can O +
be O +
also O +
present O +
in O +
smooth O +
and O +
cardiac O +
muscle O +
cells O -
, O +
the O +
isolation O +
of O +
hind O +
limb O +
skeletal O +
muscle O +
with O +
subsequent O +
purification O +
of O +
myofibers O +
away O +
from O +
all O +
interstitial O +
cells O -
, O +
as O +
well O +
as O +
purification O +
of O +
associated O +
muscle O +
stem O +
cells O +
results O +
in O +
primary O +
cultures O +
that O +
are O +
uniformly O +
of O +
skeletal O +
muscle O +
lineage O -
. O +

Every O +
desmin+ O +
cell O +
in O +
such O +
cultures O +
is O +
a O +
fusion O -
- O -
competent O +
myoblast O -
, O +
and O +
is O +
able O +
to O +
produce O +
multinucleated O +
myotubes O +
after O +
48 O +
h O +
of O +
culture O +
in O +
differentiation O -
- O -
promoting O +
medium O +
[ O -
Dulbecco O -
's O +
modified O +
Eagle O -
's O +
medium O +
( O -
DMEM O -
) O +
with O +
2 O -
% O +
horse O +
serum O -
] O -
. O +

Some O +
of O +
these O +
myogenic O +
cells O +
fuse O +
into O +
myotubes O -
, O +
even O +
in O +
the O +
mitogen O -
- O -
rich O +
medium O +
[ O -
( O -
Opti O -
- O -
MEM O +
( O -
Invitrogen O -
, O +
Carlsbad O -
, O +
CA O -
, O +
USA O -
) O +
with O +
5–10 O -
% O +
mouse O +
serum O +
or O +
DMEM O +
with O +
10 O -
% O +
fetal O +
bovine O +
serum O -
, O +
FBS O -
] O +
( O -
Conboy O +
& O +
Rando O -
, O +
2002 O -
; O +
Conboy O +
et O +
al. O -
, O +
2003 O -
; O +
and O +
see O +
below O -
) O -
. O +

An O +
experimental O +
system O +
was O +
developed O +
that O +
( O -
i O -
) O +
provided O +
the O +
ability O +
to O +
study O +
the O +
regenerative O +
response O +
of O +
hESCs O +
and O +
of O +
muscle O +
stem O +
cells O +
in O +
various O +
heterochronic O +
environments O +
in O +
vitro O -
; O +
and O +
( O -
ii O -
) O +
allowed O +
examination O +
of O +
the O +
effects O +
of O +
hESCs O +
on O +
muscle O +
repair O -
, O +
in O +
vivo O -
, O +
after O +
transplantation O +
into O +
young O +
vs. O +
old O +
hosts O -
. O +

This O +
model O +
allowed O +
us O +
to O +
address O +
both O +
the O +
negative O +
effects O +
of O +
the O +
aged O +
niche O +
on O +
key O +
stem O +
cell O +
properties O +
and O +
the O +
positive O +
effects O +
of O +
hESCs O +
on O +
the O +
aged O +
muscle O -
- O -
specific O +
organ O +
progenitor O +
cells O +
in O +
vitro O -
, O +
and O +
on O +
the O +
regenerative O +
capacity O +
of O +
old O +
muscle O +
in O +
vivo O -
. O +

The O +
resulting O +
data O +
demonstrate O +
that O +
the O +
composition O +
of O +
conserved O +
extrinsic O +
cues O -
, O +
regulating O +
stem O +
cell O +
responses O -
, O +
becomes O +
altered O +
with O +
age O +
in O +
ways O +
that O +
inhibit O +
both O +
hESCs O +
and O +
adult O +
stem O +
cell O +
regenerative O +
potential O -
. O +

Specifically O -
, O +
molecular O +
markers O +
of O +
stem O +
cell O +
functionality O -
, O +
e.g. O +
Oct4 O +
( O -
in O +
hESCs O -
) O +
and O +
Myf5 O +
( O -
in O +
muscle O +
stem O +
cells O -
) O -
, O +
the O +
rate O +
of O +
cell O +
proliferation O -
, O +
and O +
the O +
capacity O +
for O +
myogenic O +
differentiation O +
are O +
all O +
dominantly O +
inhibited O +
by O +
the O +
aged O +
systemic O +
milieu O -
, O +
and O +
by O +
the O +
old O +
differentiated O +
muscle O +
tissue O -
. O +

However O -
, O +
while O +
satellite O +
cells O +
are O +
unable O +
to O +
deter O +
the O +
inhibitory O +
affects O +
of O +
aged O +
systemic O +
and O +
local O +
niches O -
, O +
hESCs O +
are O +
capable O +
of O +
antagonizing O +
the O +
aged O +
environments O -
, O +
thereby O +
enhancing O +
the O +
regenerative O +
potential O +
of O +
both O +
young O +
and O +
old O +
muscle O +
stem O +
cells O +
in O +
vitro O +
and O +
in O +
vivo O -
. O +

Thus O -
, O +
a O +
complex O +
interplay O +
between O +
negative O +
regulation O +
of O +
hESCs O +
and O +
adult O +
muscle O +
stem O +
cells O +
by O +
the O +
aged O +
niche O -
, O +
and O +
positive O +
regulation O +
of O +
the O +
host O -
's O +
regenerative O +
responses O +
by O +
hESCs O +
will O +
likely O +
determine O +
the O +
success O +
of O +
hESC O -
- O -
based O +
cell O -
- O -
replacement O +
therapies O +
in O +
the O +
old O -
. O +

Regenerative O +
responses O +
of O +
adult O +
muscle O +
stem O +
cells O +
and O +
hESCs O +
are O +
dominantly O +
inhibited O +
by O +
the O +
aged O +
systemic O +
milieuPrevious O +
work O +
established O +
that O +
the O +
upregulation O +
of O +
repair O -
- O -
specific O +
molecular O +
signaling O +
mechanisms O -
, O +
such O +
as O +
Notch O -
, O +
and O +
successful O +
engagement O +
of O +
resident O +
muscle O +
stem O +
cells O +
in O +
tissue O +
repair O +
are O +
largely O +
determined O +
by O +
the O +
age O +
of O +
the O +
systemic O +
milieu O -
, O +
rather O +
than O +
by O +
the O +
cell O -
- O -
autonomous O +
age O +
of O +
muscle O +
cells O -
, O +
or O +
by O +
the O +
differences O +
in O +
their O +
numbers O +
( O -
Conboy O +
& O +
Rando O -
, O +
2005 O -
; O +
Conboy O +
et O +
al. O -
, O +
2005 O -
) O -
. O +

Intriguingly O -
, O +
these O +
experiments O +
also O +
hinted O +
at O +
a O +
small O +
but O +
persistent O +
inhibitory O +
effect O +
of O +
the O +
aged O +
systemic O +
milieu O +
on O +
the O +
performance O +
of O +
young O +
stem O +
cells O -
. O +

Exploring O +
this O +
further O -
, O +
we O +
found O +
that O +
young O +
serum O +
permits O +
satellite O +
cells O +
to O +
be O +
myogenic O -
, O +
while O +
old O +
serum O +
inhibits O +
the O +
satellite O +
cell O +
regenerative O +
potential O +
not O +
only O +
alone O -
, O +
but O +
also O +
when O +
mixed O +
with O +
young O +
serum O -
, O +
suggesting O +
a O +
dominant O +
over O -
- O -
riding O +
of O +
' O -
young O -
' O +
serum O +
factors O +
( O -
Fig. O +
1 O -
) O -
. O +

Myofiber O +
cultures O -
, O +
in O +
which O +
satellite O +
cells O +
have O +
been O +
activated O +
by O +
injury O +
in O +
vivo O -
, O +
were O +
established O +
from O +
young O +
( O -
2–3 O +
months O -
) O +
and O +
old O +
( O -
22–24 O +
months O -
) O +
C57-BL O -
/ O -
6 O +
male O +
mice O -
, O +
as O +
previously O +
described O +
( O -
Conboy O +
& O +
Rando O -
, O +
2002 O -
; O +
Conboy O +
et O +
al. O -
, O +
2005 O -
) O -
. O +

As O +
previously O +
shown O -
, O +
this O +
method O +
is O +
well O +
suited O +
for O +
the O +
assessment O +
of O +
satellite O +
cell O +
regenerative O +
myogenic O +
capacity O +
( O -
Conboy O +
& O +
Rando O -
, O +
2002 O -
; O +
Wagers O +
& O +
Conboy O -
, O +
2005 O -
) O -
. O +

Isolated O +
myofiber O +
explants O +
with O +
associated O +
satellite O +
cells O +
were O +
cultured O +
overnight O +
in O +
the O +
presence O +
of O +
young O +
or O +
old O +
serum O +
( O -
alone O +
at O +
5 O -
% O +
and O +
10 O -
% O -
, O +
and O +
mixed O +
at O +
5 O -
% O +
young O +
+ O +
5 O -
% O +
old O -
) O -
; O +
bromodeoxyuridine O +
( O -
BrdU O -
) O +
was O +
added O +
for O +
the O +
last O +
2 O +
h O +
of O +
culture O +
to O +
measure O +
the O +
rate O +
of O +
cell O +
proliferation O -
. O +

The O +
effects O +
of O +
heterochronic O +
systemic O +
milieu O +
on O +
myogenic O +
potential O +
were O +
examined O +
as O +
generation O +
of O +
proliferating O +
myoblasts O +
that O +
express O +
desmin O +
and O +
Myf5 O -
, O +
and O +
that O +
spontaneously O +
form O +
multinucleated O +
nascent O +
myotubes O -
. O +

As O +
shown O +
in O +
Fig. O +
1A O +
and O +
quantified O +
in O +
Fig. O +
1B O -
, O +
the O +
age O +
of O +
sera O +
clearly O +
determined O +
satellite O +
cell O +
regenerative O +
potential O +
and O +
old O +
serum O +
strongly O +
inhibited O +
the O +
myogenic O +
potential O +
of O +
young O +
satellite O +
cells O +
either O +
when O +
present O +
alone O -
, O +
or O +
when O +
mixed O +
with O +
young O +
sera O -
. O +

Similar O +
data O +
was O +
obtained O +
by O +
using O +
another O +
myogenic O +
marker O -
, O +
Pax7 O +
( O -
Supplementary O +
Fig. O +
S1 O -
) O -
. O +

Additionally O -
, O +
there O +
were O +
two O +
to O +
three O +
times O +
fewer O +
total O +
cells O +
generated O +
in O +
the O +
presence O +
of O +
aged O +
serum O +
( O -
not O +
shown O -
) O -
.Fig O -
. O +

1The O +
age O +
of O +
sera O +
determined O +
the O +
regenerative O +
potential O +
of O +
satellite O +
cells O -
. O +

( O -
A O -
) O +
Young O +
satellite O +
cells O +
were O +
cultured O +
either O +
in O +
5 O -
% O +
or O +
10 O -
% O +
young O +
( O -
Young O -
) O -
, O +
10 O -
% O +
old O +
( O -
Old O -
) O -
, O +
or O +
in O +
a O +
5%+ O +
5 O -
% O +
mouse O +
sera O +
combination O +
( O -
young O +
+ O +
old O -
) O -
. O +

Cells O +
were O +
analyzed O +
by O +
immunofluorescence O +
microscopy O -
, O +
using O +
anti O -
- O -
BrdU O +
( O -
red O -
) O -
, O +
antidesmin O +
( O -
green O -
) O +
or O +
anti O -
- O -
Myf5 O +
antibodies O +
( O -
green O -
, O +
small O +
panels O -
) O -
. O +

Similar O +
results O +
are O +
shown O +
for O +
Pax7 O +
immunodetection O +
( O -
Supplementary O +
Fig. O +
S1 O -
) O -
. O +

Hoechst O +
( O -
blue O -
) O +
labeled O +
nuclei O -
. O +

( O -
B O -
) O +
Three O +
independent O +
experiments O +
were O +
quantified O +
[ O -
300 O +
young O +
myofibers O +
per O +
experiment O -
] O +
as O +
percentage O +
of O +
desmin+ O -
/ O -
Myf5+ O -
/ O -
BrdU+ O +
de O +
novo O +
generated O +
cells O +
for O +
each O +
age O +
and O +
culture O +
condition O -
. O +

On O +
average O -
, O +
two O +
to O +
three O +
fewer O +
cells O +
were O +
generated O +
when O +
cultured O +
in O +
the O +
presence O +
of O +
old O -
. O +

Shown O +
are O +
identical O +
microscope O +
fields O +
at O +
×40 O +
magnification O -
. O +

At O +
least O +
three O +
independent O +
experiments O +
produced O +
similar O +
results O -
. O +

( O -
* O -
) O +
indicates O +
P≤ O +
0.001 O +
as O +
compared O +
to O +
young O +
sera O -
. O +

Importantly O -
, O +
it O +
was O +
not O +
simply O +
the O +
dilution O +
of O +
young O +
serum O +
factors O +
that O +
resulted O +
in O +
diminished O +
myogenic O +
capacity O +
when O +
young O +
and O +
old O +
sera O +
were O +
mixed O -
, O +
because O +
young O +
sera O +
promoted O +
robust O +
myogenesis O +
both O +
at O +
10 O -
% O +
and O +
5 O -
% O -
. O +

Thus O -
, O +
old O +
serum O +
factors O +
dominantly O +
inhibited O +
the O +
myogenic O +
capacity O +
of O +
young O +
satellite O +
cells O +
even O +
in O +
the O +
presence O +
of O +
young O +
serum O -
. O +

This O +
observation O +
suggests O +
that O +
satellite O +
cells O +
of O +
young O +
mice O +
engage O +
in O +
efficient O +
myogenic O +
responses O -
, O +
in O +
part O -
, O +
because O +
the O +
inhibitory O +
influence O +
of O +
old O +
circulatory O +
milieu O +
is O +
absent O -
. O +

These O +
data O +
reveal O +
that O +
the O +
regenerative O +
potential O +
of O +
young O +
muscle O +
stem O +
cells O +
is O +
determined O +
by O +
the O +
age O +
of O +
the O +
systemic O +
milieu O -
, O +
prompting O +
us O +
to O +
investigate O +
whether O +
hESCs O +
would O +
similarly O +
succumb O +
to O +
inhibitory O +
factors O +
present O +
in O +
the O +
aged O +
circulation O -
. O +

To O +
determine O +
the O +
effects O +
of O +
aged O +
serum O +
on O +
stem O +
cell O +
self O -
- O -
renewal O -
/ O -
pluripotency O -
, O +
we O +
analyzed O +
hESC O +
expression O +
of O +
Oct4 O +
and O +
studied O +
the O +
rate O +
of O +
hESC O +
proliferation O -
, O +
by O +
assessing O +
BrdU O +
incorporation O +
( O -
Fig. O +
2 O -
) O +
and O +
Ki67 O +
expression O +
( O -
Supplementary O +
Fig. O +
S2 O -
) O -
. O +

Specifically O -
, O +
these O +
determinants O +
of O +
hESC O +
regenerative O +
potential O +
were O +
examined O +
in O +
the O +
presence O +
of O +
heterochronic O +
( O -
young O +
vs. O +
old O -
) O +
mouse O +
sera O +
added O +
to O +
typical O +
hESC O +
medium O -
, O +
e.g. O -
, O +
MEF O -
- O -
conditioned O +
medium O +
( O -
MCM O -
) O -
. O +

Oct4 O +
is O +
expressed O +
by O +
self O -
- O -
renewing O -
, O +
pluripotent O +
ESCs O +
in O +
culture O -
, O +
by O +
the O +
totipotent O +
inner O +
cell O +
mass O +
of O +
the O +
blastocyst O +
and O +
by O +
the O +
germ O +
cells O +
( O -
Nichols O +
et O +
al. O -
, O +
1998 O -
; O +
Pesce O +
et O +
al. O -
, O +
1999 O -
) O -
. O +

Most O +
cells O +
in O +
control O +
cultures O +
or O +
young O +
conditions O +
expressed O +
high O +
levels O +
of O +
this O +
marker O +
of O +
' O -
stemness O -
' O -
, O +
and O +
maintained O +
their O +
normal O +
phenotype O +
and O +
morphology O +
throughout O +
the O +
various O +
co O -
- O -
culture O +
experiments O +
performed O +
in O +
this O +
study O +
( O -
see O +
below O -
) O -
.Fig O -
. O +

2The O +
regenerative O +
potential O +
of O +
embryonic O +
stem O +
cells O +
was O +
negatively O +
affected O +
by O +
aged O +
mouse O +
sera O -
. O +

( O -
A O -
) O +
hESCs O +
were O +
cultured O +
in O +
MCM O +
with O +
10 O -
% O +
young O +
( O -
young O -
) O +
or O +
old O +
( O -
old O -
) O +
mouse O +
serum O -
, O +
or O +
in O +
three O +
control O +
media O -
: O +
MCM O +
without O +
mouse O +
sera O -
; O +
GM O +
( O -
myoblast O +
medium O +
of O +
Ham O -
's O +
F10 O +
with O +
20 O -
% O +
FBS O -
) O +
and O +
DMEM O -
/ O -
FBS O +
( O -
hESC O +
differentiation O +
medium O +
of O +
DMEM O +
with O +
10 O -
% O +
FBS O -
) O -
. O +

BrdU O +
was O +
added O +
for O +
the O +
last O +
2 O +
h O +
of O +
culture O +
to O +
measure O +
the O +
rate O +
of O +
cell O +
proliferation O -
. O +

Immunodetection O +
assays O +
were O +
performed O +
for O +
BrdU O +
( O -
red O -
) O -
, O +
Oct4 O +
( O -
red O -
) O -
, O +
and O +
Ki67 O +
( O -
Supplementary O +
Fig. O +
S2 O -
) O -
. O +

Hoechst O +
( O -
blue O -
) O +
labels O +
nuclei O -
. O +

A O +
high O +
rate O +
of O +
hESC O +
proliferation O +
and O +
Oct4 O +
expression O +
is O +
displayed O +
in O +
all O +
control O +
media O +
and O +
in O +
the O +
presence O +
of O +
young O +
mouse O +
serum O -
. O +

In O +
contrast O -
, O +
hESC O +
proliferation O +
and O +
Oct4 O +
expression O +
are O +
inhibited O +
in O +
the O +
presence O +
of O +
old O +
mouse O +
serum O -
, O +
either O +
alone O +
or O +
when O +
mixed O +
with O +
young O +
serum O -
. O +

MCM O +
with O +
mouse O +
sera O +
at O +
5 O -
% O +
gave O +
results O +
similar O +
to O +
those O +
observed O +
with O +
10 O -
% O +
young O +
mouse O +
sera O +
or O +
in O +
control O +
media O +
( O -
Supplementary O +
Fig. O +
S3 O -
) O -
. O +

( O -
B O -
) O +
Three O +
independent O +
experiments O +
yielded O +
similar O +
results O +
and O +
were O +
quantified O +
as O +
percentage O +
of O +
BrdU+ O +
and O +
Oct4 O -
+ O +
cells O +
for O +
each O +
culture O +
condition O -
. O +

* O +
indicates O +
P O +
< O +
0.001 O +
as O +
compared O +
to O +
young O +
serum O -
. O +

Importantly O -
, O +
at O +
10 O -
% O +
aged O +
serum O +
dramatically O +
inhibited O +
the O +
self O -
- O -
renewal O +
and O +
proliferative O +
potential O +
of O +
hESCs O -
, O +
as O +
judged O +
by O +
highly O +
diminished O +
Oct4 O +
expression O +
and O +
a O +
lack O +
of O +
BrdU O +
incorporation O -
. O +

Again O -
, O +
the O +
inhibitory O +
factors O +
in O +
the O +
aged O +
milieu O +
were O +
dominant O +
over O +
the O +
young O -
, O +
as O +
evidenced O +
by O +
a O +
decline O +
in O +
Oct4 O +
expression O -
, O +
the O +
low O +
rate O +
of O +
BrdU O +
incorporation O -
, O +
and O +
Ki67 O +
expression O +
in O +
young O +
and O +
old O +
mixed O +
environments O +
( O -
5 O -
% O +
young O +
+ O +
5 O -
% O +
old O +
sera O +
in O +
MCM O -
) O -
. O +

Similar O +
to O +
the O +
data O +
shown O +
for O +
adult O +
stem O +
cells O +
( O -
ASCs O -
) O +
( O -
Fig. O +
1 O -
) O -
, O +
it O +
was O +
not O +
simply O +
a O +
dilution O +
of O +
young O +
serum O +
factors O +
as O +
hESCs O +
robustly O +
proliferated O +
and O +
expressed O +
high O +
levels O +
of O +
Oct4 O +
when O +
cultured O +
with O +
5 O -
% O +
young O +
sera O +
in O +
MCM O +
( O -
Supplementary O +
Fig. O +
S3 O -
) O -
. O +

Quantification O +
of O +
multiple O +
independent O +
experiments O +
has O +
demonstrated O +
that O +
hESC O +
expression O +
of O +
Oct4 O +
and O +
BrdU O +
incorporation O +
have O +
been O +
reduced O +
by O +
two- O +
to O +
threefold O +
in O +
the O +
aged O +
milieu O +
( O -
Fig. O +
2B O -
) O -
.As O +
expected O -
, O +
hESCs O +
cultured O +
in O +
control O +
media O -
, O +
including O +
MCM O +
alone O +
that O +
does O +
not O +
contain O +
either O +
young O +
or O +
old O +
serum O -
, O +
also O +
displayed O +
a O +
high O +
rate O +
of O +
proliferation O +
and O +
Oct4 O +
expression O +
( O -
Fig. O +
2 O -
, O +
control O +
medium O -
) O -
. O +

Additionally O -
, O +
in O +
this O +
experimental O +
set O -
- O -
up O +
there O +
was O +
no O +
general O +
inhibitory O +
effect O +
of O +
sera O +
per O +
se O +
on O +
hESC O +
proliferation O +
and O +
Oct4 O +
expression O -
, O +
as O +
10 O -
% O +
young O +
mouse O +
sera O +
( O -
young O -
) O +
and O +
10–20 O -
% O +
of O +
FBS O +
( O -
growth O +
medium O +
and O +
DMEM O -
/ O -
FBS O -
) O +
allowed O +
for O +
a O +
high O +
rate O +
of O +
cell O +
proliferation O +
and O +
for O +
uniformly O +
high O +
Oct4 O +
levels O +
( O -
Fig. O +
2 O -
) O -
.When O +
instead O +
of O +
immediate O +
exposure O +
to O +
aged O +
mouse O +
serum O -
, O +
hESCs O +
were O +
first O +
cultured O +
overnight O +
in O +
MCM O -
, O +
these O +
cells O +
were O +
no O +
longer O +
susceptible O +
to O +
the O +
negative O +
effects O +
of O +
old O +
systemic O +
milieu O +
( O -
Fig. O +
3 O -
) O -
, O +
suggesting O +
that O +
hESC O -
- O -
produced O +
factors O +
established O +
an O +
embryonic O +
microniche O +
that O +
may O +
provide O +
temporary O +
protection O +
from O +
the O +
aged O +
environment O -
. O +

It O +
appears O +
that O +
satellite O +
cells O +
do O +
not O +
have O +
such O +
anti O -
- O -
aging O +
ability O -
, O +
because O +
despite O +
an O +
initial O +
activation O +
in O +
entirely O +
young O +
environments O -
, O +
e.g. O -
, O +
after O +
muscle O +
injury O +
to O +
young O +
muscle O -
, O +
isolated O +
satellite O +
cells O +
remain O +
susceptible O +
to O +
inhibition O +
by O +
the O +
old O +
mouse O +
serum O +
( O -
Figs O +
1 O +
and O +
4C O -
) O -
. O +

Similarly O -
, O +
culturing O +
satellite O +
cells O +
isolated O +
from O +
noninjured O +
muscle O +
in O +
growth O -
- O -
promoting O +
medium O +
for O +
1–2 O +
days O +
does O +
not O +
protect O +
against O +
the O +
inhibitory O +
affects O +
of O +
aged O +
systemic O +
milieu O +
( O -
not O +
shown O -
) O -
.Fig O -
. O +

3Embryonic O +
stem O +
cells O +
produce O +
youthful O +
microniche O +
in O +
culture O -
. O +

( O -
A O -
) O +
As O +
opposed O +
to O +
immediate O +
exposure O +
to O +
old O +
mouse O +
serum O +
after O +
passaging O +
( O -
10 O -
% O +
old O -
) O -
, O +
preculturing O +
of O +
hESCs O +
for O +
24 O +
h O +
in O +
feeder O -
- O -
free O +
conditions O -
, O +
e.g. O -
, O +
Matrigel O -
™ O +
+ O +
MCM O -
, O +
prior O +
to O +
replacing O +
MCM O +
with O +
MCM O +
+ O +
10 O -
% O +
old O +
mouse O +
sera O -
, O +
resulted O +
in O +
continuously O +
high O +
BrdU O +
incorporation O +
and O +
Oct4 O +
expression O +
( O -
embryonic O +
microniche O +
+ O +
10 O -
% O +
old O -
) O -
. O +

BrdU O +
was O +
added O +
for O +
the O +
last O +
2 O +
h O +
of O +
culture O +
to O +
measure O +
the O +
rate O +
of O +
cell O +
proliferation O -
. O +

Immunodetection O +
of O +
BrdU O +
and O +
Oct4 O +
( O -
both O +
in O +
red O -
) O +
was O +
performed O +
as O +
described O +
in O +
Experimental O +
procedures O -
. O +

Hoechst O +
( O -
blue O -
) O +
labels O +
nuclei O -
. O +

( O -
B O -
) O +
Three O +
independent O +
experiments O +
yielded O +
similar O +
results O +
and O +
were O +
quantified O +
as O +
percentage O +
of O +
BrdU+ O -
/ O -
Oct4 O -
+ O +
for O +
each O +
condition O -
. O +

* O +
indicates O +
P O +
< O +
0.001 O +
as O +
compared O +
to O +
' O -
old O +
+ O +
MCM'.Fig O -
. O +

4Aged O +
muscle O +
niche O +
inhibits O +
the O +
regenerative O +
potential O +
of O +
hESCs O +
and O +
satellite O +
cells O -
. O +

( O -
A O -
) O +
Immunodetection O +
of O +
a O +
mouse O -
- O -
specific O +
M O -
- O -
cadherin O +
( O -
green O -
) O +
or O +
desmin O +
( O -
red O -
; O +
both O +
human O +
and O +
mouse O +
proteins O +
are O +
detected O -
) O +
revealed O +
that O +
hESCs O +
underwent O +
muscle O +
lineage O +
differentiation O +
when O +
co O -
- O -
cultured O +
with O +
young O -
, O +
but O +
not O +
old O +
myofibers O -
. O +

The O +
myogenic O +
progeny O +
of O +
hESCs O +
appears O +
M O -
- O -
cadherin− O -
/ O -
desmin+ O +
( O -
white O +
arrow O +
in O +
young O -
) O -
, O +
as O +
opposed O +
to O +
M O -
- O -
cadherin− O -
/ O -
desmin− O +
hESCs O +
that O +
lack O +
myogenic O +
commitment O +
( O -
white O +
arrow O +
in O +
old O -
) O -
. O +

M O -
- O -
cadherin+ O -
/ O -
desmin+ O +
cells O +
are O +
the O +
myogenic O +
progeny O +
of O +
mouse O +
satellite O +
cells O +
( O -
yellow O +
arrows O -
) O -
. O +

To O +
assess O +
the O +
effects O +
of O +
secreted O +
factors O +
produced O +
by O +
young O +
vs. O +
old O +
myofibers O +
on O +
the O +
rate O +
of O +
hESC O +
proliferation O -
, O +
transient O -
, O +
2 O +
h O +
BrdU O +
incorporation O +
was O +
examined O +
in O +
hESCs O +
cultured O +
for O +
48 O +
h O +
with O +
supernatants O +
produced O +
by O +
heterochronic O +
myofiber O +
explants O +
( O -
See O +
Experimental O +
procedures O +
for O +
details O -
) O -
. O +

As O +
compared O +
to O +
young O +
myofiber O -
- O -
derived O +
supernatants O +
( O -
young O +
myofiber O +
supernant O -
) O -
, O +
exposure O +
to O +
old O +
myofiber O -
- O -
derived O +
supernatants O +
( O -
old O +
myofiber O +
supernant O -
) O +
inhibited O +
hESCs O +
proliferation O -
, O +
as O +
judged O +
by O +
BrdU O +
immunodetection O +
( O -
red O -
) O -
. O +

As O +
expected O -
, O +
the O +
rate O +
of O +
hESCs O +
proliferation O +
was O +
high O +
in O +
control O +
media O +
( O -
shown O +
in O +
Fig. O +
2 O -
) O -
. O +

Hoechst O +
( O -
blue O -
) O +
labels O +
nuclei O +
in O +
all O +
experiments O -
. O +

Quantification O +
of O +
desmin+ O -
/ O -
BrdU+ O +
hESCs O +
in O +
direct O +
myofiber O +
cocultures O -
, O +
or O +
with O +
muscle O +
supernatants O -
, O +
is O +
shown O +
in O +
( O -
B O -
) O -
. O +

* O +
indicates O +
P≤ O +
0.001 O +
as O +
compared O +
to O +
young O -
. O +

( O -
C O -
) O +
Transwell O +
co O -
- O -
cultures O +
between O +
purified O +
young O +
satellite O +
cells O +
and O +
myofibers O +
isolated O +
from O +
uninjured O +
young O +
( O -
young O +
myofiber O -
) O +
and O +
old O +
( O -
old O +
myofiber O -
) O +
muscle O +
demonstrated O +
that O +
satellite O +
cell O +
regenerative O +
myogenic O +
capacity O +
was O +
inhibited O +
by O +
the O +
aged O +
differentiated O +
muscle O -
. O +

Myogenic O +
potential O +
was O +
determined O +
by O +
the O +
ability O +
of O +
satellite O +
cells O +
to O +
generate O +
proliferating O +
desmin+ O +
myoblasts O +
( O -
immunodetection O +
shown O +
in O +
green O -
) O +
and O +
by O +
rate O +
of O +
proliferation O +
( O -
2 O +
h O +
BrdU O +
incorporation O -
; O +
immunodetection O +
shown O +
in O +
red O -
) O -
. O +

( O -
D O -
) O +
Satellite O +
cell O +
regenerative O +
potential O +
was O +
quantified O +
as O +
percentage O +
of O +
desmin+ O -
/ O -
BrdU+ O +
cells O +
for O +
transwell O +
co O -
- O -
cultures O +
with O +
young O +
or O +
old O +
uninjured O +
myofibers O +
( O -
i.e. O -
, O +
RM O -
, O +
resting O +
muscle O -
) O -
. O +

n O +
= O +
3 O -
; O +
* O +
indicates O +
P≤ O +
0.05 O +
as O +
compared O +
to O +
young O -
. O +

Comprehensively O -
, O +
these O +
data O +
establish O +
that O +
the O +
inhibition O +
of O +
stem O +
cell O +
regenerative O +
potential O +
by O +
the O +
aged O +
systemic O +
milieu O +
is O +
conserved O +
between O +
species O +
( O -
mouse O +
vs. O +
human O -
) O +
and O +
cell O +
types O +
( O -
adult O +
vs. O +
embryonic O +
stem O +
cells O -
) O -
. O +

As O +
summarized O +
in O +
Table O +
1 O -
, O +
aged O +
mouse O +
sera O +
similarly O +
affected O +
the O +
expression O +
of O +
key O +
molecular O +
identifiers O +
of O +
both O +
embryonic O +
and O +
adult O +
stem O +
cells O -
, O +
e.g. O -
, O +
Oct4 O +
in O +
hESCs O +
and O +
Myf5 O +
in O +
mouse O +
ASCs O -
. O +

As O +
expected O -
, O +
adult O +
mouse O +
stem O +
cells O +
did O +
not O +
express O +
Oct4 O -
, O +
and O +
hESCs O +
did O +
not O +
express O +
Myf5 O +
in O +
these O +
experimental O +
conditions O +
( O -
not O +
shown O -
) O -
. O +

Moreover O -
, O +
aged O +
systemic O +
milieu O +
had O +
similar O +
inhibitory O +
effects O +
on O +
proliferation O +
of O +
hESCs O +
and O +
ASCs O -
, O +
suggesting O +
that O +
not O +
only O +
the O +
regenerative O +
capacity O -
, O +
but O +
also O +
the O +
presence O +
and O +
expansion O +
of O +
stem O +
cells O +
will O +
be O +
significantly O +
restricted O +
in O +
aged O +
organs O -
. O +

Intriguingly O -
, O +
prolonged O +
culturing O +
of O +
hESCs O +
in O +
their O +
preferred O +
in O +
vitro O +
conditions O +
enables O +
generation O +
of O +
an O +
embryonic O +
microniche O +
that O +
antagonizes O +
the O +
inhibitory O +
influences O +
of O +
aged O +
circulatory O +
factors O -
. O +

Table O +
1Conservation O +
of O +
stem O +
cell O +
aging O +
in O +
the O +
systemic O +
environmentRate O +
of O +
proliferation O +
ESC O -
/ O -
ASC O +
( O -
percentage O +
of O +
BrdU O -
) O -
Call O -
- O -
fate O +
identifier O +
ESC O +
( O -
percentage O +
of O +
Oct4 O -
) O -
/ O +
ASC O +
( O -
percentage O +
of O +
Myf5 O -
) O -
10 O -
% O +
young59.5 O +
± O +
0.8 O -
, O +
59.3 O +
± O +
4.099.0 O +
± O +
0.1 O -
, O +
50.7 O +
± O +
9.510 O -
% O +
old32.7 O +
± O +
2.1 O -
, O +
27.3 O +
± O +
3.517.6 O +
± O +
3.2 O -
, O +
18.1 O +
± O +
5.95 O -
% O +
young O +
+ O +
5 O -
% O +
old31.0 O +

± O +
2.6 O -
, O +
38.0 O +
± O +
2.020.6 O +
± O +
3.5 O -
, O +
17.1 O +
± O +
4.2Quantified O +
results O +
from O +
Figs O +
1 O -
, O +
2 O +
are O +
summarized O +
and O +
presented O +
as O +
mean O +
percentages O +
from O +
experimental O +
replicates O +
± O +
SE O -
. O +

Rate O +
of O +
proliferation O +
( O -
BrdU O -
) O +
and O +
cell O -
- O -
fate O +
identifier O +
( O -
Oct4 O +
or O +
Myf5 O -
) O +
are O +
shown O +
for O +
both O +
ESCs O +
and O +
ASCs O +
cultured O +
in O +
heterochronic O +
systemic O +
conditions O +
of O +
10 O -
% O +
young O +
( O -
young O -
) O -
, O +
10 O -
% O +
old O +
( O -
old O -
) O +
or O +
in O +
5%+ O +
5 O -
% O +
mouse O +
sera O +
combination O +
( O -
young O +
+ O +
old O -
) O -
. O +

Results O +
for O +
5 O -
% O +
young O +
mouse O +
sera O +
are O +
very O +
similar O +
to O +
those O +
for O +
10 O -
% O +
young O +
mouse O +
sera O +
and O +
are O +
shown O +
in O +
Fig. O +
1 O +
( O -
ASCs O -
) O +
and O +
Supplementary O +
Fig. O +
S3 O +
( O -
hESCs O -
) O -
. O +

The O +
regenerative O +
potential O +
of O +
hESCs O +
and O +
ASCs O +
is O +
inhibited O +
by O +
aged O +
differentiated O +
muscleAfter O +
establishing O +
that O +
the O +
aged O +
systemic O +
niche O +
negatively O +
affects O +
the O +
regenerative O +
capacity O +
of O +
hESCs O +
and O +
of O +
ASCs O -
, O +
we O +
then O +
assessed O +
whether O +
myogenic O +
potential O +
and O +
the O +
rate O +
of O +
cell O +
proliferation O +
would O +
be O +
inhibited O +
in O +
hESCs O +
and O +
ASCs O +
by O +
the O +
aged O +
local O +
muscle O +
niche O -
. O +

Myofibers O +
with O +
associated O +
satellite O +
cells O +
were O +
isolated O +
from O +
young O +
and O +
old O +
injured O +
muscle O -
, O +
and O +
were O +
directly O +
co O -
- O -
cultured O +
with O +
hESCs O +
in O +
typical O +
hESC O +
differentiation O +
medium O +
( O -
DMEM O -
/ O -
FBS O -
) O -
. O +

Similar O +
to O +
Fig. O +
1 O -
, O +
the O +
myogenic O +
potential O +
in O +
these O +
co O -
- O -
cultures O +
was O +
assayed O +
by O +
the O +
expression O +
of O +
desmin O -
, O +
which O +
is O +
present O +
in O +
both O +
fusion O -
- O -
competent O +
myoblasts O +
and O +
newly O +
formed O +
myotubes O -
. O +

To O +
analyze O +
whether O +
hESCs O -
, O +
mouse O +
myogenic O +
progenitor O +
cells O +
or O +
both O +
could O +
express O +
desmin O +
in O +
direct O +
co O -
- O -
cultures O -
, O +
we O +
costained O +
these O +
cells O +
with O +
a O +
mouse O -
- O -
specific O +
antibody O +
to O +
a O +
myogenic O +
marker O -
, O +
M O -
- O -
cadherin O -
, O +
which O +
does O +
not O +
react O +
with O +
human O +
protein O -
, O +
and O +
a O +
desmin O -
- O -
specific O +
antibody O +
that O +
recognizes O +
both O +
mouse O +
and O +
human O +
proteins O -
. O +

As O +
shown O +
in O +
Fig. O +
4A O -
, O +
hESCs O +
underwent O +
myogenic O +
differentiation O +
in O +
co O -
- O -
cultures O +
with O +
young O +
myofibers O +
( O -
M O -
- O -
cadherin− O -
/ O -
desmin+ O +
mononucleated O +
cells O -
, O +
white O +
arrow O +
in O +
young O -
) O -
. O +

These O +
myogenic O +
progeny O +
of O +
hESCs O +
in O +
co O -
- O -
cultures O +
with O +
young O +
myofibers O +
could O +
be O +
of O +
skeletal O -
, O +
smooth O +
or O +
cardiac O +
muscle O +
lineages O +
( O -
Debus O +
et O +
al. O -
, O +
1983 O -
; O +
Fischman O +
& O +
Danto O -
, O +
1985 O -
; O +
Schultz O +
& O +
McCormick O -
, O +
1994 O -
) O -
. O +

As O +
expected O -
, O +
the O +
young O +
mouse O +
muscle O +
progenitor O +
cells O +
( O -
M O -
- O -
cadherin+ O -
/ O -
desmin+ O -
) O +
were O +
more O +
advanced O +
in O +
their O +
degree O +
of O +
myogenic O +
differentiation O -
, O +
which O +
was O +
of O +
skeletal O +
muscle O +
lineage O -
, O +
as O +
judged O +
by O +
the O +
formation O +
of O +
large O -
, O +
multinucleated O +
de O +
novo O +
myotubes O +
( O -
yellow O +
arrow O +
in O +
young O -
) O -
. O +

In O +
addition O +
to O +
the O +
myogenically O +
differentiated O +
human O +
cells O -
, O +
co O -
- O -
cultures O +
with O +
young O +
myofiber O +
explants O +
also O +
contained O +
some O +
small O +
undifferentiated O +
hESC O +
colonies O -
, O +
as O +
determined O +
by O +
immunoreactivity O +
to O +
a O +
human O -
- O -
specific O +
antibody O +
to O +
the O +
nuclear O +
mitotic O +
apparatus O +
protein O -
, O +
NuMA O +
and O +
Oct4 O +
expression O +
( O -
Supplementary O +
Fig. O +
S4 O -
) O -
.In O +
contrast O -
, O +
when O +
co O -
- O -
cultured O +
with O +
the O +
aged O +
mouse O +
myofibers O -
, O +
only O +
mouse O +
cells O +
appeared O +
desmin+ O +
( O -
Fig. O +
4A O -
, O +
yellow O +
arrow O +
in O +
old O -
) O -
. O +

These O +
aged O +
myogenic O +
cells O +
were O +
of O +
skeletal O +
muscle O +
lineage O -
, O +
based O +
on O +
spontaneous O +
generation O +
of O +
multinucleated O +
myotubes O +
( O -
see O +
Fig. O +
5B O -
) O +
and O +
based O +
on O +
induced O +
differentiation O +
into O +
myotubes O +
in O +
DMEM O +
+ O +
2 O -
% O +
horse O +
serum O +
( O -
not O +
shown O -
) O -
. O +

Importantly O -
, O +
the O +
myogenic O +
differentiation O +
of O +
hESCs O +
failed O +
in O +
the O +
aged O +
co O -
- O -
cultures O +
( O -
Fig. O +
4A O -
, O +
white O +
arrow O +
in O +
old O -
) O -
. O +

Furthermore O -
, O +
colonies O +
of O +
hESCs O +
in O +
co O -
- O -
cultures O +
with O +
aged O +
myofibers O +
typically O +
differentiated O +
into O +
cells O +
with O +
fibroblast O +
morphology O -
, O +
which O +
lacked O +
Oct4 O +
expression O +
( O -
not O +
shown O -
) O -
. O +

Spontaneous O +
production O +
of O +
desmin+ O +
myogenic O +
cells O +
in O +
control O +
hESC O +
cultures O +
without O +
myofibers O -
, O +
or O +
with O +
young O -
/ O -
old O +
mouse O +
sera O +
was O +
less O +
than O +
0.1 O -
% O +
( O -
not O +
shown O -
) O -
.Fig O -
. O +

5In O +
vitro O +
co O -
- O -
culture O +
with O +
hESCs O +
enhanced O +
myogenesis O +
of O +
mouse O +
cells O -
. O +

( O -
A O -
) O +
1 O +
× O +
105 O +
hESCs O +
or O +
control O +
hMSCs O +
were O +
co O -
- O -
cultured O +
with O +
5 O +
× O +
106 O +
primary O +
mouse O +
myoblasts O -
. O +

hESCs O +
expressing O +
Oct4 O +
( O -
immunodetection O +
shown O +
in O +
red O -
) O +
dramatically O +
enhanced O +
myotube O +
formation O +
of O +
co O -
- O -
cultured O +
mouse O +
myoblasts O +
( O -
immunodetection O +
of O +
eMyHC O +
is O +
shown O +
in O +
green O -
) O -
, O +
as O +
compared O +
to O +
co O -
- O -
cultures O +
between O +
mouse O +
myoblasts O +
and O +
human O +
mesenchymal O +
stem O +
cells O +
( O -
Mb O +
+ O +
hMSCs O -
) O +
or O +
myoblasts O +
alone O +
( O -
Mb O +
alone O -
) O -
. O +

Experiments O +
were O +
carried O +
out O +
in O +
myoblast O +
differentiation O +
medium O -
. O +

Hoechst O +
( O -
blue O -
) O +
labels O +
nuclei O +
throughout O +
this O +
figure O -
. O +

( O -
B O -
) O +
1 O +
× O +
105 O +
hESCs O +
or O +
control O +
hMSCs O +
were O +
co O -
- O -
cultured O +
with O +
young O +
or O +
old O +
myofiber O -
- O -
associated O +
satellite O +
cells O -
, O +
as O +
described O +
in O +
Experimental O +
procedures O -
. O +

Co O -
- O -
culture O +
with O +
hESCs O +
( O -
myofiber O +
+ O +
hESC O -
) O -
, O +
but O +
not O +
hMSCs O +
( O -
myofiber O +
+ O +
hMSC O -
) O +
or O +
control O +
medium O +
( O -
DMEM O -
/ O -
FBS O -
) O -
, O +
greatly O +
enhanced O +
the O +
myogenic O +
potential O +
of O +
both O +
young O +
and O +
old O +
myofiber O -
- O -
associated O +
satellite O +
cells O -
, O +
based O +
on O +
immunodetection O +
of O +
percentage O +
of O +
desmin+ O +
de O +
novo O +
generated O +
myoblasts O +
and O +
multinucleated O +
myotubes O -
. O +

These O +
experiments O +
were O +
carried O +
out O +
in O +
GM O -
. O +

Shown O +
are O +
myogenic O +
responses O +
of O +
mouse O +
cells O +
only O -
, O +
judged O +
by O +
lack O +
of O +
immunoreactivity O +
to O +
human O -
- O -
specific O -
/ O -
hESC O -
- O -
specific O +
antigens O -
, O +
such O +
as O +
NuMA O +
and O +
Oct4 O -
; O +
and O +
presence O +
of O +
mouse O -
- O -
specific O +
immunoreactivity O -
, O +
e.g. O -
, O +
M O -
- O -
cadherin O +
( O -
not O +
shown O -
) O -
. O +

Both O +
young O +
and O +
old O +
myofiber O +
associated O +
satellite O +
cells O +
exhibited O +
considerable O +
myogenic O +
improvement O +
over O +
control O +
conditions O -
. O +

n O +
= O +
3.In O +
concert O +
with O +
the O +
conservation O +
of O +
inhibitory O +
affects O +
of O +
aged O +
systemic O +
niche O -
, O +
the O +
negative O +
influence O +
of O +
local O +
muscle O +
niche O +
was O +
also O +
found O +
to O +
be O +
conserved O +
in O +
its O +
inhibition O +
of O +
hESC O +
and O +
ASC O +
regenerative O +
responses O -
. O +

Specifically O -
, O +
the O +
myogenic O +
capacity O +
( O -
generation O +
of O +
desmin+ O +
myoblasts O -
) O +
was O +
inhibited O +
in O +
young O +
satellite O +
cells O +
co O -
- O -
cultured O +
in O +
a O +
transwell O +
system O +
with O +
aged O +
myofibers O +
( O -
Fig. O +
4B O -
) O -
. O +

In O +
addition O -
, O +
hESC O +
and O +
ASC O +
proliferation O +
( O -
BrdU O +
incorporation O -
) O +
was O +
also O +
inhibited O +
by O +
aged O +
differentiated O +
muscle O +
( O -
Fig. O +
4A O -
, O -
C O -
) O -
. O +

These O +
data O +
suggest O +
that O +
not O +
only O +
systemic O +
but O +
also O +
local O +
organ O +
niches O +
would O +
inhibit O +
key O +
stem O +
cell O +
properties O -
, O +
e.g. O -
, O +
myogenic O +
capacity O +
and O +
the O +
rate O +
of O +
proliferation O +
in O +
the O +
aged O +
organism O -
. O +

The O +
conserved O +
inhibitory O +
influences O +
of O +
the O +
differentiated O +
muscle O +
niche O +
on O +
hESC O +
and O +
ASC O +
regenerative O +
responses O +
are O +
summarized O +
in O +
Table O +
2.Table O +
2Conservation O +
of O +
stem O +
cell O +
aging O +
in O +
the O +
local O +
organ O +
nicheRate O +
of O +
proliferation O +
ESC O -
/ O -
ASC O +
( O -
percentage O +
of O +
BrdU O -
) O -
Myogenic O +
differentiation O +
ESC O -
/ O -
ASC O +
( O -
percentage O +
of O +
desmin O -
) O -
Young O +
myofiber60.2 O +
± O +
2.5 O -
, O +
40.5 O +
± O +
2.67.4 O +
± O +
0.9 O -
, O +
47.6 O +
± O +
5.0Old O +
myofiber30.1 O +
± O +
4.3 O -
, O +
21.5 O +
± O +
4.11.3 O +
± O +
0.7 O -
, O +
19.7 O +
± O +
4.7Quantified O +
results O +
from O +
Fig. O +
4 O +
are O +
summarized O +
and O +
presented O +
as O +
mean O +
percentages O +
from O +
experimental O +
replicates O +
± O +
SE O -
. O +

Rate O +
of O +
proliferation O +
( O -
BrdU O -
) O +
and O +
myogenic O +
differentiation O +
( O -
desmin O -
) O +
are O +
shown O +
for O +
both O +
ESCs O +
and O +
ASCs O -
, O +
in O +
the O +
presence O +
of O +
young O +
vs. O +
old O +
differentiated O +
muscle O +
environments O +
( O -
young O +
myofiber O +
or O +
old O +
myofiber O -
) O -
. O +

hESCs O +
indirectly O +
enhance O +
and O +
rejuvenate O +
the O +
regeneration O +
of O +
skeletal O +
muscleWhile O +
hESC O +
properties O +
were O +
inhibited O +
by O +
aged O +
differentiated O +
muscle O -
, O +
the O +
myogenic O +
potential O +
of O +
aged O +
satellite O +
cells O +
seemed O +
to O +
be O +
enhanced O +
by O +
co O -
- O -
cultures O +
with O +
hESCs O +
( O -
Fig. O +
4A O -
) O -
. O +

Therefore O -
, O +
we O +
further O +
explored O +
the O +
enhancing O +
and O +
rejuvenating O +
effects O +
of O +
hESCs O +
on O +
myogenic O +
potential O +
in O +
vitro O +
and O +
in O +
vivo O -
, O +
using O +
human O +
mesenchymal O +
stem O +
cells O +
( O -
hMSCs O -
) O +
as O +
a O +
negative O +
control O -
. O +

First O -
, O +
we O +
examined O +
the O +
effects O +
of O +
hESCs O +
on O +
myotube O +
generation O +
by O +
co O -
- O -
culture O +
with O +
primary O +
myoblasts O +
freshly O +
derived O +
from O +
activated O -
- O -
by O -
- O -
injury O +
satellite O +
cells O +
( O -
Conboy O +
et O +
al. O -
, O +
2003 O -
) O -
. O +

As O +
shown O +
in O +
Fig. O +
5A O +
( O -
Mb O +
+ O +
hESC O -
) O -
, O +
primary O +
myoblasts O +
underwent O +
very O +
rapid O +
and O +
robust O +
nascent O +
myotube O +
formation O -
, O +
when O +
co O -
- O -
cultured O +
with O +
hESCs O +
for O +
48 O +
h O +
in O +
myoblast O +
differentiation O +
medium O -
. O +

Namely O -
, O +
remarkably O +
large O +
fused O +
myotubes O +
containing O +
approximately O +
50–70 O +
nuclei O +
formed O +
around O +
hESCs O +
colonies O +
( O -
Fig. O +
5A O -
) O -
. O +

In O +
contrast O -
, O +
when O +
co O -
- O -
cultured O +
with O +
hMSCs O -
, O +
myotube O +
formation O +
was O +
no O +
greater O +
than O +
in O +
myoblast O +
cultures O +
alone O +
( O -
Fig. O +
5A O -
, O +
Mb O +
+ O +
hMSC O +
and O +
Mb O +
alone O -
) O -
. O +

Encouraged O +
by O +
these O +
data O -
, O +
we O +
analyzed O +
the O +
myogenic O +
potential O +
of O +
young O +
and O +
old O +
satellite O +
cells O +
co O -
- O -
cultured O +
with O +
hESCs O +
for O +
48 O +
h. O +
As O +
shown O +
in O +
Fig. O +
5B O -
, O +
hESCs O +
conferred O +
a O +
much O -
- O -
enhanced O +
myogenic O +
capacity O +
on O +
both O +
young O +
and O -
, O +
importantly O -
, O +
old O +
myofiber O -
- O -
associated O +
satellite O +
cells O +
( O -
rapid O +
formation O +
of O +
desmin+ O +
myogenic O +
cells O -
, O +
many O +
of O +
which O +
formed O +
de O +
novo O +
multinucleated O +
myotubes O -
) O -
. O +

Control O +
co O -
- O -
cultures O +
of O +
these O +
satellite O +
cells O +
with O +
hMSCs O +
displayed O +
no O +
enhanced O +
myogenicity O -
. O +

In O +
summary O -
, O +
while O +
the O +
myogenic O +
potential O +
( O -
production O +
of O +
desmin+ O +
fusion O -
- O -
competent O +
cells O -
) O +
was O +
more O +
pronounced O +
in O +
young O +
vs. O +
old O +
myofiber O -
- O -
associated O +
satellite O +
cells O +
under O +
all O +
experimental O +
conditions O -
, O +
a O +
finding O +
that O +
is O +
consistent O +
with O +
previous O +
data O +
( O -
Conboy O +
et O +
al. O -
, O +
2003 O -
) O -
, O +
a O +
clear O +
increase O +
in O +
myogenic O +
potential O +
of O +
old O +
satellite O +
cells O +
was O +
noted O +
in O +
co O -
- O -
cultures O +
with O +
hESCs O -
, O +
as O +
compared O +
to O +
control O +
cultures O +
devoid O +
of O +
hESCs O +
( O -
Fig. O +
4A O -
, O -
B O -
) O -
.Interestingly O -
, O +
in O +
addition O +
to O +
the O +
rejuvenating O +
effects O +
of O +
direct O +
co O -
- O -
cultures O +
shown O +
in O +
Fig. O +
5 O -
, O +
soluble O +
factors O +
present O +
in O +
hESC O -
- O -
conditioned O +
culture O +
supernatants O +
were O +
also O +
able O +
to O +
enhance O +
myogenesis O +
of O +
aged O +
satellite O +
cells O +
( O -
Supplementary O +
Fig. O +
S5 O -
) O -
. O +

Thus O -
, O +
in O +
agreement O +
with O +
the O +
notion O +
that O +
an O +
established O +
embryonic O +
microniche O +
antagonizes O +
the O +
inhibitory O +
effects O +
of O +
the O +
aged O +
environment O +
on O +
stem O +
cell O +
responses O +
( O -
Fig. O +
3 O -
) O -
, O +
the O +
hESC O -
- O -
produced O +
factors O +
enhanced O +
myogenic O +
capacity O +
of O +
even O +
old O +
mouse O +
satellite O +
cells O -
. O +

Establishing O +
that O +
hESC O -
- O -
produced O +
factors O +
enhance O +
adult O +
myogenesis O +
and O +
rejuvenate O +
the O +
regenerative O +
capacity O +
of O +
even O +
aged O +
satellite O +
cells O +
in O +
vitro O +
prompted O +
us O +
to O +
examine O +
whether O +
the O +
regeneration O +
of O +
old O +
injured O +
muscle O +
will O +
be O +
improved O +
by O +
hESC O +
transplantation O +
in O +
vivo O -
. O +

Additionally O -
, O +
based O +
on O +
the O +
data O +
shown O +
above O -
, O +
we O +
speculated O +
that O +
even O +
if O +
the O +
host O -
's O +
repair O +
capacity O +
is O +
improved O -
, O +
hESCs O +
themselves O +
will O +
not O +
be O +
efficiently O +
maintained O +
or O +
expanded O +
in O +
the O +
context O +
of O +
old O +
systemic O +
and O +
local O +
organ O +
environments O -
, O +
and O +
will O +
not O +
directly O +
contribute O +
to O +
the O +
repair O +
of O +
aged O +
skeletal O +
muscle O -
. O +

To O +
test O +
these O +
hypotheses O -
, O +
we O +
injected O +
5 O +
× O +
105 O +
hESCs O +
or O +
control O +
hMSCs O +
into O +
the O +
tibialis O +
anterior O +
( O -
TA O -
) O +
and O +
gastrocnemius O +
muscles O +
of O +
young O +
and O +
old O +
mice O +
at O +
24 O +
h O +
after O +
cardiotoxin O -
- O -
induced O +
injury O -
, O +
when O +
activation O -
/ O -
proliferation O +
of O +
endogenous O +
satellite O +
cells O +
normally O +
begins O +
( O -
Conboy O +
et O +
al. O -
, O +
2003 O -
, O +
2005 O -
; O +
Wagers O +
& O +
Conboy O -
, O +
2005 O -
) O -
. O +

To O +
avoid O +
immune O +
response O +
against O +
hESC O +
antigens O -
, O +
mice O +
were O +
immunosuppressed O +
using O +
FK506 O +
( O -
Ito O +
& O +
Tanaka O -
, O +
1997 O -
; O +
Dumont O -
, O +
2000 O -
) O -
. O +

Muscle O +
was O +
isolated O +
5 O +
days O +
post O -
- O -
injury O -
, O +
when O +
nascent O +
differentiated O +
myofibers O +
normally O +
replace O +
the O +
damaged O +
tissue O +
( O -
Conboy O +
et O +
al. O -
, O +
2003 O -
) O -
, O +
and O +
10 O +
µm O +
cryosections O +
were O +
analyzed O +
for O +
the O +
success O +
in O +
tissue O +
repair O +
using O +
hematoxylin O +
and O +
eosin O +
( O -
H&E O -
) O +
histochemistry O +
and O +
eMyHC O +
immunodetection O -
. O +

H&E O +
analysis O +
reveals O +
newly O +
formed O +
myofibers O -
, O +
based O +
on O +
their O +
smaller O +
size O +
and O +
centrally O +
located O +
nuclei O -
. O +

Additionally O -
, O +
de O +
novo O +
myofibers O +
in O +
the O +
damaged O +
area O +
appear O +
positive O +
for O +
eMyHC O -
, O +
while O +
undamaged O +
myofibers O +
remain O +
negative O -
. O +

As O +
shown O +
in O +
Fig. O +
6A O +
and O +
quantified O +
in O +
6B O -
, O +
injection O +
of O +
hESCs O +
significantly O +
enhanced O +
regeneration O +
of O +
skeletal O +
muscle O -
. O +

Remarkably O -
, O +
this O +
positive O +
embryonic O +
effect O +
was O +
especially O +
pronounced O +
in O +
old O +
tissue O -
. O +

Fig. O +

6Skeletal O +
muscle O +
regeneration O +
following O +
hESC O +
transplantation O +
is O +
a O +
balance O +
between O +
the O +
inhibitory O +
influence O +
of O +
aged O +
niches O +
and O +
the O +
rejuvenating O +
effects O +
of O +
hESCs O -
. O +

Young O +
and O +
old O +
tibialis O +
anterior O +
and O +
gastrocnemius O +
muscles O +
were O +
injured O +
by O +
cardiotoxin O +
injection O -
. O +

hESCs O +
or O +
hMSCs O +
were O +
transplanted O +
at O +
the O +
site O +
of O +
injury O +
and O +
were O +
analyzed O +
by O +
cryosectioning O +
at O +
Day O +
5 O +
after O +
injury O +
( O -
as O +
described O +
in O +
Experimental O +
procedures O -
) O -
. O +

( O -
A O -
) O +
Newly O +
regenerated O +
myofibers O +
were O +
detected O +
using O +
eMyHC O -
- O -
specific O +
antibody O +
( O -
green O -
) O +
and O +
staining O +
with O +
H&E. O +
In O +
H&E O +
staining O -
, O +
newly O +
regenerated O +
areas O +
contain O +
smaller O -
, O +
immature O +
myofibers O +
with O +
centrally O +
located O +
nuclei O -
. O +

Uninjured O +
myofibers O +
are O +
much O +
larger O -
, O +
by O +
comparison O -
, O +
with O +
peripherally O +
restricted O +
nuclei O -
. O +

Poorly O +
regenerated O +
areas O +
lack O +
new O +
myofibers O +
and O +
contain O +
areas O +
of O +
fibrosis O +
and O +
inflammation O -
. O +

eMyHC O +
immunodetection O +
is O +
specific O +
for O +
regenerating O +
areas O +
of O +
muscle O +
only O -
. O +

Both O +
assays O +
showed O +
dramatic O +
enhancement O +
of O +
muscle O +
regeneration O +
in O +
' O -
old O +
+ O +
hESC O -
' O +
vs. O +
' O -
old O +
+ O +
hMSC O -
' O -
. O +

Regeneration O +
improvement O +
was O +
also O +
seen O +
in O +
young O +
+ O +
hESC O -
, O +
as O +
compared O +
to O +
young O +
+ O +
hMSC O -
. O +

( O -
B O -
) O +
Quantification O +
of O +
muscle O +
regeneration O +
was O +
performed O +
by O +
analyzing O +
the O +
density O +
of O +
newly O +
formed O +
myofibers O +
per O +
mm2 O +
of O +
injury O +
site O -
, O +
which O +
is O +
the O +
volume O +
that O +
typically O +
covers O +
the O +
whole O +
injured O +
area O -
. O +

Multiple O -
, O +
10 O +
µm O +
H&E O +
sections O +
were O +
examined O +
through O +
the O +
entire O +
volume O +
of O +
injury O +
in O +
multiple O -
, O +
independently O +
injured O +
muscles O -
. O +

n O +
= O +
20 O -
; O +

* O +
indicates O +
P O +
< O +
0.001 O +
( O -
' O -
old O +
+ O +
hMSC O -
' O +
compared O +
to O +
young O +
+ O +
hMSC O +
and O +
' O -
old O +
+ O +
hMSC O -
' O +
compared O +
to O +
' O -
old O +
+ O +
hESC O -
' O -
. O +

( O -
C O -
) O +
H&E O +
and O +
immunofluoresence O +
staining O +
for O +
Oct4 O -
, O +
and O +
a O +
human O -
- O -
specific O +
antibody O +
to O +
NuMA O -
, O +
revealed O +
the O +
failure O +
of O +
hESCs O +
to O +
expand O +
or O +
persist O +
in O +
old O -
, O +
but O +
the O +
presence O +
of O +
hESCs O +
in O +
young O +
muscle O +
at O +
5 O +
days O +
post O -
- O -
transplantation O -
. O +

Hoechst O +
( O -
blue O -
) O +
labels O +
nuclei O -
. O +

Importantly O -
, O +
such O +
enhanced O +
and O +
rejuvenated O +
muscle O +
repair O +
stems O +
from O +
an O +
indirect O +
induction O -
, O +
as O +
hESCs O +
themselves O +
( O -
or O +
control O +
hMSCs O -
) O +
did O +
not O +
physically O +
contribute O +
to O +
the O +
mouse O +
myofibers O -
, O +
as O +
judged O +
by O +
near O +
absence O +
( O -
less O +
than O +
0.1 O -
% O -
) O +
of O +
human O -
- O -
specific O +
NuMA+ O +
nuclei O +
in O +
de O +
novo O +
desmin+ O +
myofibers O -
, O +
analyzed O +
through O +
multiple O +
injury O +
sites O -
. O +

An O +
example O +
of O +
one O +
regenerated O +
myofiber O +
from O +
young O +
muscle O +
injected O +
with O +
hESCs O -
, O +
with O +
NuMA+ O +
nucleus O +
in O +
a O +
field O +
of O +
NuMA− O -
/ O -
desmin+ O +
mouse O +
myofibers O -
, O +
is O +
shown O +
in O +
Supplementary O +
Fig. O +
S6 O -
. O +

No O +
such O +
NuMA+ O -
/ O -
desmin+ O +
myofibers O +
were O +
detected O +
in O +
aged O +
regenerated O +
muscle O +
( O -
not O +
shown O -
) O -
.In O +
agreement O +
with O +
the O +
in O +
vitro O +
data O -
, O +
establishing O +
that O +
aged O +
systemic O +
and O +
local O +
niches O +
inhibit O +
hESC O +
proliferation O +
and O +
Oct4 O +
expression O +
( O -
Figs O +
2 O +
and O +
4 O +
and O +
Supplementary O +
Fig. O +
S2 O -
) O -
, O +
hESCs O +
failed O +
to O +
expand O +
or O +
even O +
persist O +
in O +
old O +
muscle O -
, O +
as O +
judged O +
by O +
the O +
absence O +
of O +
NuMA+ O -
/ O -
Oct4 O -
+ O +
hESC O -
- O -
derived O +
cells O +
in O +
the O +
aged O +
tissue O -
. O +

In O +
contrast O -
, O +
colonies O +
of O +
Numa+ O -
/ O -
Oct4 O -
+ O +
hESC O -
- O -
derived O +
cells O +
that O +
did O +
not O +
undergo O +
myogenic O +
differentiation O +
were O +
easily O +
detected O +
in O +
young O +
regenerating O +
muscle O +
( O -
Fig. O +
6C O -
) O -
. O +

This O +
finding O +
validates O +
several O +
technical O +
aspects O +
of O +
these O +
experiments O -
, O +
and O +
confirms O +
the O +
contrasting O +
effects O +
of O +
young O +
and O +
old O +
systemic O +
and O +
local O +
organ O +
niches O +
on O +
hESC O +
self O -
- O -
renewal O -
. O +

These O +
data O +
further O +
confirm O +
and O +
extrapolate O +
our O +
findings O +
and O +
demonstrate O +
that O +
when O +
exposed O +
to O +
both O +
aged O +
systemic O +
and O +
local O +
organ O +
niches O -
, O +
hESCs O +
fail O +
to O +
persist O +
and O +
do O +
not O +
contribute O +
to O +
tissue O +
repair O +
directly O -
. O +

At O +
the O +
same O +
time O -
, O +
these O +
embryonic O +
cells O +
indirectly O +
but O +
significantly O +
improve O +
the O +
repair O +
of O +
aged O +
injured O +
muscle O +
in O +
vivo O -
. O +

The O +
data O +
presented O +
here O +
establish O +
for O +
the O +
first O +
time O +
that O +
both O +
the O +
local O +
environment O +
of O +
old O +
differentiated O +
organ O -
, O +
e.g. O -
, O +
skeletal O +
muscle O +
and O +
the O +
systemic O +
milieu O +
dramatically O +
affect O +
the O +
regenerative O +
potential O +
of O +
both O +
hESCs O +
and O +
mouse O +
post O -
- O -
natal O +
myogenic O +
progenitor O +
cells O -
. O +

Not O +
only O +
are O +
the O +
factors O +
promoting O +
myogenic O +
differentiation O +
and O +
proliferation O +
of O +
hESCs O +
likely O +
to O +
become O +
depleted O +
with O +
age O -
, O +
but O +
the O +
aged O +
systemic O +
and O +
local O +
organ O +
niches O +
are O +
likely O +
to O +
contain O +
dominant O +
inhibitors O +
of O +
ASC O +
and O +
hESC O +
regenerative O +
potential O +
( O -
Figs O +
1 O -
, O +
2 O -
, O +
and O +
4 O -
, O +
summarized O +
in O +
Tables O +
1 O +
and O +
2 O -
) O -
. O +

Importantly O -
, O +
the O +
similar O +
inhibitory O +
effects O +
of O +
old O +
mouse O +
serum O +
and O +
old O +
myofibers O +
on O +
satellite O +
cell O +
( O -
Figs O +
1 O +
and O +
4C O -
) O +
and O +
hESC O +
( O -
Figs O +
2 O +
and O +
4A O -
) O +
proliferation O +
and O +
regenerative O +
capacity O +
suggest O +
the O +
conservation O +
of O +
elements O +
in O +
age O -
- O -
specific O +
extrinsic O +
regulatory O +
mechanisms O +
between O +
evolutionarily O +
distinct O +
species O +
and O +
stem O +
cell O +
types O -
. O +

Additionally O -
, O +
a O +
similarity O +
in O +
the O +
inhibitory O +
properties O +
between O +
systemic O +
and O +
local O +
organ O +
niches O +
is O +
also O +
of O +
interest O +
and O +
may O +
indicate O +
that O +
molecules O +
produced O +
by O +
old O +
tissues O +
have O +
circulatory O -
/ O -
endocrine O +
activity O -
; O +
and/or O +
that O +
age O -
- O -
specific O +
systemic O +
inhibitory O +
components O +
become O +
deposited O +
in O +
the O +
old O +
tissues O -
. O +

Humans O +
display O +
broad O +
genetic O +
polymorphisms O +
and O +
behavioral O +
variations O -
, O +
which O +
makes O +
the O +
identification O +
of O +
age O -
- O -
specific O +
molecular O +
changes O +
complicated O -
. O +

In O +
contrast O -
, O +
laboratory O +
mice O +
are O +
genetically O +
and O +
environmentally O +
controlled O -
. O +

Establishing O +
that O +
age O -
- O -
specific O +
signals O -
, O +
regulating O +
stem O +
cell O +
responses O -
, O +
are O +
evolutionarily O +
conserved O +
and O +
soluble O +
enables O +
the O +
formation O +
of O +
rational O +
approaches O +
for O +
the O +
identification O +
and O +
characterization O +
of O +
the O +
inhibitors O +
involved O -
, O +
and O +
for O +
revealing O +
the O +
precise O +
timing O +
of O +
their O +
first O +
appearance O +
in O +
serum O +
and O +
differentiated O +
tissues O +
with O +
advancing O +
age O -
. O +

Significantly O -
, O +
these O +
experiments O +
have O +
also O +
revealed O +
that O +
not O +
only O +
are O +
hESCs O +
able O +
to O +
protect O +
themselves O +
against O +
the O +
negative O +
influences O +
of O +
aged O +
mouse O +
sera O +
( O -
Fig. O +
3 O -
) O -
, O +
but O +
these O +
cells O +
also O +
produce O +
factors O +
that O +
dramatically O +
enhance O +
the O +
myogenic O +
capacity O +
of O +
primary O +
myoblasts O +
and O +
young O +
and O +
old O +
satellite O +
cells O +
( O -
Fig. O +
5 O -
) O -
, O +
and O +
also O +
significantly O +
improve O +
repair O +
of O +
young O +
and O +
old O +
injured O +
muscle O +
in O +
vivo O +
( O -
Fig. O +
6 O -
) O -
. O +

Identification O +
of O +
these O +
embryonic O +
factors O +
would O +
allow O +
us O +
to O +
potentially O +
enrich O +
the O +
arsenal O +
of O +
therapeutic O +
tools O +
for O +
combating O +
age O -
- O -
specific O +
degenerative O +
disorders O -
. O +

The O +
interactions O +
between O +
hESCs O +
and O +
heterochronic O +
differentiated O +
niches O -
, O +
initially O +
identified O +
in O +
vitro O -
, O +
have O +
been O +
confirmed O +
by O +
in O +
vivo O +
experiments O -
. O +

Namely O -
, O +
while O +
the O +
regenerative O +
capacity O -
, O +
or O +
presence O -
, O +
of O +
hESCs O +
is O +
greatly O +
restricted O +
in O +
aged O -
, O +
as O +
compared O +
to O +
young O +
skeletal O +
muscle O +
( O -
where O +
transplanted O +
cells O +
experience O +
both O +
old O +
systemic O +
and O +
local O +
environments O -
) O -
, O +
embryonic O +
cells O +
indirectly O +
enhance O +
and O +
rejuvenate O +
muscle O +
repair O +
when O +
introduced O +
at O +
the O +
time O +
of O +
muscle O +
stem O +
cell O +
activation O +
in O +
the O +
host O -
, O +
e.g. O -
, O +
at O +
Day O +
1 O +
after O +
the O +
injury O +
( O -
Fig. O +
6 O -
) O -
. O +

It O +
remains O +
to O +
be O +
determined O +
whether O +
the O +
percentage O +
of O +
hESCs O +
direct O +
contribution O +
to O +
desmin+ O +
myofibers O +
in O +
young O +
muscle O +
will O +
be O +
increased O +
by O +
transplanting O +
these O +
cells O +
at O +
a O +
different O +
time O -
- O -
point O +
after O +
muscle O +
injury O -
, O +
e.g. O -
, O +
at O +
Days O +
3–5 O +
( O -
as O +
in O +
co O -
- O -
cultures O +
with O +
myofibers O +
pre O -
- O -
injured O +
for O +
3 O +
days O -
, O +
Fig. O +
4A O -
) O -
. O +

In O +
any O +
case O -
, O +
the O +
virtual O +
lack O +
of O +
hESC O +
and O +
hMSC O +
direct O +
contribution O +
to O +
the O +
newly O +
regenerated O +
skeletal O +
muscle O -
, O +
when O +
small O +
numbers O +
of O +
these O +
cells O +
were O +
injected O +
into O +
injured O +
tissue O -
, O +
is O +
completely O +
consistent O +
with O +
the O +
body O +
of O +
previous O +
data O +
demonstrating O +
that O +
myofiber O -
- O -
associated O +
satellite O +
cells O +
conduct O +
rapid O +
and O +
robust O +
muscle O +
repair O +
and O +
greatly O +
outnumber O +
injected O +
human O +
cells O +
( O -
Collins O +
et O +
al. O -
, O +
2005 O -
; O +
Wagers O +
& O +
Conboy O -
, O +
2005 O -
) O -
; O +
that O +
compared O +
to O +
muscle O -
- O -
specific O +
satellite O +
cells O -
, O +
the O +
myogenic O +
differentiation O +
of O +
hESCs O +
in O +
vitro O +
remains O +
very O +
small O +
( O -
Fig. O +
5 O -
, O +
Table O +
2 O -
) O -
, O +
and O +
that O +
control O +
hMSCs O +
are O +
not O +
normally O +
myogenic O +
unless O +
these O +
cells O +
overexpress O +
exogenous O +
constitutively O +
active O +
domain O +
of O +
Notch O +
( O -
Dezawa O +
et O +
al. O -
, O +
2005 O -
) O -
. O +

Intriguingly O -
, O +
the O +
failure O +
of O +
hESCs O +
to O +
strive O +
in O +
old O +
skeletal O +
muscle O +
might O +
represent O +
a O +
therapeutically O +
desirable O +
outcome O -
. O +

For O +
example O -
, O +
while O +
in O +
young O +
tissue O +
hESC O +
derivatives O +
putatively O +
would O +
go O +
on O +
to O +
produce O +
teratomas O -
, O +
it O +
is O +
unlikely O +
that O +
teratoma O +
formation O +
would O +
occur O +
after O +
hESC O +
transplantation O +
into O +
aged O +
skeletal O +
muscle O -
. O +

Thus O -
, O +
the O +
indirect O +
beneficial O +
effects O +
of O +
hESCs O +
on O +
tissue O +
repair O +
are O +
unlikely O +
to O +
be O +
compromised O +
by O +
the O +
oncogenic O +
properties O +
of O +
these O +
embryonic O +
cells O +
in O +
the O +
context O +
of O +
old O +
skeletal O +
muscle O -
. O +

Comprehensively O -
, O +
the O +
results O +
of O +
this O +
work O +
increase O +
our O +
understanding O +
of O +
aging O +
as O +
a O +
process O -
, O +
reveal O +
evolutionary O +
conserved O +
age O -
- O -
specific O +
interactions O +
between O +
stem O +
cells O +
and O +
their O +
differentiated O +
niches O -
, O +
and O +
suggest O +
novel O +
therapeutic O +
approaches O +
for O +
improving O +
the O +
regenerative O +
responses O +
of O +
endogenous O +
or O +
transplanted O +
stem O +
cells O +
in O +
old O +
individuals O -
. O +

Animal O +
strainsYoung O +
( O -
2–3 O +
months O -
) O -
, O +
C57-BL O -
/ O -
6 O +
male O +
mice O +
were O +
obtained O +
from O +
pathogen O -
- O -
free O +
breeding O +
colonies O +
at O +
Jackson O +
Laboratories O +
( O -
Bar O +
Harbor O -
, O +
ME O -
, O +
USA O -
) O -
. O +

Aged O +
22–24 O +
months O +
C57-BL O -
/ O -
6 O +
male O +
mice O +
were O +
obtained O +
from O +
the O +
National O +
Institute O +
on O +
Aging O +
( O -
NIH O -
) O -
. O +

Animals O +
were O +
maintained O +
in O +
the O +
North O -
- O -
West O +
Animal O +
Facility O +
of O +
the O +
University O +
of O +
California O -
, O +
Berkeley O -
, O +
CA O -
, O +
USA O -
, O +
and O +
handled O +
in O +
accordance O +
with O +
the O +
Administrative O +
Panel O +
on O +
Laboratory O +
Animal O +
Care O +
at O +
UC O +
Berkeley O -
. O +

Muscle O +
injury O +
and O +
isolationMyofiber O +
cultures O -
, O +
in O +
which O +
satellite O +
cells O +
were O +
activated O +
by O +
in O +
vivo O +
injury O -
, O +
were O +
set O +
up O +
as O +
previously O +
described O +
( O -
Conboy O +
& O +
Rando O -
, O +
2002 O -
; O +
Conboy O +
et O +
al. O -
, O +
2005 O -
) O -
. O +

Briefly O -
, O +
mice O +
were O +
injured O +
by O +
direct O +
injection O +
with O +
5 O +
ng O +
cardiotoxin O +
( O -
CTX-1 O -
) O +
( O -
Sigma O -
, O +
St O +
Louis O -
, O +
MO O -
, O +
USA O -
) O +
into O +
the O +
tibialis O +
anterior O +
and O +
gastrocnemius O +
muscles O +
using O +
a O +
28-gauge O +
needle O -
. O +

After O +
1–5 O +
days O +
post O -
- O -
injection O -
, O +
injured O +
or O +
uninjured O +
muscle O +
tissue O +
was O +
dissected O +
out O -
. O +

Once O +
isolated O -
, O +
whole O +
muscle O +
was O +
prepared O +
for O +
cryosectioning O +
( O -
see O +
below O -
) O +
or O +
myofiber O +
fragments O +
were O +
obtained O +
from O +
hind O +
limb O +
muscles O +
by O +
enzymatic O +
digestion O +
( O -
see O +
below O -
) O -
, O +
trituration O -
, O +
and O +
multiple O +
sedimentation O +
and O +
washing O +
procedures O -
. O +

Additionally O -
, O +
blood O +
was O +
collected O +
from O +
mice O +
for O +
the O +
isolation O +
of O +
sera O -
. O +

Briefly O -
, O +
blood O +
cells O +
were O +
coagulated O +
at O +
37 O +
° O -
C O +
for O +
15 O -
' O +
and O +
then O +
were O +
centrifuged O +
repeatedly O +
at O +
5900 O +
g O -
, O +
4 O +
° O -
C O +
in O +
a O +
microfuge O +
for O +
3 O -
' O +
to O +
isolate O +
sera O -
. O +

Mixtures O +
of O +
young O +
and O +
old O +
sera O +
were O +
made O +
1 O +
: O +
1 O -
. O +

For O +
example O -
, O +
in O +
5%+ O +
5 O -
% O +
conditions O -
, O +
50 O +
µL O +
of O +
young O +
and O +
50 O +
µL O +
old O +
serum O +
were O +
added O +
to O +
900 O +
µL O +
of O +
culture O +
medium O +
( O -
Opti O -
- O -
MEM O +
or O +
MCM O -
, O +
see O +
co O -
- O -
culture O +
procedures O +
below O -
) O -
. O +

Myofiber O +
explant O +
culturesExplant O +
and O +
primary O +
cell O +
cultures O +
were O +
generated O +
from O +
C57-BL O -
/ O -
6 O +
mice O -
, O +
as O +
previously O +
described O +
( O -
Conboy O +
& O +
Rando O -
, O +
2002 O -
; O +
Conboy O +
et O +
al. O -
, O +
2003 O -
) O -
. O +

Dissected O +
gastrocnemius O +
and O +
tibialis O +
anterior O +
muscles O +
underwent O +
enzymatic O +
digestion O +
at O +
37 O +
° O -
C O +
in O +
DMEM O +
( O -
Invitrogen O -
) O -
/ O -
Pen O -
- O -
Strep O +
( O -
Invitrogen O -
) O -
/ O -
0.2 O -
% O +
Collagenase O +
Type O +
IIA O +
( O -
Sigma O -
) O +
solution O -
. O +

Isolated O +
fibers O +
were O +
resuspended O +
in O +
GM O +
( O -
Ham O -
's O +
F10 O +
nutrient O +
mixture O +
( O -
Mediatech O -
, O +
Inc. O -
, O +
Herndon O -
, O +
VA O -
, O +
USA O -
) O -
, O +
20 O -
% O +
FBS O +
( O -
Mediatech O -
) O -
, O +
5 O +
ng O +
mL−1 O +
bFGF O +
( O -
Chemicon O -
, O +
Temecula O -
, O +
CA O -
, O +
USA O -
) O +
and O +
1 O -
% O +
Pen O -
- O -
Strep O -
, O +
and O +
cultured O +
on O +
ECM O -
- O -
coated O +
( O -
BD O +
Biosciences O -
, O +
San O +
Jose O -
, O +
CA O -
, O +
USA O -
) O +
plates O +
( O -
diluted O +
1 O +
: O +
500 O +
in O +
PBS O -
) O -
. O +

Cultures O +
of O +
primary O +
myoblasts O +
were O +
derived O +
from O +
isolated O +
fibers O -
, O +
through O +
repeated O +
passaging O -
, O +
and O +
were O +
maintained O +
in O +
GM O -
. O +

Myoblast O +
differentiation O +
medium O +
[ O -
DMEM O -
, O +
supplemented O +
with O +
2 O -
% O +
horse O +
serum O +
( O -
Mediatech O -
) O -
] O +
was O +
used O +
to O +
promote O +
rapid O +
formation O +
of O +
myotubes O +
from O +
cultured O +
myoblasts O +
( O -
Morgan O +
& O +
Partridge O -
, O +
2003 O -
) O -
. O +

Human O +
embryonic O +
and O +
mesenchymal O +
stem O +
cell O +
cultureThe O +
federally O +
approved O +
hESC O +
line O -
, O +
H7 B-CellLine +
( O -
NIH O +
no. O +
WA07 B-CellLine -
, O +
obtained O +
from O +
WiCell O +
Research O +
Institue O -
, O +
Madison O -
, O +
WI O -
, O +
USA O -
) O -
, O +
was O +
used O +
in O +
accordance O +
with O +
the O +
UC O +
Berkeley O +
and O +
UC O +
San O +
Francisco O +
Committee O +
on O +
Human O +
Research O +
guidelines O -
, O +
and O +
in O +
accordance O +
with O +
NIH O +
guidelines O -
. O +

To O +
propagate O +
hESCs O -
, O +
routine O +
culturing O +
and O +
maintenance O +
was O +
performed O +
using O +
standard O +
in O +
vitro O +
conditions O +
for O +
both O +
feeder O -
- O -
dependent O +
and O +
feeder O -
- O -
free O +
cultures O +
( O -
Geron O +
Corporation O -
, O +
2002 O -
) O -
. O +

Briefly O -
, O +
hESCs O +
grown O +
on O +
MEFs O +
were O +
cultured O +
in O +
standard O +
hESC O +
medium O +
[ O -
Knockout O -
™ O +
DMEM O -
, O +
20 O -
% O +
KSR O -
, O +
1 O -
% O +
NEAA O -
, O +
1 O +
mm O +
l O -
- O -
glutamine O +
( O -
Invitrogen O -
) O -
, O +
0.1 O +
mmβ O -
- O -
mercaptoethanol O +
( O -
Sigma O -
) O -
] O +
and O +
were O +
supplemented O +
with O +
4 O +
ng O +
mL−1 O +
hbFGF O +
( O -
Invitrogen O -
) O -
. O +

Feeder O -
- O -
free O +
hESC O +
cultures O +
were O +
maintained O +
in O +
MEF O -
- O -
conditioned O +
hESC O +
medium O +
( O -
MCM O -
) O -
, O +
4 O +
ng O +
mL−1 O +
hbFGF O -
. O +

Differentiation O +
medium O +
for O +
hESCs O +
( O -
DMEM O -
/ O -
FBS O -
) O +
was O +
made O +
by O +
replacing O +
KSR O +
with O +
20 O -
% O +
FBS O +
( O -
Hyclone O -
, O +
Logan O -
, O +
UH O -
, O +
USA O -
) O -
. O +

hMSCs O +
were O +
maintained O +
in O +
mesenchymal O +
stem O +
cell O +
GM O -
, O +
MSC O -
- O -
GM O -
™ O +
and O +
were O +
cultured O +
according O +
to O +
supplier O +
recommendations O +
( O -
Cambrex O +
Walkersville O -
, O +
MD O -
, O +
USA O -
) O -
. O +

hESCs O +
and O +
hMSCs O +
were O +
typically O +
seeded O +
onto O +
chambered O +
slides O +
coated O +
with O +
a O +
3 O -
% O +
GFR O +
Matrigel O -
™ O +
( O -
BD O +
Biosciences O -
) O +
substrate O +
in O +
PBS O -
. O +

Cells O +
were O +
typically O +
incubated O +
for O +
48 O +
h O +
at O +
37 O +
° O -
C O -
, O +
5 O -
% O +
CO2 O -
, O +
under O +
the O +
various O +
experimental O +
conditions O +
employed O -
, O +
then O +
were O +
fixed O +
with O +
70 O -
% O +
EtOH O -
/ O -
PBS O +
at O +
4 O +
° O -
C O -
. O +

hESCs O +
and O +
hMSCs O +
were O +
analyzed O +
24–48 O +
h O +
after O +
experimental O +
treatments O -
, O +
during O +
which O +
no O +
apoptosis O -
- O -
related O +
differences O +
in O +
cell O +
numbers O +
were O +
observed O -
. O +

Heterochronic O +
co O -
- O -
culture O +
systemsHeterochronic O +
systemic O +
cultures O +
were O +
established O +
by O +
culturing O +
myofiber O +
explants O +
( O -
in O +
GM O -
) O +
or O +
hESCs O +
( O -
in O +
MCM O -
) O +
in O +
the O +
presence O +
of O +
young O -
, O +
old O +
or O +
young O +
+ O +
old O +
sera O +
for O +
48 O +
h O +
( O -
Figs O +
1 O +
and O +
2 O +
and O +
Supplementary O +
Figs O +
S1–3 O -
) O -
. O +

In O +
such O +
cultures O -
, O +
hESCs O +
were O +
passaged O +
immediately O +
prior O +
to O +
sera O +
exposure O -
. O +

In O +
contrast O -
, O +
preculturing O +
of O +
hESCs O +
for O +
24 O +
h O +
in O +
MCM O -
, O +
prior O +
to O +
replacing O +
MCM O +
with O +
MCM O +
+ O +
10 O -
% O +
old O +
mouse O +
sera O +
was O +
done O +
for O +
embryonic O +
microniche O +
experiments O +
( O -
Fig. O +
3 O -
) O -
. O +

For O +
heterochronic O +
local O +
organ O +
niche O +
cultures O -
, O +
hESCs O +
were O +
co O -
- O -
cultured O +
directly O +
with O +
myofiber O +
explants O +
for O +
48 O +
h O +
in O +
GM O -
, O +
or O +
were O +
cultured O +
in O +
the O +
presence O +
of O +
supernatants O +
derived O +
from O +
cultured O +
myofiber O +
explants O +
for O +
48 O +
h O +
( O -
Figs O +
4A O +
and O +
5 O -
) O -
. O +

Specifically O -
, O +
1 O +
× O +
105 O +
hESCs O +
or O +
control O +
hMSCs O +
were O +
co O -
- O -
cultured O +
with O +
identical O +
volume O -
, O +
e.g. O -
, O +
100 O +
µL O -
, O +
of O +
young O +
or O +
old O +
myofiber O +
fragments O +
with O +
their O +
associated O +
satellite O +
cells O +
( O -
Fig. O +
5 O -
) O -
. O +

In O +
experiments O +
shown O +
in O +
Supplementary O +
Fig. O +
S5 O -
, O +
culture O -
- O -
conditioned O +
supernatant O +
produced O +
by O +
hESCs O +
grown O +
in O +
MCM O +
was O +
used O +
as O +
a O +
medium O +
in O +
which O +
1 O +
× O +
105 O +
of O +
myofiber O -
- O -
associated O +
young O +
or O +
old O +
satellite O +
cells O +
were O +
cultured O +
for O +
48 O +
h. O +
In O +
direct O +
co O -
- O -
cultures O -
, O +
mouse O +
vs. O +
human O +
cells O +
were O +
distinguished O +
by O +
immunodetection O +
with O +
human O -
- O -
specific O -
/ O -
hESC O -
- O -
specific O +
and O +
mouse O -
- O -
specific O +
antibodies O +
( O -
Supplementary O +
Fig. O +
S4 O +
and O +
see O +
below O -
) O -
. O +

To O +
prepare O +
muscle O +
supernatants O -
, O +
explants O +
were O +
cultured O +
for O +
24 O +
h O +
in O +
GM O +
and O +
cellular O +
debris O +
was O +
removed O +
from O +
conditioned O +
media O +
by O +
multiple O +
rounds O +
of O +
centrifugation O -
. O +

The O +
absence O +
of O +
cells O +
was O +
confirmed O +
by O +
microscopic O +
examination O -
. O +

To O +
mimic O +
the O +
local O +
organ O +
niche O +
for O +
satellite O +
cell O +
assays O +
( O -
Fig. O +
4B O -
) O -
, O +
1.0 O +
µm O +
transwell O +
( O -
Corning O -
, O +
NY O -
, O +
USA O -
) O +
co O -
- O -
cultures O +
of O +
uninjured O +
explants O +
with O +
activated O +
satellite O +
cells O +
were O +
established O -
. O +

Activated O -
- O -
by O -
- O -
injury O +
( O -
24 O +
h O +
post O -
- O -
injury O -
) O +
satellite O +
cells O +
were O +
seeded O +
onto O +
ECM O -
- O -
coated O +
12-well O +
plates O +
in O +
Opti O -
- O -
MEM O +
( O -
Invitrogen O -
) O +
and O +
5 O -
% O +
FBS O -
. O +

Transwells O +
were O +
placed O +
over O +
satellite O +
cells O +
and O +
contained O +
isolated O +
myofiber O +
explants O +
from O +
uninjured O +
young O +
or O +
old O +
muscle O +
( O -
i.e. O -
, O +
resting O +
muscle O -
) O -
. O +

Satellite O +
cells O +
were O +
cultured O +
for O +
72–96 O +
h O +
in O +
the O +
presence O +
of O +
myofiber O +
explants O +
and O +
were O +
fixed O +
for O +
immunodetection O -
, O +
as O +
described O +
above O -
. O +

Cell O +
transplantationhESCs O +
were O +
grown O +
on O +
MEFs O +
and O +
expanded O +
in O +
6-well O +
plates O -
. O +

Cells O +
were O +
treated O +
with O +
1 O +
mg O +
mL−1 O +
Collagenase O +
Type O +
IV O +
( O -
Invitrogen O -
) O +
for O +
5–10 O +
min O -
, O +
were O +
washed O +
and O +
then O +
incubated O +
with O +
0.5 O +
mg O +
mL−1 O +
Dispase O +
( O -
Invitrogen O -
) O +
to O +
lift O +
only O +
human O +
cell O +
colonies O -
. O +

Isolated O +
hESCs O +
were O +
washed O +
several O +
times O +
and O +
resuspended O +
in O +
100 O +
µL O +
hESC O +
medium O -
. O +

Similarly O -
, O +
hMSCs O +
were O +
expanded O +
in O +
6-well O +
plates O -
, O +
lifted O +
with O +
Trypsin O -
/ O -
EDTA O +
( O -
Invitrogen O -
) O -
, O +
washed O +
and O +
resuspended O +
in O +
100 O +
µL O +
hESC O +
medium O -
. O +

Approximately O +
5 O +
× O +
105 O +
hESCs O +
or O +
hMSCs O +
were O +
injected O +
into O +
24 O +
h O +
post O -
- O -
injured O +
gastrocnemius O +
and O +
tibialis O +
anterior O +
muscles O +
of O +
young O +
and O +
old O +
mice O -
, O +
using O +
a O +
21-gauge O +
needle O -
. O +

Immunosuppression O +
of O +
animals O +
was O +
achieved O +
by O +
intraperitoneal O +
injection O +
of O +
1 O +
mg O +
kg−1 O +
FK506 O +
( O -
Sigma O -
) O +
at O +
48 O +
h O +
prior O +
to O +
cell O +
transplantation O -
, O +
and O +
on O +
each O +
day O +
following O +
transplantation O -
. O +

Immunodetection O +
and O +
histological O +
analysisTo O +
assay O +
the O +
affects O +
of O +
heterochronic O +
local O +
and O +
systemic O +
environments O +
on O +
stem O +
cell O +
regenerative O +
potential O -
, O +
hESC O -
, O +
hMSC O -
, O +
and O +
myofiber O -
- O -
derived O +
precursor O +
cell O +
cultures O +
were O +
fixed O +
with O +
70 O -
% O +
EtOH O -
/ O -
PBS O +
at O +
4 O +
° O -
C O -
, O +
and O +
were O +
analyzed O +
by O +
indirect O +
immunofluorescence O -
. O +

Combinations O +
of O +
antibodies O +
were O +
used O +
to O +
co O -
- O -
stain O +
cultures O +
and O +
histosections O -
, O +
in O +
order O +
to O +
determine O +
the O +
percentages O +
of O +
cells O +
that O +
proliferated O +
or O +
differentiated O +
and O +
to O +
distinguish O +
hESCs O +
from O +
mouse O +
cells O -
. O +

Antibodies O +
to O +
the O +
myogenic O +
transcription O +
factors O -
, O +
Myf5 O -
/ O -
Pax7 O -
, O +
the O +
intermediate O +
filament O +
protein O -
, O +
desmin O -
, O +
and O +
the O +
marker O +
of O +
newly O +
formed O +
myotubes O -
, O +
eMyHC O -
, O +
were O +
used O +
to O +
reveal O +
commitment O +
to O +
myogenic O +
differentiation O -
. O +

Cell O +
commitment O +
to O +
this O +
differentiation O +
program O +
was O +
assessed O +
by O +
the O +
efficiency O +
of O +
myotube O +
formation O -
, O +
estimated O +
by O +
the O +
number O +
of O +
nuclei O +
per O +
myotube O -
. O +

Ki67 O -
, O +
a O +
cell O +
cycle O +
related O +
nuclear O +
protein O +
consistently O +
absent O +
in O +
quiescent O +
cells O -
, O +
was O +
used O +
as O +
a O +
marker O +
for O +
proliferation O -
. O +

Whereas O +
Ki67 O +
appears O +
in O +
all O +
active O +
phases O +
of O +
the O +
cell O +
cycle O -
, O +
BrdU O +
staining O +
allowed O +
exclusive O +
detection O +
of O +
cells O +
in O +
S O -
- O -
phase O -
, O +
thereby O +
enabling O +
accurate O +
quantification O +
of O +
DNA O +
synthesis O -
. O +

In O +
select O +
cultures O -
, O +
10 O +
µm O +
BrdU O +
was O +
added O +
for O +
2 O +
h O +
prior O +
to O +
fixation O -
. O +

BrdU O -
- O -
specific O +
immunostaining O +
required O +
nuclear O +
permeabilization O +
with O +
treatment O +
of O +
4N O +
HCl O -
. O +

hESCs O +
were O +
distinguished O +
from O +
mouse O +
cells O +
by O +
using O +
a O +
species O -
- O -
specific O +
antibody O +
to O +
the O +
cell O -
- O -
surface O +
marker O +
M O -
- O -
cadherin O +
for O +
murine O +
and O +
the O +
nuclear O +
marker O +
NuMA O +
for O +
human O +
cells O -
. O +

Antibodies O +
to O +
Oct4 O +
were O +
used O +
as O +
a O +
marker O +
of O +
hESC O +
self O -
- O -
renewal O -
/ O -
pluripotency O -
. O +

Following O +
permeabilization O +
in O +
PBS O -
, O +
+ O -
1 O -
% O +
FBS O -
, O +
+ O -
0.25 O -
% O +
Triton O +
X-100 O -
, O +
cells O +
were O +
incubated O +
with O +
primary O +
antibodies O +
( O -
concentration O +
determined O +
as O +
per O +
manufacturer O -
's O +
recommendations O -
) O +
for O +
1 O +
h O +
at O +
room O +
temperature O +
in O +
PBS O -
, O +
+ O -
1 O -
% O +
FBS O -
, O +
washed O +
several O +
times O -
, O +
and O +
then O +
incubated O +
with O +
fluorophore O -
- O -
conjugated O -
, O +
species O -
- O -
specific O +
secondary O +
antibodies O +
( O -
diluted O +
1 O +
: O +
500 O +
in O +
PBS O +
+ O +
1 O -
% O +
FBS O -
) O +
for O +
1 O +
h O +
at O +
room O +
temperature O -
. O +

For O +
histological O +
analysis O -
, O +
dissected O +
muscle O +
was O +
treated O +
in O +
a O +
25 O -
% O +
sucrose O -
/ O -
PBS O +
solution O -
, O +
frozen O +
in O +
OCT O +
compound O +
( O -
Tissue O +
Tek O -
) O +
and O +
cryosectioned O +
at O +
10 O +
µm O -
. O +

Immunostaining O +
was O +
performed O +
in O +
the O +
manner O +
described O +
above O -
, O +
or O +
H&E O +
staining O +
of O +
cryosections O +
was O +
performed O -
. O +

Nuclei O +
were O +
visualized O +
by O +
Hoechst O +
staining O +
for O +
all O +
immunostains O -
. O +

Samples O +
were O +
analyzed O +
at O +
room O +
temperature O +
by O +
using O +
a O +
Zeiss O +
Axioscope O +
40 O +
fluorescent O +
microscope O -
, O +
and O +
imaged O +
with O +
an O +
Axiocan O +
MRc O +
camera O +
and O +
AxioVision O +
software O -
. O +

All O +
images O +
depict O +
identical O +
microscope O +
fields O +
at O +
×20 O +
magnification O -
, O +
unless O +
otherwise O +
noted O -
. O +

ReagentsAntibodies O +
to O +
Oct4 O +
( O -
ab18976 O -
) O -
, O +
BrdU O +
( O -
BU1 O -
/ O -
75 O +
( O -
ICR1 O -
) O -
, O +
and O +
Ki67 O +
( O -
ab15580 O -
) O +
were O +
purchased O +
from O +
Abcam O +
( O -
Cambridge O -
, O +
MA O -
, O +
USA O -
) O -
. O +

Antibody O +
to O +
M O -
- O -
cadherin O +
( O -
clone O +
12G4 O -
) O +
was O +
acquired O +
from O +
Upstate O +
Biotechnology O +
( O -
Lake O +
Placid O -
, O +
NY O -
, O +
USA O -
) O -
, O +
and O +
NuMA O +
antibody O +
( O -
Catalog O +
number O +
NA09L O -
) O +
from O +
EMD O +
Biosciences O +
( O -
San O +
Diego O -
, O +
CA O -
, O +
USA O -
) O -
. O +

Antibody O +
to O +
developmental O +
eMyHC O +
( O -
clone O +
RNMy2 O -
/ O -
9D2 O -
) O +
was O +
acquired O +
from O +
Vector O +
Laboratories O +
( O -
Burlingame O -
, O +
CA O -
, O +
USA O -
) O -
. O +

Myf5 O +
( O -
GTX77876 O -
) O +
and O +
Pax7 O +
( O -
GTX77888 O -
) O +
antibodies O +
were O +
obtained O +
from O +
GeneTex O +
( O -
San O +
Antonio O -
, O +
TX O -
, O +
USA O -
) O -
. O +

Desmin O +
antibodies O +
( O -
clone O +
DE O -
- O -
U-10 O +
and O +
Catalog O +
number O +
D8281 O -
) O -
, O +
BrdU O +
labeling O +
reagent O +
and O +
FK506 O +
( O -
Catalog O +
number O +
F4679 O -
) O +
were O +
obtained O +
from O +
Sigma O -
. O +

Fluorophore O -
- O -
conjugated O +
secondary O +
antibodies O +
( O -
Alexa O +
Fluor O -
) O +
were O +
obtained O +
from O +
Molecular O +
Probes O +
( O -
Eugene O -
, O +
OR O -
, O +
USA O -
) O -
. O +

Statistical O +
analysesA O +
minimum O +
of O +
three O +
replicates O +
were O +
undertaken O +
for O +
each O +
experimental O +
condition O -
. O +

Quantified O +
data O +
are O +
presented O +
as O +
means O +
± O +
SE O -
. O +

Significance O +
testing O +
was O +
performed O +
using O +
one O -
- O -
way O +
analysis O +
of O +
variance O +
( O -
anova O -
) O +
to O +
compare O +
data O +
from O +
different O +
experimental O +
groups O -
. O +

P O +
values O +
of O +
< O +
0.05 O +
were O +
considered O +
as O +
statistically O +
significant O -
. O +

